Tender Offer Statement by Issuer (sc To-i)

YOU MUST COMPLETE THE FOLLOWING CERTIFICATE IF YOU

CHECK THE BOX IN PART 4 OF SUBSTITUTE FORM W-9

PAYER’S NAME: American Stock Transfer & Trust Company, LLC

CERTIFICATE OF AWAITING TAXPAYER IDENTIFICATION NUMBER

I certify, under penalties of perjury, that a taxpayer identification number has not been issued to me, and either (a) I have mailed or delivered an application to receive a taxpayer identification number to the appropriate Internal Revenue Service Center or Social Security Administration Office or (b) I intend to mail or deliver an application in the near future. I understand that if I do not provide a taxpayer identification number before payment is made, a portion of such reportable payment will be withheld.

As filed with the Securities and Exchange Commission on October 3, 2014

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

SCHEDULE TO

Tender Offer Statement under Section 14(d)(1) or 13(e)(1)

of the Securities Exchange Act of 1934

RAND WORLDWIDE, INC.

(Name of Subject Company (issuer))

RAND WORLDWIDE, INC.

(Names of Filing Persons (offeror and issuer))

Common Stock, Par Value $0.01 per share

(Title of Class of Securities)

05349Y104

(CUSIP Number of Class of Securities)

(Underlying Common Stock)

Marc L. Dulude

Chief Executive Officer

161 Worcester Road

Suite 401

Framingham, Massachusetts 01701

508-663-1400

(Name, address and telephone number of person authorized to receive notices and communications on behalf of filing person)

Copies to:

James T. Barrett, Esq.

Eugene W. McDermott Jr., Esq.

Edwards Wildman Palmer LLP

111 Huntington Avenue

Boston, MA 02199-7613

Tel: (617) 239-0100

CALCULATION OF FILING FEE


Transaction valuation*		Amount of filing fee**
$33,036,979.20		$3,838.90

**	The transaction value is estimated only for purposes of calculating the filing fee. This amount is based on the offer to purchase not more than in aggregate up to 27,530,816 shares of common stock, par value $0.01 per share, at the tender offer price of $1.20 per share.

*	The Filing Fee is calculated in accordance with Rule 0-11(b) of the Securities Exchange Act of 1934, as amended, and equals $116.20 for each $1,000,000 of the value of the transaction.

¨	Check the box if any part of the fee is offset as provided by Rule 0-11(a)(2) and identify the filing with which the offsetting fee was previously paid. Identify persons filing by registration statement number, or the Form or Schedule and the date of its filing.


Amount Previously Paid: Not Applicable		Filing Party: Not Applicable
Form or Registration No.: Not Applicable		Date Filed: Not Applicable

¨	Check the box if the filing relates solely to preliminary communications made before the commencement of a tender offer.

Check the appropriate boxes below to designate any transactions to which the statement relates:

third-party tender offer subject to Rule 14d-1.

issuer tender offer subject to Rule 13e-4.

going-private transaction subject to Rule 13e-3.

amendment to Schedule 13D under Rule 13d-2.

Check the following box if the filing is a final amendment reporting the results of the tender offer: ¨

If applicable, check the appropriate box(es) below to designate the appropriate rule provision(s) relied upon:

Rule 13e-4(i) (Cross-Border Issuer Tender Offer)

Rule 14d-1(d) (Cross-Border Third Party Tender Offer)

This Tender Offer Statement on Schedule TO (“Schedule TO”) is being filed by Rand Worldwide, Inc., a Delaware corporation (“Rand Worldwide” or the “Company”) pursuant to Rule 13e-4 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), in connection with the Company’s offer to purchase up to 27,530,816 shares of its common stock, par value $0.01 per share, at a purchase price of $1.20 per share, net to the seller in cash, less any applicable withholding taxes and without interest (the “Offer”). The Company’s offer is being made upon the terms and subject to the conditions set forth in the Offer to Purchase, dated October 3, 2014 (“Offer to Purchase”), and in the related Letter of Transmittal (“Letter of Transmittal”) which, as amended or supplemented from time to time, together constitute the Offer. This Schedule is being filed in accordance with Rule 13e-4(c)(2) under the Exchange Act.

All information in the Offer to Purchase and the related Letter of Transmittal is hereby expressly incorporated by reference in answer to all items in this Schedule TO, and as more particularly set forth below.

Item 1.

Summary Term Sheet.

The information set forth in the section of the Offer to Purchase attached hereto as Exhibit 99(a)(1)(i), entitled “Summary Term Sheet,” is incorporated herein by reference.

Item 2.

Subject Company Information.

(a) Name and Address. The name of the issuer is Rand Worldwide, Inc. The address of its principal executive office is 161 Worcester Road, Suite 401, Framingham, MA 01701; and the telephone number of its principal executive office is (508) 663-1400.

(b) Securities. The title of the securities that are the subject of this Tender Offer Statement on Schedule TO is common stock. As of the close of business on September 22, 2014, there were 54,492,296 shares of the Company’s common stock, par value $0.01 per share (“Common Stock”) outstanding. Subject to the conditions set forth in the Offer to Purchase, the Company will purchase up to 27,530,816 shares of Common Stock (the “Shares”) at a purchase price of $1.20 per share (the “Purchase Price”) upon the terms and subject to the conditions set forth in the Offer to Purchase and the related Letter of Transmittal (which together with any amendments or supplements thereto collectively constitute the Offer).

(c) Trading Market and Price. The information set forth in the Offer to Purchase entitled “Price Range of Shares; Dividends” is incorporated herein by reference.

Item 3.

Identity and Background of Filing Person.

(a) Name and Address. The Company is the filing person and the subject company. The information set forth under Item 2(a) above and in the Offer to Purchase under Section 12 (“Interest of Directors, Executive Officers and Principal Stockholders; Transactions and Arrangements Concerning Shares”) and Section 14 (“Certain Information Concerning Rand”), including Appendix A thereto, is incorporated herein by reference.

Item 4.

Terms of the Transaction.

(a) Material Terms. The information set forth in the Offer to Purchase under the “Summary Term Sheet,” Section 5 (“Effects of the Offer”), Section 6 (“Number of Shares; Priority of Purchases; Odd Lots; Proration”), Section 7 (“Procedures for Tendering Shares”), Section 8 (“Withdrawal Rights”), Section 9 (“Purchase of Shares and Payment of Purchase Price”), Section 16 (“United States Federal Income Tax Consequences”), and Section 17 (“Extension of the Offer; Termination; Amendment”) is incorporated herein by reference.

(b) Purchases. The information set forth in the Offer to Purchase under Section 1 (“Purpose and Background of the Offer”), Section 4 (“Our Plans After the Offer”), Section 5 (“Effects of the Offer”), and Section 12 (“Interest of Directors, Executive Officers and Principal Stockholders; Transactions and Arrangements Concerning Shares”) is incorporated herein by reference.

Item 5.

Past Contacts, Transactions, Negotiations and Agreements.

(e) Agreements Involving the Subject Company’s Securities. The information set forth in the Offer to Purchase under the “Summary Term Sheet,” Section 4 (“Our Plans After the Offer”), and Section 12 (“Interest of Directors, Executive Officers and Principal Stockholders; Transactions and Arrangements Concerning Shares”) is incorporated herein by reference.

Item 6.

Purposes of the Transaction and Plans or Proposals.

(a) Purposes. The information set forth in the Offer to Purchase under the “Summary Term Sheet” and Section 1 (“Purpose and Background of the Offer”) is incorporated herein by reference.

(b) Use of Securities Acquired. The information set forth in the Offer to Purchase under Section 5 (“Effects of the Offer”) is incorporated herein by reference.

(c) Plans. The information set forth in the “Summary Term Sheet,” Section 1 (“Purpose and Background of the Offer”), Section 4 (“Our Plans After the Offer”), Section 5 (“Effects of the Offer”), Section 10 (“Conditions of the Offer”), Section 12 (“Interest of Directors, Executive Officers and Principal Stockholders; Transactions and Arrangements Concerning Shares”), and Section 13 (“Source and Amount of Funds”) of the Offer to Purchase is incorporated herein by reference.

Item 7.

Source and Amount of Funds or Other Consideration.

(a) Source of Funds. The information set forth in the Offer to Purchase under the “Summary Term Sheet” and Section 13 (“Source and Amount of Funds”) is incorporated herein by reference.

(b) Conditions. The information set forth in the Offer to Purchase under Item 10 (“Conditions of the Offer”) and Section 13 (“Source and Amount of Funds”) is incorporated herein by reference.

(d) Borrowed Funds. The information set forth in the Offer to Purchase under Section 13 (“Source and Amount of Funds”) is incorporated herein by reference.

Item 8.

Interest in Securities of the Subject Company.

(a) Securities Ownership. The information set forth in the Offer to Purchase under Section 12 (“Interest of Directors, Executive Officers and Principal Stockholders; Transactions and Arrangements Concerning Shares”) is incorporated herein by reference.

(b) Securities Transactions. The information set forth in the Offer to Purchase under Section 12 (“Interest of Directors, Executive Officers and Principal Stockholders; Transactions and Arrangements Concerning Shares”) is incorporated herein by reference.

Item 9. Persons/Assets, Retained, Employed, Compensated or Used.

(a) Solicitations or Recommendations. The information set forth in the Offer to Purchase under Section 18 (“Fees and Expenses”) is incorporated herein by reference.

Item 10. Financial Statements.

(a) Financial Information. The information set forth in the Offer to Purchase under Section 14 (“Certain Information Concerning Rand”) is incorporated herein by reference.

(b) Pro Forma Financial Information. The information set forth in the Offer to Purchase under Section 14 (“Certain Information Concerning Rand”) is incorporated herein by reference.

Item 11. Additional Information.

(a) Agreements, Regulatory Requirements and Legal Proceedings. The information set forth in the Offer to Purchase under Section 4 (“Our Plans After the Offer”) and Section 12 (“Interest of Directors, Executive Officers and Principal Stockholders; Transactions and Arrangements Concerning Shares”) is incorporated herein by reference.

(c) Other Material Information. The entire text of the Offer to Purchase and the related Letter of Transmittal, attached hereto as Exhibit 99(a)(1)(i) and Exhibit 99(a)(1)(ii), respectively, is incorporated herein by reference.

Item 12. Exhibits.


EXHIBIT NO.		DESCRIPTION

(a)(1)(i)		Offer to Purchase, dated October 3, 2014

(a)(1)(ii)		Letter of Transmittal

(a)(1)(iii)		Notice of Guaranteed Delivery

(a)(1)(iv)		Letter to Stockholders

(a)(1)(v)		Letter to Brokers, Dealers, Banks, Trust Companies and Other Nominees

(a)(1)(vi)		Letter to Clients

(a)(5)		Press Release issued by Rand Worldwide, Inc. on October 3, 2014

(b)(1)		Commitment Letter of JPMorgan Chase Bank, National Association, dated September 26, 2014

(c)(1)		Fairness Opinion of Covington Associates, dated September 29, 2014 (incorporated by reference to Annex A to the Offer to Purchase)

(d)(1)		Stock Purchase Agreement by and between RWWI Holdings LLC and 3K Limited Partnership, dated September 26, 2014 (incorporated by reference to Exhibit 99.2 to Amendment No. 1 to Schedule 13D filed on September 29, 2014 by Ampersand 2006 Limited Partnership and the other filing persons named therein)

(d)(2)		Letter to Optionholders

Item 13. Information Required by Schedule 13E-3.

Not applicable.

SIGNATURE

After due inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Dated: October 3, 2014


Rand Worldwide, Inc.

By:		/s/ Marc L. Dulude

Name:		Marc L. Dulude

Title:		Chief Executive Officer

Exhibit (a)(1)(i)

OFFER TO PURCHASE FOR CASH

RAND WORLDWIDE, INC.

UP TO 27,530,816 SHARES OF ITS COMMON STOCK

AT A PURCHASE PRICE OF $1.20 PER SHARE

THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON NOVEMBER 3, 2014, UNLESS THE OFFER IS EXTENDED OR EARLIER TERMINATED.

Rand Worldwide, Inc., a Delaware corporation (the “Company”, “we” or “us”) hereby invites you to tender your shares of our common stock for purchase by us at a price of $1.20 per share in cash, without interest, on the terms and subject to the conditions set forth in this Offer to Purchase and the related Letter of Transmittal (which together, as they may be amended and supplemented from time to time, constitute the “Offer”). Unless the context otherwise requires, all references to shares shall refer to the shares of common stock of the Company, par value $0.01 per share.

We will purchase up to 27,530,816 shares in the Offer. Only shares properly tendered and not properly withdrawn will be purchased. If the number of shares properly tendered is less than 27,530,816, we will purchase all of the shares properly tendered. If the number of shares tendered is more than 27,530,816, we will purchase 27,530,816 shares in the aggregate, on a pro rata basis from all stockholders who tendered shares. We reserve the right, in our sole discretion, to increase the number of shares we purchase by an amount that does not exceed 2% of our outstanding shares.

The Offer will expire at 5:00 p.m., New York City time, on Monday, November 3, 2014, unless extended or earlier terminated. If you want to tender your shares pursuant to the Offer, you must specify the number of shares you want to tender, and follow the instructions in this document and the related documents, including the accompanying Letter of Transmittal.

The Offer is not conditioned on any minimum number of shares being tendered, but is subject to other conditions discussed in this Offer to Purchase, including the Financing Condition (as defined in this document).

Our Board of Directors has approved this Offer. However, neither we nor our Board of Directors, nor the Information Agent or the Depositary, make any recommendation to you as to whether you should tender your shares. You must decide whether to tender your shares and, if so, how many shares to tender.

Our directors and executive officers have advised us that they intend to tender an aggregate of approximately 291,295 shares in the Offer. See Section 12. Further, we have been informed that RWWI Holdings LLC, the holder of approximately 46.3% of our common shares, intends to tender all of the

shares that it holds (subject to proration in the event that the total number of shares tendered in the Offer by all stockholders is greater than 27,530,816). Because of this, and because of the debt financing being used in order to finance the Offer, our capital and ownership structure following completion of the Offer will be materially different from our capital and ownership structure prior to the Offer. See Section 5.

THIS TRANSACTION HAS NOT BEEN APPROVED OR DISAPPROVED BY THE SECURITIES AND EXCHANGE COMMISSION NOR HAS THE COMMISSION PASSED UPON THE FAIRNESS OR MERITS OF SUCH TRANSACTION NOR UPON THE ACCURACY OR ADEQUACY OF THE INFORMATION CONTAINED IN THIS DOCUMENT. ANY REPRESENTATION TO THE CONTRARY IS UNLAWFUL.

Questions about the Offer or requests for assistance may be directed to Georgeson, Inc., the Information Agent for the Offer, at the address and phone number set forth on the back cover page of this Offer to Purchase. Requests for additional copies of this Offer to Purchase, the Letter of Transmittal, the Notice of Guaranteed Delivery or any document incorporated herein by reference may be directed to the Information Agent at the address and phone number set forth on the back cover page of this Offer to Purchase.

This document contains important information about the Offer. We urge you to read it in its entirety.

Offer to Purchase dated October 3, 2014

TABLE OF CONTENTS


			Page

SUMMARY TERM SHEET				1

IMPORTANT PROCEDURES				6

FORWARD-LOOKING STATEMENTS				8

SPECIAL FACTORS				9

	SECTION 1.	PURPOSE AND BACKGROUND OF THE OFFER		9

	SECTION 2.	FAIRNESS OF THE OFFER		13

	SECTION 3.	FAIRNESS OPINION OF FINANCIAL ADVISOR		15

	SECTION 4.	OUR PLANS AFTER THE OFFER		22

	SECTION 5.	EFFECTS OF THE OFFER		24

THE OFFER				26

	SECTION 6.	NUMBER OF SHARES; PRIORITY OF PURCHASES; ODD LOTS; PRORATION		26

	SECTION 7.	PROCEDURES FOR TENDERING SHARES		27

	SECTION 8.	WITHDRAWAL RIGHTS		32

	SECTION 9.	PURCHASE OF SHARES AND PAYMENT OF PURCHASE PRICE		33

	SECTION 10.	CONDITIONS OF THE OFFER		34

	SECTION 11.	PRICE RANGE OF SHARES; DIVIDENDS		36

	SECTION 12.	INTEREST OF DIRECTORS, EXECUTIVE OFFICERS AND PRINCIPAL STOCKHOLDERS; TRANSACTIONS AND ARRANGEMENTS CONCERNING SHARES		36

	SECTION 13.	SOURCE AND AMOUNT OF FUNDS		40

	SECTION 14.	CERTAIN INFORMATION CONCERNING RAND		41

	SECTION 15.	LEGAL MATTERS; REGULATORY APPROVALS		45

	SECTION 16.	UNITED STATES FEDERAL INCOME TAX CONSEQUENCES		45

	SECTION 17.	EXTENSION OF THE OFFER; TERMINATION; AMENDMENT		47

	SECTION 18.	FEES AND EXPENSES		48

	SECTION 19.	MISCELLANEOUS		49

	APPENDIX A – DIRECTORS AND EXECUTIVE OFFICERS OF RAND WORLDWIDE, INC.

	APPENDIX B – FAIRNESS OPINION OF COVINGTON ASSOCIATES

SUMMARY TERM SHEET

We are providing this summary term sheet for your convenience. It highlights material information in this document, but you should realize that it does not describe all of the details of the Offer to the same extent that they are described in the body of this document. We urge you to read the entire document and the related Letter of Transmittal because they contain the full details of the Offer. Where helpful, we have included references to the sections of this document where you will find a more complete discussion. As used in this document, the terms “Rand Worldwide,” “Rand,” “the Company,” “we,” “our” and “us” refer to Rand Worldwide, Inc., a Delaware corporation.

Who is offering to purchase my shares?

•

The issuer of the shares, Rand Worldwide, Inc., is offering to purchase your shares. See Section 6.

How much will the Company pay me for my shares?

•

We are offering to purchase shares of common stock at a price of $1.20 per share. If your shares are purchased in the Offer, we will pay you the purchase price, in cash, without interest, promptly after the expiration of the Offer. See Section 9.

How many shares is the Company offering to purchase?

•

We will purchase up to 27,530,816 shares pursuant to the Offer, or approximately 50.5% of our outstanding common stock. We also reserve the right to increase the number of shares we purchase by an amount that does not exceed 2% of our outstanding shares, subject to applicable legal requirements. See Section 6.

Do I have to sell my shares to the Company?

•

No. This is a voluntary offer. You are not required to tender any shares.

If I tender my shares, how many of my shares will the Company purchase?

•

We may not purchase all of the shares that you tender pursuant to the Offer. If more than 27,530,816 shares are tendered, we will purchase shares from all stockholders who properly tender shares, on a pro rata basis based on the aggregate number of shares tendered. As a result, we will purchase the same percentage of shares from each tendering stockholder who properly tenders shares and does not withdraw them. We will announce final results on any proration promptly after the expiration date. If you hold fewer than 100 shares and tender all of the shares you hold, we will accept your shares first, without proration. See Section 6.

What is the market value of my shares as of a recent date?

•

On September 26, 2014, the last trading day prior to our announcement of our intention to commence the Offer, the closing price per share of our common stock, as quoted on the OTCQB, was $1.15. The purchase price in the Offer is thus approximately 4.3% above the stock’s closing price as of that date. We urge you to obtain a current market quotation for your shares before deciding whether to tender your shares. See Section 11.

What is the purpose of the Offer?

•

We believe that the purchase of our shares is consistent with our long-term goal of maximizing stockholder value. See Section 1.

•

We are making the Offer to provide all stockholders an opportunity for liquidity in our common stock, which is not heavily traded.

•

Our largest stockholder, RWWI Holdings LLC, which is majority-owned by funds affiliated with Ampersand Capital Partners, has indicated its intention to seek an exit from its investment. Accordingly, we are also making the Offer to facilitate the exit of RWWI Holdings LLC from our common stock, while making the same opportunity available to unaffiliated stockholders, without the potential disruption to the market price of the common stock that would likely result from market sales.

•

The Offer may give all of our stockholders the opportunity to sell their shares at a premium to the currently prevailing and historical market prices for the shares, in a short period of time, which would not be possible through an open market repurchase program.

Will the Company remain a public company after the completion of the Offer?

•

We have fewer than 300 stockholders of record prior to the commencement of the Offer, and therefore we are eligible to terminate the registration of our common stock under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), which would terminate our requirement to file financial reports, proxy statements and other items with the Securities and Exchange Commission (the “SEC”). As of September 22, 2014, we had 280 stockholders of record of our common stock.

•

We nevertheless currently intend to remain a reporting company after the completion of the Offer and expect that our common stock will continue to be quoted on the OTCQB tier of OTC Markets Group Inc., although we cannot guarantee that we will remain a reporting company or predict the liquidity of the market which will thereafter exist for our common stock. As a result of the lower number of shares outstanding that will exist following the Offer, it may become more difficult for our remaining stockholders to sell their shares.

Who will be the majority stockholder after the completion of the Offer?

•

RWWI Holdings LLC, which is majority-owned by funds affiliated with Ampersand Capital Partners, currently owns 25,232,682 shares, or approximately 46.3%, of our outstanding common stock and has indicated its intention to tender all of its common shares in the Offer, subject to the proration procedures for the Offer. RWWI Holdings LLC held a majority of our common stock until September 26, 2014, when it sold 9,000,000 shares to an affiliate of 3K Limited Partnership (described below) at a purchase price of $1.20 per share. See Section 12 for a description of the Purchase Agreement.

•

3K Limited Partnership (“3K”), which together with its affiliates holds approximately 30.9% of Rand’s common stock, has indicated that they do not intend to tender shares in the Offer. After giving effect to the Offer and the reduction in shares outstanding, 3K and its affiliates will hold approximately 62.5% of Rand’s common stock (assuming that the maximum 27,530,816 shares are tendered in the Offer and purchased by us).

•

See Section 4, “Our Plans After the Offer,” for a description of anticipated changes to our Board of Directors and management team following the completion of the Offer.

How will the Company pay for the shares?

•

Assuming that the maximum 27,530,816 shares are tendered in the Offer, the aggregate purchase price will be approximately $33.0 million. We plan to pay for the shares tendered in the Offer and purchased by us with (a) cash on hand of approximately $9.5 million and (b) borrowings under a new debt facility to be entered into with JP Morgan Chase Bank National Association (“JPMCB” or the “Bank”). We expect to incur approximately $25 million in additional indebtedness under a

new term loan as a result of the financing arrangements pursuant to the Offer, and we will also enter into a new $10 million revolving credit facility. The Offer is subject to the Financing Condition, meaning that if we are unable to obtain financing in an amount sufficient to fund the share purchases in the Offer, we will not be required to close the Offer. We received a commitment letter from JPMCB relating to the new facility on September 26, 2014. See Sections 10 and 13.

Are there any conditions to the Offer?

•

Yes. Our obligation to accept for payment and pay for your tendered shares depends on a number of conditions that must be satisfied in our reasonable judgment or waived by us, on or prior to the expiration of the Offer. Such conditions include, but are not limited to the consummation of certain debt financing transactions, resulting in aggregate proceeds to us that are sufficient to fund our purchase of shares in the Offer (the “Financing Condition”). We expect to obtain this financing on the terms outlined in JPMCB’s commitment letter.

•

These and other conditions, including a minimum consolidated adjusted EBITDA condition for the twelve months ended August 30, 2014, are described in greater detail in Section 10. The Offer is not conditioned on our stockholders tendering any minimum number of shares.

How long do I have to decide whether to tender my shares pursuant to the Offer?

•

You may tender your shares until the Offer expires. Currently, the Offer is scheduled to expire at 5:00 p.m., New York City time, on Monday, November 3, 2014. If your shares are held by a nominee or broker, they will likely have an earlier deadline for accepting the Offer.

Can the Company extend the Offer past the initial expiration date or amend the terms of the Offer?

•

We can extend the Offer past the scheduled expiration date in our sole discretion. If we choose to do so, you will be able to tender your shares until the end of the day selected as the new expiration date. We reserve the right in our sole discretion to amend the Offer in any respect. See Sections 1 and 17.

How will I know if the Company extends the Offer or amends the terms of the Offer?

•

We will announce any amendment to the Offer by making a public announcement of the amendment. We will issue a press release announcing any extension of the Offer no later than 9:00 a.m., New York City time, on the next business day after the last previously scheduled or announced expiration date. In the event of an extension, termination or postponement of the Offer, we will also give written or oral notice to the Depositary and the Information Agent. See Section 17.

How do I tender my shares?

•

You must complete one of the actions described under the section entitled “Important Procedures” in this document before the Offer expires. You may also contact the Depositary or your broker for assistance. The contact information for the Depositary is on the back page of this document. For a more detailed explanation of the tendering procedures, see Section 7.

How and when will I be paid?

•

If your shares are purchased pursuant to the Offer, you will be paid the purchase price, in cash, without interest, promptly after the expiration of the Offer period and the acceptance of the shares for payment.

•

We will pay for the shares accepted for payment by depositing the aggregate purchase price with the Depositary promptly after the expiration date of the Offer. The Depositary will act as your agent and will transmit to you or you broker the payment for all of your shares accepted for payment. See Section 9.

What do I have to do if I have lost my stock certificates, or if they have been mutilated, destroyed or stolen, but I still want to tender them?

•

Call the Depositary at (877) 248-6417 for instructions on how to tender shares in such circumstances.

Can I withdraw my previously tendered shares?

•

You can withdraw your previously tendered shares at any time prior to 5:00 p.m., New York City time, on Monday, November 3, 2014, or such later time and date to which we may extend the Offer. In addition, if we have not accepted for payment the shares you have tendered to us, you may withdraw your shares at any time after 12:00 midnight, New York City time on December 2, 2014. See Section 8.

How do I withdraw my previously tendered shares?

•

To withdraw your previously tendered shares, you must deliver a written or facsimile notice of withdrawal with the required information to the Depositary while you still have the right to withdraw. If you have tendered by giving instructions to a broker or a bank, you must instruct the broker or bank to arrange for withdrawal of your shares. See Section 8.

What are the United States federal tax consequences if I tender my shares to the Company?

•

If you are a U.S. Holder (as defined in Section 16), the receipt of cash for your tendered shares generally will be treated for United States federal income tax purposes either as (a) a sale or exchange eligible for capital gain or loss treatment, or (b) a dividend. See Section 16. If you are a Non-U.S. Holder (as defined in Section 16), the payment of cash for your tendered shares may be subject to United States federal income tax withholding. See Section 7.

Will I have to pay brokerage commissions or stock transfer taxes if I tender my shares to the Company?

•

If you are a registered stockholder and tender your shares directly to the Depositary, you will not have to pay any brokerage commissions. If you hold shares through a broker or bank, however, you should ask your broker or bank if you will be charged a fee to tender your shares. See Section 7.

•

If you instruct the Depositary in the Letter of Transmittal to make payment for the shares to the registered holder of your shares, you will not incur any stock transfer tax. See Section 7.

If I own fewer than 100 shares and I tender all of my shares, will I be subject to proration?

•

If you own beneficially or of record fewer than 100 shares, tender all of such shares before the Offer expires, and complete the section entitled “Odd Lots” in the Letter of Transmittal and, if applicable, the Notice of Guaranteed Delivery, we will purchase all of your shares without subjecting them to the proration procedure.

What does the Board of Directors of the Company think of the Offer?

•

Our Board of Directors has unanimously approved the Offer and found it to be fair to the Company and its unaffiliated stockholders. See Section 2. However, none of our Board of

Directors, the Depositary, the Information Agent, JPMCB or Rand is making any recommendation to you as to whether you should tender your shares. We are not making a recommendation as to whether you should tender shares pursuant to the Offer because we believe that you should make your own decision based on your views as to the value of our common stock and our prospects, as well as your liquidity needs, investment objectives, and other individual considerations. You must decide whether to tender your shares and, if so, how many shares to tender. You should discuss whether to tender your shares with your broker or other financial or tax advisor.

•

Some of our directors and executive officers have informed us that they intend to tender an estimated 291,295 shares, in the aggregate in the Offer. These are shares estimated to be received upon net settlement of 1,154,400 outstanding stock options upon the exercise of those options. See Section 12. These directors and executive officers have advised us that they are tendering shares to obtain liquidity or for tax planning or asset diversification purposes. Their tender of shares is not intended to be a reflection of their views of the Company or its short or long-term prospects. They will not receive any preferential treatment in the event we need to prorate the shares tendered. See Sections 1, 6, and 12.

•

In addition, our largest stockholder, RWWI Holdings LLC, which currently holds approximately 46.3% of our common stock, has indicated its intention to tender all of its common shares in the Offer, subject to the proration procedures for the Offer. 3K, which has indicated that it will not tender shares in the Offer and which currently holds (together with its affiliates) approximately 30.9% of our common stock, has substantially increased its ownership position in Rand by buying, through an affiliate, 9 million shares of our common stock from RWWI Holdings LLC, at the same price being offered to stockholders in the Offer, on September 26, 2014. Giving effect to the reduction in our outstanding shares as a result of the Offer (assuming the maximum 27,530,816 shares are tendered in the Offer and purchased by us), we estimate that 3K will increase its ownership to approximately 62.5% of our common stock. See Sections 1, 4, 5 and 12.

Did the Board of Directors receive any fairness opinions or similar reports regarding the fairness of the Offer?

•

Yes. Covington Associates (“Covington”), the Company’s financial advisor, delivered an opinion to the Board of Directors that the consideration to be received in the Offer is fair, from a financial point of view, to our unaffiliated stockholders. A copy of Covington’s opinion is attached to this document as Appendix B and should be read in its entirety by each stockholder. For a description of the information presented by Covington, see Section 3. In addition, the Board of Directors also received a report on the solvency of the Company, under Delaware law, giving effect to the financing arrangements contemplated in the Offer and the effect of the Offer on our capital and surplus, prior to approving the Offer.

How will stock options be treated?

•

If you hold vested but unexercised stock options, you may exercise such options in accordance with the terms of our policies and procedures under our equity compensation plan and your awards, and tender the shares received upon such exercise in accordance with this Offer. An exercise of a stock option cannot be revoked for any reason even if shares received upon the exercise thereof and tendered in the Offer are not purchased in the Offer for any reason. See Section 7. You should evaluate this Offer carefully to determine if participation would be advantageous to you, based on your stock option exercise prices, the date of your stock option grants, the years left to exercise your stock options and the provisions for pro rata purchases by the Company described in Section 6. We encourage you to discuss the Offer with your financial or tax advisor or broker, if any.

•

In light of the limited liquidity in our stock, and with the intent to permit holders of Company stock options to benefit from the liquidity opportunity that the Offer provides to those who wish to participate, our Board of Directors has determined to accelerate, upon the commencement of the Offer, the vesting of all unvested stock options granted under the Company’s stock option or omnibus equity compensation plans. This will permit optionholders, including holders of unvested options, if they so wish, to exercise their options and participate in the Offer on the same terms as other stockholders. Our Board of Directors has agreed, as permitted under the applicable plans, to allow for the “net settlement” of stock options for those holders of Company stock options who wish to participate in the Offer. See Section 12.

•

Based on its inquiry, the Company believes that its executive officers and directors intend to exercise an aggregate of approximately 1,154,400 options, with a weighted average exercise price of $0.796 per share, in order to tender the 291,295 underlying shares in the aggregate expected to be received upon net settlement of such options in the Offer.

How will the Company’s preferred stock be treated?

•

As of the date of this Offer to Purchase, there are two series of the Company’s convertible preferred stock outstanding: 384,495 shares of the Company’s Series D Convertible Preferred Stock and 862 shares of the Company’s Series E Convertible Preferred Stock. Each share of Series D Convertible Preferred Stock is currently convertible into two shares of the Company’s common stock (768,990 shares of common stock in the aggregate), and each share of Series E Convertible Preferred Stock is currently convertible into 1,538.5 shares of the Company’s common stock (1,326,187 shares of common stock in the aggregate). We are not offering to purchase these shares of preferred stock. Holders of these preferred shares can participate in the Offer by exercising their right to convert such preferred shares into common stock and then tendering those shares of common stock in the Offer.

Whom can I talk to if I have questions about the Offer?

•

The Depositary can help answer your questions regarding the procedures for tendering your shares, including how to complete the enclosed forms. The Depositary is American Stock Transfer & Trust Company, LLC. Its contact information appears on the back cover of this document. You may also contact the Information Agent for more information about Rand or the Offer. The Information Agent is Georgeson, Inc. Its contact information appears on the back cover of this document.

IMPORTANT PROCEDURES

If you want to tender all or part of your shares, you must do one of the following before the Offer expires:

•

if your shares are registered in the name of a broker, dealer, commercial bank, trust company or other nominee, contact the nominee and instruct the nominee to tender your shares for you, or

•

if you hold certificates in your own name, properly complete and sign a Letter of Transmittal according to its instructions, and deliver it, together with any required signature guarantees, the certificates for your shares and any other documents required by the Letter of Transmittal, to American Stock Transfer & Trust Company, LLC, the Depositary for the Offer, at the address appearing on the back cover of this document, or

•

if you are an institution participating in The Depositary Trust Company, which we call the “Book-Entry Transfer Facility” in this document, tender your shares according to the procedure for book-entry transfer described in Section 7, or

•

if you are a holder of stock options to purchase shares under the Company’s stock option or omnibus equity compensation plans, you may exercise your stock options and tender any of the shares issued upon exercise in accordance with the Company’s policies and procedures for the applicable equity plan, subject to the optional provisions for net settlement described in Section 12, or

•

holders of the Company’s Series D Convertible Preferred Stock and Series E Convertible Preferred Stock can participate in the Offer by exercising their right to convert such preferred shares into common stock and then tendering those shares of common stock in the Offer.

If you want to tender your shares but (a) the certificates for your shares are not immediately available or cannot be delivered to the Depositary by the Expiration Date, (b) you cannot comply with the procedure for book-entry transfer by the Expiration Date, or (c) your other required documents cannot be delivered to the Depositary by the Expiration Date, you may still tender your shares if you comply with the guaranteed delivery procedure described in Section 7 of this Offer to Purchase.

To tender your shares properly, you must follow the procedures described in this document, the Letter of Transmittal and the other documents related to the Offer.

If you have questions or need assistance, you should contact the Depositary regarding the procedures for tendering your shares, including how to complete the enclosed forms, or the Information Agent regarding Rand or the Offer at their respective address or telephone number on the back cover of this document. You may also request additional copies of this document and the Letter of Transmittal or the Notice of Guaranteed Delivery from the Information Agent.

We have not authorized any person to make any recommendation on our behalf as to whether you should tender shares in the Offer. We have not authorized any person to give any information or to make any representation on our behalf in connection with the Offer other than those contained in this document or in the related Letter of Transmittal. If any such recommendation, information or representation is given or made, it must not be relied upon as having been authorized by us, the Information Agent or the Depositary.

FORWARD-LOOKING STATEMENTS

This document contains a number of forward-looking statements, including, among others, statements dealing with the benefits that the Offer may provide to our stockholders, the fulfillment of conditions to the Offer (including the financing of the Offer), the date on which we will announce the final proration factor or pay for tendered shares, our possession of sufficient capital to fund our operations, prospects for our business, the repurchase of additional shares in the future, the fees and expenses we will incur in connection with the Offer, and the quotation and tradability of our stock after the Offer is completed. The forward-looking statements regarding these matters are made by us based on various assumptions and analyses made by us in light of our management’s experience and our perception of historical trends, current conditions and expected future developments, as well as other factors we believe are appropriate under the circumstances.

Forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties and other factors (many of which are beyond our control) that could cause actual results to differ materially from future results expressed or implied by such forward-looking statements. The words “anticipate,” “believe,” “could,” “estimate,” “expect,” “intend,” “may,” “outlook,” “plan,” “potential,” “predict,” “project,” “should,” “will,” “would” and similar terms and phrases, including references to assumptions, are intended to identify forward-looking statements.

Forward-looking statements made in connection with the Offer do not fall within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We caution readers that the important factors set forth below, as well as factors discussed in other documents filed by us with the SEC, among others, could cause our actual results to differ materially from those expected or anticipated in the forward-looking statements contained in this document.

Important factors that could cause actual results to differ materially from those implicit in forward-looking statements include, without limitation, the following:

•

the timing and occurrence or non-occurrence of events, including the conditions to the Offer, may be subject to circumstances beyond our control;

•

the financial covenants of our credit arrangements, including the debt being incurred in connection with the financing of the Offer, will restrict our ability to borrow additional funds and pay dividends and may adversely affect our capital resources, financial condition and liquidity;

•

changes in accounting principles, policies or guidelines may cause our financial condition to be perceived differently;

•

general economic conditions, either nationally or locally in some or all areas in which we do business, or conditions in the securities markets or the value added reseller industry may be less favorable than we currently anticipate;

•

legislation or regulatory changes may adversely affect our business;

•

technological changes may be more difficult or expensive than we anticipate; or

•

success or consummation of new business initiatives may be more difficult or expensive than we anticipate.

The list of factors above is illustrative, but by no means exhaustive. All forward-looking statements should be evaluated with the understanding of their inherent uncertainty. All subsequent written and oral forward-looking statements concerning the Offer or other matters addressed in this document and attributable to us or any person acting on our behalf are qualified by these cautionary statements. We do not undertake any obligation to release publicly any revisions to such forward-looking statements to reflect events or circumstances after the date of this document or to reflect the occurrence of unanticipated events.

SPECIAL FACTORS

SECTION 1. PURPOSE AND BACKGROUND OF THE OFFER.

Purpose of the Offer

We are making this Offer to enable you to decide whether you desire to continue your investment in the Company or whether you desire to obtain current value for your shares. The purposes of the Offer include:

•

We believe that the purchase of our shares is consistent with our long-term goal of maximizing stockholder value.

•

We are making the Offer to provide all stockholders an opportunity for liquidity in our stock, which is not heavily traded.

•

Following discussions between the Company and certain other parties relating to the potential acquisition of the Company in early 2014, our largest stockholder, RWWI Holdings LLC, which is majority-owned by funds affiliated with Ampersand Capital Partners, has indicated its desire to seek an exit from its investment on the condition that a similar opportunity for liquidity could be made available to other stockholders. Accordingly, we are also making the Offer to facilitate the exit of RWWI Holdings LLC from our common stock, while making the same opportunity available to unaffiliated stockholders, without the potential disruption to the market price of the common stock that would likely result from market sales.

•

The offer will give the Company’s stockholders the opportunity to sell some or all of their shares at a premium to the currently prevailing market prices for the shares, in a short period of time, which would not be possible through an open market repurchase program.

Managing the Company’s Capital. We believe that the purchase of our shares is an attractive use of a portion of our capital resources (including the availability of debt financing) on behalf of our stockholders and is consistent with our long-term goal of increasing stockholder value. Among other things, we believe that the anticipated borrowings we will incur to finance the Offer will result in a more efficient capital structure that more effectively uses financial leverage, thus making possible improved future earnings per share for our continuing stockholders. The effect of the Offer will be to increase our return on equity, a key indicator of financial performance. We believe that the beneficial impact on return on equity makes an investment in our common stock a better use of our capital than other investment opportunities available to us at this time, given current market and economic conditions.

Providing Liquidity. We believe that the Offer represents an efficient mechanism to provide the Company’s stockholders with the opportunity to tender all or a portion of their shares of common stock for purchase by us, and thereby receive a return of some or all of their investment if they so elect. The purpose of the Offer is ultimately to provide stockholders with an opportunity for liquidity for their shares of our common stock, without the disruption to the share price and the usual transaction costs that are typically associated with market sales, especially of thinly traded companies.

Further information on the alternatives to the Offer that were considered by the Company’s Board of Directors is presented below under “Background of the Offer.”

Certain Disclosures

The rules of the SEC require certain additional disclosure relating, primarily, to the fairness of a proposed transaction when a company or its affiliates purchase the company’s equity securities in a transaction that has either a reasonable likelihood or a purpose of having certain effects, including having the effect of causing any class of the company’s equity securities to become eligible for termination of registration under the Exchange Act, or the effect of causing the reporting obligations with respect to such class to become eligible for termination under applicable SEC rules. These transactions are referred to as “going private” transactions under Rule 13e-3 under the Exchange Act, or “Rule 13e-3 transactions.”

Rand does not believe that the Offer qualifies as a Rule 13e-3 transaction. The Company currently has fewer than 300 stockholders of record, as calculated under Rule 12g5-1 under the Exchange Act, meaning the Company is already eligible to terminate the registration of its common stock under the Exchange Act. Consequently, under applicable interpretations of the staff of the SEC, the Offer would not be deemed to cause the common stock to become eligible for termination of registration, even if it were to decrease the number of stockholders of record.

However, as part of its review and approval of the Offer, the Board of Directors considered many of the factors to which Rule 13e-3 disclosure requirements are addressed. In light of the substantial effect that the Offer (together with the recent sale of shares from our then-majority stockholder to 3K) is expected to have on the Company’s stockholder base and capitalization, we are voluntarily providing certain additional disclosure, primarily relating to our conclusions regarding the fairness of the Offer to stockholders. However, you should be aware that not all of the disclosure that would be required in a Rule 13e-3 transaction are presented in this Offer to Purchase.

Background of the Offer

As part of its ongoing oversight and management of our business, our Board of Directors and senior management have regularly reviewed and discussed our performance, risks, long-term goals, prospects, market capitalization, liquidity and overall strategic direction. In the course of these discussions and in light of economic, competitive and other conditions, the Board of Directors and senior management have evaluated various strategic alternatives to enhance stockholder value. These discussions from time to time focused on a potential sale or recapitalization or other means of offering liquidity to stockholders. However, since the Company’s reverse merger with Avatech Solutions, Inc. in August 2010, no specific transactions were pursued until the events described below.

In January 2014, based on the factors above, and specifically on the strong performance of our IMAGINiT business and the positioning of our Rand Secure Data business for profitability, our Board of Directors requested that director Charles Yie lead the process of selecting a financial advisor to explore the possibility of a strategic transaction involving the Company. After a discussion regarding a range of financial advisors, the Board selected five firms with which to enter into non-disclosure agreements and ask for proposals. Three firms returned proposals. After reviewing the terms of each proposal and the experience of each firm, the Board engaged Covington Associates, LLC (“Covington”) as its financial advisor on February 13, 2014. The Board selected Covington on the basis of its qualifications, experience and reputation in mergers and acquisitions and similar strategic transactions. The Board then continued discussions with Covington with respect to investigating potential strategic transactions.

In considering how best to present the Company’s business to potential strategic partners or buyers, and following discussions between and among Covington, senior management and the Board of Directors, the Board decided to present for potential sale two distinct businesses that were part of Rand: the core Rand business (“Rand Core”), which represented the majority of our business as the value-added reseller of Autodesk and other software and services; and Rand Secure Data (“Rand SD”), which sells data governance and archiving software solutions and which represented a small proportion of revenue compared to the core business. In making this distinction, some Board members considered that Rand SD was a non-core, non-complementary business in the data security market that had occupied management time and resources that might better be focused on growing the Rand Core business.

These discussions marked the beginning of a process, outlined in more detail below, commencing April 13, 2014 and extending through the week of August 11, 2014, during which Covington, working with management and the Board of Directors, identified and contacted 41 potential strategic buyers and 62 potential financial buyers in connection with a possible strategic transaction involving the Company. Of the potential strategic buyers, 19 parties were identified as potential logical buyers of either Rand Core alone or both Rand

Core and Rand SD, and an additional 22 were identified as potential logical buyers of Rand SD as a standalone business. All of these parties were contacted, starting in April 2014, with a high-level description of the business and purchase opportunity being sent to 17 of them. Of these parties, eleven ultimately signed confidentiality agreements with us, and a detailed confidential information presentation (“CIP”) was sent to eight parties.

Of the 62 potential financial buyers identified as being likely to be interested, 30 received the Company’s high-level business description, signed confidentiality agreements and received the CIP, starting in late April 2014.

Over the course of April and May 2014, Covington engaged in numerous discussions with the potential buyers in order to provide further details about us and to gauge interest in pursuing a transaction. In mid-May, following consultation with our management and Board of Directors, Covington requested indications of interest the week of June 2, 2014, and sent bid process letters to all interested parties (approximately 21 potential buyers), together with updated information based upon our third quarter 2014 earnings report.

Ultimately, none of the prospective strategic buyers with which there had been discussions submitted an indication of interest. One private equity firm submitted an indication of interest to acquire all of Rand, proposing a combination of debt and equity as consideration. Discussions continued with this private equity firm through the week of June 30, 2014, when the firm indicated that it no longer wished to pursue a transaction, citing complications stemming from our public company status and our Autodesk concentration as reasons. Another private equity firm submitted an indication of interest to purchase Rand SD alone. Discussions with this firm continued through September 24, 2014, when the sale of Rand SD to that firm was completed for a purchase price of $500,000.

At the same time, during the week of June 2, 2014, Peter Kamin, a director of the Company and the managing partner of 3K Limited Partnership, contacted board member Richard Charpie to discuss a possible interest in pursuing a strategic transaction. Until this point, 3K had not been active in the process. Covington was put in touch with 3K to help evaluate its interest. Following 3K’s expression of interest, directors Peter Kamin and Lawrence Rychlak did not participate in any Board deliberations regarding a potential strategic transaction. Mr. Rychlak’s exclusion from these discussions was because of a presumed employment relationship with the Company following any transaction in which 3K obtained control of the Company.

3K had initially indicated an interest in acquiring a controlling stake in the Company from RWWI Holdings LLC, our majority stockholder at the time and an affiliate of Ampersand Capital Partners. After an analysis of financing and other requirements, its proposal evolved into one involving a combination of a direct investment in our shares and a borrowing by us to redeem all or part of the shares of RWWI Holdings LLC. In discussions between 3K and Ampersand, Ampersand expressed its willingness to explore a transaction that would lead to its exit from its ownership of stock of the Company provided that, if the Company would be borrowing funds to help fund the transaction, our public stockholders would have an opportunity for liquidity at the same time. Over the next several months, discussions continued among 3K, Ampersand, Covington and us relating to potential structures that would accomplish the exit of Ampersand from its majority position in our stock, the extension of similar liquidity opportunity to our public stockholders, and the acquisition by 3K of a controlling interest in us.

During these discussions, a number of transaction structures were considered, including a purchase of shares by 3K directly from RWWI Holdings LLC, a redemption of RWWI Holdings LLC’s shares by the Company, an investment by 3K into our common stock directly in order to fund a portion of a self-tender offer, a joint offer by 3K and us, and other alternatives. 3K had initially indicated a willingness to purchase up to 9 million shares at a price of $1.15 per share, which it agreed to increase to $1.20 on August 19, 2014 on the basis of improved performance of Rand Core. 3K also had initially proposed that all preferred stock be redeemed by the Company prior to any purchase of shares by 3K, but agreed on that same date not to insist on the redemption of the preferred stock. In discussing a potential tender offer, 3K had also proposed to repurchase all

of the shares that RWWI Holdings LLC may be unable to sell in a tender offer due to pro rata acceptance procedures or for any other reason, in order to guarantee a full exit by Ampersand and RWWI Holdings LLC from our common stock. Both the Special Committee and Ampersand rejected this guaranteed exit proposal due to its preferential treatment of the majority stockholder, and 3K agreed to drop the proposal. However, like other participants in the early strategic discussions, 3K indicated that it would be willing to purchase shares only on the condition that Rand SD be divested, and only if it could obtain a majority position in our common stock. Throughout, 3K also indicated its intention that we would remain a reporting company following any transaction.

Throughout the process we and Covington also revisited a number of other potential private equity partners in an effort to re-engage them in the process. However, efforts to re-engage additional potential buyers were unsuccessful.

On July 27, 2014, the Board of Directors formally designated the Special Committee, consisting of Messrs. Charpie, Dulude, Parpia and Yie, with full power and authority to establish a process for the evaluation and negotiation of strategic proposals, to evaluate and negotiate the terms of any definitive agreements, to make recommendations to the Board of Directors in connection with such transactions to the extent it deemed necessary or appropriate, and to engage advisors.

On August 20, 2014, the Special Committee convened to evaluate the transaction as it had progressed to that time. Members of the Special Committee reviewed the process to date: how we had engaged Covington to explore a sale process in February 2014, and how Covington had performed what the Special Committee believed to be a robust market test, resulting in the submission of strategic proposals from third parties. They noted that a transaction involving a 3K purchase of our shares and an issuer tender offer, as insisted upon by Ampersand because of the use of funds from Company borrowings, was modeled on the most favorable third-party proposal received, with the distinction that under the proposal being considered, each of our stockholders would have the benefit of a choice of either selling and achieving liquidity, or retaining its equity position in us. They discussed the benefits of the transaction due to 3K’s familiarity with the Company, such as ease of due diligence, lower costs, expedited completion, and an overall higher degree of closing certainty. The members of the Special Committee also noted that the Company would incur debt in any contemplated recapitalization scenario and considered the Company’s ability to support such leverage, including the Company’s ongoing solvency and adequacy of capital.

A representative of Covington explained that a leveraged repurchase of shares by Rand in connection with the transaction would result in a positive effect on earnings per share, due to the reduced number of outstanding shares. He further explained that the proposed transaction would have a moderate effect on the concentration of ownership of our shares, our public float, and the liquidity of our shares (noting that our shares are currently relatively illiquid). The Special Committee then unanimously determined to continue to pursue a transaction involving a purchase of shares by 3K and an issuer tender offer as expeditiously as possible.

Over the course of discussions in September 2014, 3K and its legal counsel reiterated their willingness to pursue a transaction, but expressed an unwillingness for 3K to be involved in a tender offer directly as a bidder. Following further discussions, the parties determined to focus on pursuing a direct sale of a portion of RWWI Holdings LLC’s shares to 3K, and a debt-funded issuer tender offer by us in order to give all stockholders (including RWWI Holdings LLC with respect to its remaining shares) an opportunity for liquidity.

Throughout the process, we were in contact with numerous lenders relating to the financing of a share repurchase. Several different lenders were identified and approached by the Company and members of its Board of Directors, including JP Morgan Chase Bank, National Association (“JPMCB”) which was initially identified by 3K. Following detailed discussions with three banks, which were led by our management and Ampersand, and the review of non-binding term sheets from each, the Company determined that JPMCB offered the most favorable terms to the Company. Following further discussions, the Company received a commitment letter from JPMCB on September 26, 2014.

During the week of September 22, 2014, Ampersand and 3K negotiated a Purchase Agreement between the parties with respect to the sale by RWWI Holdings LLC of 9 million shares of our common stock to an affiliate of 3K. The Purchase Agreement was executed on September 26, 2014, at which time 9 million shares were sold by RWWI Holdings LLC to an affiliate of 3K for $1.20 per share. 3K will have the right to require RWWI Holdings LLC to repurchase the shares if this Offer is not commenced by October 10, 2014, or if the Offer is not completed by November 15, 2014, among other conditions. See Section 12. On September 29, 2014, the Special Committee met to discuss various aspects of the Offer, including the pricing, terms, and conditions to the Offer (including the Financing Condition). The Special Committee reviewed the terms of the debt commitment letter received on September 26, 2014. A representative of Edwards Wildman Palmer LLP, our legal counsel, reviewed again the Board’s fiduciary duties in the context of the proposed Offer, including the requirements relating to the repurchase of shares by the Company. A representative of Covington reviewed its financial analysis with the Special Committee and, following discussion by the Committee, delivered an oral opinion, which was subsequently confirmed in writing, that the Offer was fair from a financial point of view to the stockholders participating in the Offer. Factors considered by the Board in concluding that the Offer is fair to our stockholders, are summarized in Section 2 below. The Special Committee also received an opinion from an independent valuation firm relating to our solvency following the Offer and related transactions, and satisfied itself based on that report and its own inquiry that the transactions being considered would not impair our capital under Delaware law, and that otherwise we would have adequate capital to fund our ongoing operations for the foreseeable future. The Special Committee unanimously recommended, and the Board then unanimously approved, the commencement of the Offer.

SECTION 2. FAIRNESS OF THE OFFER.

On September 29, 2014, our Board of Directors, acting on the recommendation of its Special Committee, approved the Offer as fair and in the best interests of the Company and its unaffiliated stockholders.

The Board of Directors took into account a number of factors, including the following, in support of its determination that the Offer is substantively fair and in the best interest of the Company and its unaffiliated stockholders:

•

The opinion delivered to the Board of Directors by Covington that the consideration to be received by stockholders tendering their shares in the Offer is fair, from a financial point of view, to our unaffiliated stockholders, and the oral and written presentations of Covington supporting this opinion. A copy of Covington’s opinion is attached to this document as Appendix B and should be read in its entirety by each stockholder. For a description of the information presented by Covington to us, see Section 3.

•

The limited trading market for our common stock, including limited liquidity and trading volume.

•

The offer price of $1.20 per share, which represents a 4.3% premium over our stock’s closing price on September 26, 2014, is believed to be fair and equitable consideration for stockholders tendering their shares, as discussed below.

•

Our financial condition and results of operations, including our earnings per share and capital levels for the years ended June 30, 2013 and 2014.

•

The percentage by which the per share price to be paid in the Offer exceeds recent trading prices and estimated trading values of our common stock. See Sections 3 and 11.

•

The likelihood that the transaction will be consummated.

•

The fact that the Offer is a voluntary transaction in which our stockholders may or may not participate. Stockholders are not required to tender their shares.

•

The fact that our stockholders would be able to participate in the Offer by selling a portion of their shares and have the opportunity to participate in any future growth following consummation of the Offer by retaining a portion of their shares.

•

The fact that stockholders who tender their shares directly to us will avoid the usual transaction costs that would otherwise be incurred if the shares were sold in open market transactions, and the fact that the sale of shares in the Offer will avoid the market disruption that could be expected to result from a sale of shares in an illiquid market.

•

The fact that the reduction in shares resulting from the Offer will increase the relative percentage ownership in us of those stockholders who retain shares after the Offer.

The Board weighed these factors against the fact that tendering stockholders will no longer benefit from any future earnings and growth in the Company or our common stock with respect to shares tendered and purchased in the Offer. In addition, in considering the Offer, the Board took into account the expected financial effects of the Offer and the transactions contemplated by the Offer, including the increased indebtedness described in Section 13.

In evaluating the effects of the Offer and the related transactions on us, including the fairness of the Offer to stockholders who elect to remain our stockholders following the Offer (or who tender all of their shares but who remain our stockholders due to the proration procedures of the Offer), the Board believes that the anticipated borrowings used to finance the Offer will result in a more efficient capital structure, making possible improved future earnings per share for the Company’s continuing stockholders through the use of leverage. We believe we have adequate cash generating capacity, including sources of capital and cash from operations, to both complete the share repurchase and continue with our regular pursuit of business opportunities. The effect of the Offer will be to increase our return on equity, a key indicator of financial performance. The Board of Directors considered the effect of the repurchase of shares on our solvency, as required by Delaware law, and satisfied itself (after reviewing a report by an independent valuation firm) that our capital would not be impaired by the completion of the Offer. In particular, the Board concluded that after the Offering, (i) our assets, at fair valuation, would exceed our debts; (ii) we should be able to pay our debts as they come due; (iii) we will not have an unreasonably small amount of assets (or capital) for the business in which we are engaged; and (iv) the present fair saleable value of our assets is more than the sum of our capital, as determined under Delaware law, and the our liabilities, including contingent liabilities.

In making its determination that the Offer is substantively fair and in the best interests of our unaffiliated stockholders, in addition to the factors above, our Board of Directors considered the opinion of Covington and the oral and written presentations of Covington discussing the material factors included in its analysis, and such opinion and related discussion were accepted and adopted by the Board. Covington’s analysis is described in Section 3.

Our Board of Directors has approved the Offer. The Special Committee, which comprises a majority of the Board of Directors, has approved the Offer. We have not retained an unaffiliated representative to act solely on behalf of our unaffiliated stockholders for purposes of negotiating terms of the Offer. The Offer does not require the approval of a majority of unaffiliated stockholders. Despite the lack of an unaffiliated representative acting solely on behalf of the unaffiliated stockholders and despite the fact that the Offer is not structured to require the approval of the unaffiliated stockholders, we believe that the Offer is procedurally fair. We base these beliefs on the approval of the Offer by all of our directors and on the following factors, in addition to those discussed above:

•

all stockholders have the same opportunity to tender their shares in the Offer;

•

stockholders are not compelled to tender;

•

stockholders are provided with full disclosure of the terms and conditions of the Offer; and

•

stockholders are afforded sufficient time to consider the Offer.

Based upon the aforementioned factors, our Board believes that the Offer is both substantively and procedurally fair to unaffiliated stockholders. For those stockholders who tender shares and are no longer

stockholders of Rand, the Board of Directors has determined that such stockholders will receive a fair price for their shares. The Board also believes that the transaction is fair to those stockholders who remain our stockholders following the completion of the Offer because they will retain a greater equity interest in us. See Section 5 for a detailed discussion of the consequences that result from remaining a continuing stockholder of Rand.

No Recommendation

None of the Company, our Board of Directors, nor any advisors retained by the us or our Board of Directors, nor our lenders, in this Offer makes any recommendation to any stockholder as to whether to tender or refrain from tendering any or all of the stockholder’s shares and has not authorized any person to make any such recommendation. To the extent known to us after reasonable inquiry, none of our executive officers or directors has made a recommendation either in support of or opposed to the Offer. We recommend that stockholders evaluate carefully all information in the Offer, consult their own investment and tax advisors and make their own decision whether to tender shares and, if so, how many shares to tender.

SECTION 3. FAIRNESS OPINION OF FINANCIAL ADVISOR.

Covington has acted as financial advisor to us in connection with the Offer to Purchase, pursuant to which the Company will conduct the Offer and pay $1.20 per share (the “Offer Price”) for each share accepted in the Offer. At the September 29, 2014 meeting of the Special Committee of the Board of Directors, Covington delivered its oral opinion and subsequently confirmed its oral opinion in a written opinion to the Special Committee indicating that, as of September 29, 2014, the date of such written opinion, based upon and subject to the assumptions made, matters considered and limits of the review undertaken by Covington, it is Covington’s opinion as investment bankers that the Offer Price to be received by stockholders tendering their shares in the Offer is fair, from a financial point of view, to such holders (without giving effect to any impact of the Offer on any tendering holder other than in its capacity as a tendering holder).

The full text of Covington’s written opinion, dated September 29, 2014 (referred to as the “Covington Opinion”), which sets forth, among other things, the assumptions made, matters considered and limits on the review undertaken by Covington in connection with the Covington Opinion, is attached as Appendix B to this Offer to Purchase and is incorporated herein by reference. The opinion expressed by Covington was provided for the information and assistance of the Special Committee in connection with its consideration of the Offer, and such opinion does not constitute a recommendation as to any action that any stockholder of the Company should take in connection with the Offer and is not a recommendation as to whether or not any stockholder should tender their shares in connection with the Offer or how any stockholder otherwise should act in connection with the Offer. Rand stockholders are urged to read the Covington Opinion carefully and in its entirety. The summary of the Covington Opinion set forth in this Offer to Purchase is qualified in its entirety by reference to the full text of the Covington Opinion.

In connection with Covington’s role as financial advisor to Rand, and in arriving at its opinion, Covington reviewed certain publicly available financial and other information concerning Rand, certain internal analyses, financial forecasts and other information relating to Rand prepared by management of Rand. Covington also held discussions with certain senior officers of Rand regarding the businesses, operations, condition and prospects of Rand and the terms and background of the Offer. In addition, Covington has (i) reviewed the current and historical reported prices and trading volume activity for the Shares, (ii) to the extent publicly available, compared certain financial and stock market information for Rand with similar information for certain other companies it considered relevant whose securities are publicly traded, (iii) to the extent publicly available, reviewed the financial terms of certain recent business combinations which it deemed relevant, (iv) reviewed the Offer to Purchase and related documents, (v) considered a review of the financial condition of Rand with respect to its liquidity and capital position, and (vi) performed such other studies and analyses and considered such other factors as it deemed appropriate.

Covington’s Opinion was only one of many factors taken into consideration by the Special Committee in making its determination with respect to the Offer. Covington’s Opinion should not be construed as creating any fiduciary duty on the part of Covington to any party. Covington has not undertaken, and is under no obligation, to update, revise, reaffirm or withdraw the Covington Opinion, or otherwise comment on or consider events occurring or coming to its attention after the date of the Covington Opinion.

In preparing the Covington Opinion, Covington, with the consent of Rand, did not assume responsibility for the independent verification of, and did not independently verify, any information, whether publicly available or furnished to it, concerning Rand, including, without limitation, any financial information considered in connection with the rendering of its opinion. Accordingly, for purposes of the Covington Opinion, Covington, with the permission of Rand, assumed and relied upon the accuracy and completeness of all such information. Covington further relied upon the fact that the Board, the Special Committee and Rand have been advised by counsel as to all legal matters with respect to the Offer, including whether all procedures duly required by law to be taken in connection with the Offer have been duly, validly and timely taken. Covington did not conduct a physical inspection of any of the properties or assets, and did not prepare or obtain any independent evaluation or appraisal of any of the assets or liabilities of Rand, or any of their respective subsidiaries, nor has it evaluated the solvency or fair value of Rand under any state or federal law relating to bankruptcy, insolvency or similar matters. With respect to the financial forecasts made available to Covington and used in its analyses, Covington assumed with the permission of the Special Committee that they have been reasonably prepared on bases reflecting the best currently available estimates and judgments of the management of Rand as to the matters covered thereby. Covington also assumed that there had been no material change in the assets, financial condition, business or prospects of Rand since the respective dates of all financial information and other information made available to Covington. In rendering the Covington Opinion, Covington expressed no view as to the reasonableness of such forecasts and projections or the assumptions on which they are based. The Covington Opinion was necessarily based upon economic, market and other conditions as in effect on, and the information made available to Covington as of, the date of such opinion. In conducting its analysis and arriving at the Covington Opinion, Covington utilized pro-forma financials to take into account the disposition of the Rand SD business to a third party. With respect to documents reviewed in connection with the Offer, Covington assumed that the final versions of all such documents reviewed by Covington in draft form conformed in all material respects to the drafts reviewed.

For purposes of rendering the Covington Opinion, Covington also assumed, with the Special Committee’s permission, that in all respects material to its analysis, the Offer will be consummated in accordance with its terms and all conditions required to implement the Offer would be satisfied, without any material waiver, modification or amendment of any term, condition or agreement. Covington has also assumed that all material governmental, regulatory or other approvals and consents required in connection with the consummation of the Offer will be obtained and that in connection with obtaining any necessary governmental, regulatory or other approvals and consents, no material restrictions will be imposed. Covington is not a legal, regulatory, tax or accounting expert and has relied on the assessments made by Rand and its advisors with respect to such issues. The issuance of the Covington Opinion was approved by the persons within Covington authorized to approve opinions of such nature.

Set forth below is a brief summary of certain financial and comparative analyses performed by Covington in connection with rendering the Covington Opinion and reviewed with the Rand Board at its meeting on September 29, 2014.

Historical Stock Performance. Covington reviewed and analyzed recent and historical market prices and trading volume for the shares and compared such market prices to certain stock market and industry indices. Covington analyzed the Offer Price to be received by Rand stockholders in the Offer in relation to one and three year price and volume activity. The three year average closing price as of September 26, 2014 was $0.90 and the three year average daily trading volume as of September 26, 2014 was 3,950 shares. The one year average closing price as of September 26, 2014 was $1.90 and the one year average daily trading volume as of

September 26, 2014 was 5,500. Also, when comparing stock performance against comparable public companies (further defined below), Rand appreciated 60% vs. 75% for three years from September 26, 2014. In addition, Covington analyzed trading multiples compared to the comparable public companies. Rand’s enterprise value as a multiple of revenue (“EV/Revenue”) has historically traded at a premium to the public comparable companies, closing at 0.6x vs. 0.3x as of September 26, 2014. And Rand’s enterprise value as a multiple of earnings before interest, taxes, depreciation, and amortization (“EBITDA”) (“EV/EBITDA”) has varied historically in relation to the public comparable companies, closing below the comparable group as of September 26, 2014 at 7.6x vs. 7.9x. Covington also performed a share price analysis, concluding that less than 0.15% of shares were purchased above $1.20 over the past three years, and less than 0.45% over the past twelve months. The analysis indicated the Offer Price represented a reasonable price based upon historic one and three year median trading prices, volume, and multiples given Rand’s size and relative illiquidity.

Analysis of Selected Publicly Traded Companies. Covington compared certain financial information and commonly used valuation measurements for Rand to corresponding information and measurements for a group of publicly traded software and technology distribution and value-added resellers: CDW Corporation, Arrow Electronics, Avnet, SYNNEX, Tech Data, ComputaCenter, Insight Enterprises, ScanSource, PC Connection, ePlus, Inc., and Wayside Technology Group. Such financial information and valuation measurements included, among other things, (i) common equity market valuation; (ii) operating performance; (iii) ratios of common equity market value as adjusted for debt and cash (“Enterprise Value”) to revenues and EBITDA; and (iv) ratios of common equity market prices per share (“Equity Value”) to earnings per share (“EPS”). To calculate the trading multiples for Rand and the selected companies, Covington used publicly available information concerning historical and projected financial performance and reviewed the selected public companies taken as a group. Covington also used the Rand proforma and Wall Street estimates to properly evaluate the Company in comparison to peers. The median last twelve months (“LTM”) EV/Revenue was 0.3x while Rand trades at 0.6x and Rand proforma at 0.6x as of September 26, 2014. The median LTM EV/EBITDA was 7.1x while Rand trades at 7.6x and Rand proforma at 4.9x as of September 26, 2014. None of the companies utilized as a comparison are identical to Rand. Accordingly, Covington believes the analysis of publicly traded comparable companies is not simply mathematical. Covington identifies many factors that provide a significant difference between Rand and the comparable companies, including but not limited to, size, vendor concentration (primarily Autodesk), and bottom quartile operating metrics relative to comparable companies. In addition, Covington also evaluated a different comparable group, comprised of three public value-added software resellers, all foreign entities. Based on substantially different revenue recognition and accounting policies, as well as diverse markets, no valuation comparison could be drawn. Given the complex and subjective considerations and qualitative judgments, Covington concluded the trading metrics against comparable companies is consistent with market factors.

Analysis of Selected Precedent Transactions. Covington reviewed the financial terms, to the extent publicly available, of completed mergers and acquisition transactions in recent history. Covington calculated various financial multiples based on certain publicly available information for each of the selected transactions and compared them to corresponding financial multiples in the Offer.

Covington evaluated two sources of merger and acquisition transaction data; first, relevant software and technology distribution and value-added resellers with implied enterprise values less than $100 million over the past three years; and second, all public company merger and acquisition data within the twelve months ended September 26, 2014, in the United States, for companies with market capitalizations between $25 and $150 million. In evaluating the first of the M&A transaction analyses, Covington identified seven total relevant transactions and of the transactions where an EV/Revenue multiple was disclosed, the average was 0.3x and of the transactions where an EV/EBITDA multiple was disclosed, the average was 4.4x. Rand proforma multiples based on the Offer are 0.6x EV/Revenue and 5.1x EV/EBITDA.

The second M&A analysis utilized over 25 recent transaction across a diverse set of industries, geographies and deal structures producing a median EV/Revenue multiple of 0.6x and a median EV/EBITDA

multiple of 8.0x. Additionally, the median premium was 34.9% with a range of 1.9% to 95.2% compared to 4.3% based on the Offer. Given the wide range of transaction premiums and the fact these transactions were acquisitions of an entire enterprise and not tender offers, Covington believes the multiples and premium from the Offer are consistent with market conditions and company related factors. All multiples for the selected transactions were based on public information available at the time of announcement of such transaction, without taking into account differing market and other conditions during the period of time during which the selected transactions occurred. Because the reasons for, and circumstances surrounding, each of the precedent transactions analyzed were so diverse, and due to the inherent differences between the operations and financial conditions of Rand and the companies involved in the selected transactions and other transactions described herein, no transaction was identical to the Offer and Covington believes that a comparable transaction or premiums paid analysis is not simply mathematical. Rather, it involves complex and subjective considerations and qualitative judgments, reflected in Covington’s opinion, concerning differences between the characteristics of these transactions and the Offer that could affect the value of the subject companies and businesses and Rand.

Additionally, Covington also evaluated precedent tender offer transactions relevant to the Offer. Covington focused on evaluating transactions that had one of two characteristics; first, a current shareholder purchased a larger stake in the respective company, and second, the tender offer resulted in a change of control with the new majority shareholder holding less than 90% of the company. Because the reasons for, and circumstances surrounding, each of the precedent tender offer transactions analyzed are so diverse, and due to the inherent differences between the operations and financial conditions of Rand and the companies involved in the selected transactions and other transactions described herein, no transaction was identical to the Offer. The premiums associated with said tender offers varied from a minimum of (26.2%) to 46.2%. The Offer at hand represents a 4.3% premium as of September 26, 2014 and given the wide range and unique nature of each respective offer analyzed, Covington believes the Offer to be consistent with the scope of precedent tender offers.

Discounted Cash Flow Analysis. Covington performed a discounted cash flow (“DCF”) analysis of Rand based on proforma financials provided by the Company through 2017 and projected by Covington through 2020. The projections provided by management through 2017 have been confirmed by various executive members of the Rand management team and are the best estimate of the future performance of the Company. Covington projected the years including 2018 – 2020 using a conservative growth rate of less than 2% per year and held margins consistent in order to best project the performance of the business through the end of fiscal year 2020. The aforementioned projections were not prepared for public disclosure, may not comply with all GAAP accounting rules, and results will likely differ from projections, and possibly substantially differ given a number of macro and internal factors.

Based on these assumptions, Covington calculated the discounted cash flow values for Rand as the sum of the net present values of (i) the estimated unleveraged free cash flows that Rand will generate for the fiscal years ending June 2015 through 2020, plus (ii) the terminal value of Rand at the end of such period. The terminal values of Rand were calculated based on both the EBITDA multiple and perpetuity growth methods. Covington used discount rates based on its judgment of the estimated weighted average cost of capital (“WACC”) of Rand, calculated by using the unlevered betas of the previously mentioned public company comparable companies. Given the fact that none of the comparable companies are identical to Rand, Covington used Rand’s size, liquidity, vendor concentration, and other market factors to calculate, to the best of its ability, the WACC for the Company. Based on these analyses, Covington determined that a WACC of 28.5% was appropriate and fair for the DCF analysis.

In the two DCF calculations, Covington used EBITDA multiples based on market knowledge and comparable transaction data to arrive at per share range of $1.19 - $1.38. Using perpetuity growth rates based on long term projected growth of the macro economy as the second analysis, the per share range was $1.20 - $1.25. Covington believes the discounted cash flow analysis relating to said transaction is not simply mathematical. Rather, it involves complex and subjective considerations and qualitative judgments, reflected in Covington’s opinion, concerning differences between the characteristics of these transactions and the Offer that could affect the value of the subject companies and businesses and Rand.

The foregoing summary describes all analyses and factors that Covington deemed material in its presentation to the Special Committee, but is not a comprehensive description of all analyses performed and data, information and factors considered by Covington in connection with preparing its opinion. The preparation of a fairness opinion is a complex process involving the application of subjective business judgment in determining the most appropriate and relevant methods of financial analysis and the application of those methods to the particular circumstances and, therefore, is not readily susceptible to summary description.

In conducting its analyses and arriving at the Covington Opinion, Covington utilized a variety of generally accepted valuation methods and analytical techniques. Each analytical technique has inherent strengths and weaknesses, and the nature of available information may further affect the strengths and weaknesses of any particular technique. While the conclusions reached in connection with each analysis were considered carefully by Covington in arriving at its opinion, Covington did not consider it practicable to, nor did it attempt to, assign relative weights to the individual analyses and specific factors considered in reaching its opinion. The conclusion reached by Covington was based on all analyses and factors taken, as a whole, and also on application of Covington’s own experience and judgment. No one method of analysis should be regarded as critical to the overall conclusion. Accordingly, Covington believes that its analyses must be considered as a whole, and that selecting portions of its analyses and of the factors considered by it, without considering all analyses and factors, could create a misleading or incomplete view of the evaluation process underlying its opinion.

The analyses were prepared solely for the purpose of enabling Covington to provide the Covington Opinion to the Special Committee as to the fairness, from a financial point of view, of the Offer Price to be received by stockholders in the Offer, and do not purport to be appraisals or necessarily reflect the prices at which securities actually may be bought or sold, which are inherently subject to uncertainty. In connection with its analyses and the preparation of its opinion, Covington made, and was provided by Rand management with, numerous assumptions with respect to industry performance, general business, market and economic conditions and other matters, many of which are beyond the control of any party involved in the Offer. To the extent that any of the foregoing assumptions or any of the facts on which Covington’s opinion is based prove to be untrue in any material respect, its opinion cannot and should not be relied upon. The Covington Opinion is necessarily based upon market, economic, financial and other conditions as they exist and can be evaluated as of September 26, 2014, the date on which the Covington Opinion was effectively prepared, and Covington disclaims any undertaking or obligation to advise any person of any change in any factor matter affecting its opinion which may come or be brought to the attention of Covington after such date. In the event of any such change prior to the completion of the Offer, Covington reserves the right to change, modify or withdraw its opinion.

Analyses based on estimates or forecasts of future results are not necessarily indicative of actual past or future values or results, which may be significantly more or less favorable than suggested by such analyses. Because such analyses are inherently subject to uncertainty, being based upon numerous factors or events beyond the control of Rand, Covington or their respective advisors, neither Rand nor Covington nor any other person assumes responsibility if future results or actual values are materially different from these forecasts or assumptions.

The terms of the Offer were determined through discussions among Rand and certain of its major stockholders and were approved by the Board. Although Covington provided advice to Rand during the course of these discussions, the decision to make the Offer was solely that of the Board. As described above, the opinion (and supported by the presentation of Covington to the Special Committee) was only one of a number of factors taken into consideration by the Special Committee in making its determination to approve the Offer. The Covington Opinion was provided to the Special Committee to assist it in connection with its consideration of the Offer and should not be construed as creating a fiduciary duty on the part of Covington to any party. Covington expressed no opinion as to the merits of the underlying decision by Rand to engage in the Offer, whether any stockholder should tender shares in the Offer or the price at which shares will trade at any time. Covington has not undertaken, and is under no obligation, to update, revise, reaffirm or withdraw the Covington Opinion, or otherwise comment on or consider events occurring or coming to its attention after the date of the Covington Opinion.

Rand selected Covington as financial advisor in connection with the Offer and other strategic alternatives it considered based on Covington’s qualifications, expertise, reputation and experience in mergers and acquisitions and related transactions. Rand has retained Covington pursuant to a letter agreement dated February 13, 2014 (the “Engagement Letter”). As compensation for Covington’s services in connection with the Offer, Rand agreed to pay Covington a fee from the Company upon the closing of the Offer, which is contingent upon the successful completion of the Offer. In addition, regardless of whether the Offer is completed, Covington will receive a non-refundable fee of $200,000 upon delivery of the Covington Opinion. Regardless of whether the Offer is completed, Rand has agreed to reimburse Covington for the reasonable fees and disbursements of Covington’s counsel and all of Covington’s reasonable travel and other out-of-pocket expenses incurred in connection with the Transaction or otherwise arising out of the retention of Covington under the Engagement Letter. Rand has also agreed to indemnify Covington and certain related persons to the full extent lawful against certain liabilities, including certain liabilities under the federal securities laws arising out of its engagement or the Offer.

Covington has, from time to time, provided certain investment banking and other financial services to the Company and has received compensation for such services. In the ordinary course of its business, Covington may trade in the securities and other instruments and obligations of the Company for its own account and for the accounts of its customers and, accordingly, may at any time hold a long or short position in such securities, instruments and obligations.

To conclude, Covington delivered its oral opinion and subsequently confirmed its oral opinion in a written opinion to the Special Committee indicating that, as of September 29, 2014, the date of such written opinion, based upon the analysis described herein, matters considered and limits of the review undertaken by Covington it is Covington’s opinion as investment bankers that the Offer Price to be received by stockholders in the Offer is fair, from a financial point of view, to such holders (without giving effect to any impact of the Offer on any tendering holder other than in its capacity as a tendering holder).

Certain Financial Information

Rand does not publicly disclose long-term projections as to future revenues, earnings or other results due to, among other reasons, the uncertainty and subjectivity of the underlying assumptions and estimates. As a result, Rand does not endorse the unaudited prospective financial information as a reliable indication of future results. Rand is including limited unaudited prospective financial information in this document solely because it was among the financial information made available to the Company’s Board of Directors and Covington in connection with their evaluation of the Offer. The unaudited prospective financial data presented below includes projections prepared by Rand management for internal planning purposes in the first half of 2014. Moreover, Rand’s internally prepared unaudited prospective financial information was based on estimates and assumptions made by management in the first half of 2014 and speak only as of that time. Rand management reviews and updates its internal projections regularly, and confirmed to the Company’s Board of Directors and Covington that the internal projections remained reasonable as of the date Covington delivered its opinion. However, except to the extent required by applicable law, Rand has no obligation to update prospective financial data included in this document and, except as provided herein, has not done so and does not intend to do so.

The inclusion of this information should not be regarded as an indication that any of Rand, Covington or any other recipient of this information considered, or now considers, it to be necessarily predictive of actual future results. There can be no assurance that the prospective results will be realized or that actual results will not be significantly higher or lower than estimated.

Since the unaudited prospective financial information covers multiple years, such information by its nature becomes less predictive with each successive year. The Company’s stockholders are urged to review the risks and other factors described under “Forward-Looking Statements” in this Offer to Purchase. The unaudited prospective financial information was not prepared with a view toward public disclosure, nor was it prepared

with a view toward compliance with published guidelines of the SEC regarding projections and the use of non-GAAP measures or the guidelines established by the American Institute of Certified Public Accountants for preparation and presentation of prospective financial information. The Company’s independent registered public accounting firm has not audited, reviewed, compiled or performed any procedures with respect to the accompanying unaudited prospective financial information for the purpose of its inclusion herein, and accordingly, the Company’s independent registered public accounting firm does not express an opinion or provide any form of assurance with respect thereto for the purpose of this Offer to Purchase. Furthermore, the unaudited prospective financial information does not take into account any circumstances or events occurring after the date it was prepared. The unaudited prospective financial information does not give effect to the Offer.

The following table presents selected unaudited prospective financial data provided by Rand to Covington. The unaudited prospective income statement data assumed only Rand Core financial results.


	2015E			2016E			2017E
	Total			Total			Total
Fiscal year ended	30-Jun-15			30-Jun-16			30-Jun-17
Total Revenue	$	95,282,000		$	103,973,000		$	113,583,000
COGS		46,429,000			50,320,000			54,307,000
Gross Profit	$	48,853,000		$	53,653,000		$	59,276,000
GM %		51.3	%		51.6	%		52.2	%
Operating Expenses
SG&A		35,720,000			37,579,000			39,595,000
Depreciation and Amortization		1,800,000			1,800,000			1,800,000
EBIT		11,333,000			14,274,000			17,881,000
Other Expenses
Interest Expense		852,679			985,032			749,959
Currency Exchange		—			—			—
Other Expense		172,000			172,000			172,000
EBT		10,308,321			13,116,968			16,959,041
Income Tax (Benefit) Expense		3,607,912			4,590,939			5,935,665
Net Income		6,700,409			8,526,029			11,023,377
Preferred Dividends		109,000			109,000			109,000
Net Income to Common Stockholders		6,591,409			8,417,029			10,914,377

*Non-GAAP Projections*

EBITDA		13,133,000			16,074,000			19,681,000
Adjustments		161,250			—			—

Adj. EBITDA	$	13,294,250		$	16,074,000		$	19,681,000

Adj. EBITDA Margin %		14.0	%		15.5	%		17.3	%

Although presented with numerical specificity, the above unaudited prospective financial information reflects numerous assumptions and estimates as to future events made by the management of Rand. At the time the unaudited prospective financial information was prepared, Rand’s management believed such assumptions and estimates were reasonable. In preparing the foregoing unaudited projected financial information, Rand made assumptions regarding, among other things, pricing and volume of products and services sold, interest rates, corporate financing activities, the effective tax rate and the amount of general and administrative costs.

No assurances can be given that the assumptions made in preparing the above unaudited prospective financial information will accurately reflect future conditions. The estimates and assumptions underlying the unaudited prospective financial information involve judgments with respect to, among other things, future economic, competitive, regulatory and financial market conditions and future business decisions which may not be

realized and that are inherently subject to significant business, economic, competitive and regulatory uncertainties and contingencies, including, among others, risks and uncertainties described under “Forward-Looking Statements” in this Offer to Purchase, all of which are difficult to predict and many of which are beyond the control of the Company. There can be no assurance that the underlying assumptions will prove to be accurate or that the projected results will be realized, and actual results likely will differ, and may differ materially, from those reflected in the unaudited prospective financial information, whether or not the Offer is completed.

Readers of this document are cautioned not to place undue reliance on the unaudited prospective financial information set forth above. No representation is made by Rand, Covington, or any other person to any Rand stockholders regarding the ultimate performance of Rand compared to the information included in the above unaudited prospective financial information. The inclusion of unaudited prospective financial information in this document should not be regarded as an indication that such prospective financial information will be an accurate prediction of future events, and such information should not be relied on as such.

THE COMPANY DOES NOT INTEND TO UPDATE OR OTHERWISE REVISE THE ABOVE UNAUDITED PROSPECTIVE FINANCIAL INFORMATION TO REFLECT CIRCUMSTANCES EXISTING AFTER THE DATE WHEN MADE OR TO REFLECT THE OCCURRENCE OF FUTURE EVENTS, EVEN IN THE EVENT THAT ANY OR ALL OF THE ASSUMPTIONS UNDERLYING SUCH PROSPECTIVE FINANCIAL INFORMATION ARE NO LONGER APPROPRIATE, EXCEPT AS MAY BE REQUIRED BY LAW.

SECTION 4. OUR PLANS AFTER THE OFFER.

We have no current plans or intentions to deregister our common stock under the Exchange Act or to terminate our reporting obligations as a public company after the completion of the Offer, and we expect that our common stock will continue to be quoted on the OTCQB tier of OTC Markets Group, Inc. However, we cannot predict the liquidity of the market which will thereafter exist for our common stock. As a result of the lower number of shares outstanding that will exist following the Offer, it may become more difficult for our remaining stockholders to sell their shares. Because we currently have (and following the Offer expect to continue to have) fewer than 300 stockholders of record as calculated under applicable rules of the SEC, we are eligible to deregister our common stock under the Exchange Act. Stockholders in the Company following the Offer should be aware that changes in circumstance applicable to us, changes in intention of us or of our controlling stockholder following the Offer, or changes in the costs involved in remaining a public company (or our ability or willingness to bear such costs) may lead us to deregister our common shares at a future date. If this happens, we anticipate that our shares may continue to be quoted in the over the counter market (“pink sheets”), but the liquidity of the trading market may be limited.

RWWI Holdings LLC, which is majority-owned by funds affiliated with Ampersand Capital Partners, currently owns 25,232,682 shares, or approximately 46.3%, of the Company’s outstanding common stock and has indicated its intention to tender all 25,232,682 of its shares in the Offer, subject to the proration procedures described in this document. Assuming that RWWI Holdings LLC will, after these transactions, own less than 25% of the Company’s outstanding common stock that it received in the August 2010 merger with Avatech Solutions, Inc., the Stockholders’ Agreement dated August 17, 2010 giving it certain board designation rights (the “Existing Stockholders’ Agreement”) will expire pursuant to its terms. To the extent the Existing Stockholders’ Agreement does not expire following these transactions, RWWI Holdings LLC has agreed in the Purchase Agreement with an affiliate of 3K, dated September 26, 2014, not to exercise its board designation rights under the Existing Stockholders’ Agreement after such time.

3K currently holds (together with its affiliates) approximately 30.9% of our common stock and has indicated that it will not tender shares in the Offer. On September 26, 2014, 3K substantially increased its ownership position in us by purchasing, through an affiliate, 9,000,000 shares of our common stock directly from RWWI Holdings LLC. As a result of that purchase, with the reduction in the number of shares of our common

stock that will remain outstanding following the Offer (assuming at least 27,530,816 shares are tendered in the Offer), we estimate that 3K (together with its affiliates) will hold approximately 62.5% of our common stock following completion of the Offer, and will become our new controlling stockholder.

If the Offer is completed as outlined above, 3K will have a majority of the voting power represented by our common stock, and will be able to control the outcome of the election of members of our Board of Directors or other items for which stockholder approval is required or sought. 3K will also be able to block certain actions by us that require the approval of our stockholders, including (among other transactions) the sale of the Company. In its Purchase Agreement relating to its September 26, 2014 sale of 9,000,000 shares of common stock to an affiliate of 3K, RWWI Holdings LLC agreed not to exercise any further board appointment rights under the Existing Stockholders Agreement. It is the Company’s belief that following its acceptance of and payment for the shares tendered in the Offer, the two members of its board of directors who are currently serving as designees of Ampersand – Dr. Richard A. Charpie and Charles D. Yie – will resign from the Board, as will Manu Parpia, an independent director. The Company and Marc L. Dulude, its Chairman and Chief Executive Officer, have also reached an understanding that Mr. Dulude will step down from each of his positions at the Company, including from the Board. It is the Company’s expectation that Lawrence Rychlak, currently President and Chief Financial Officer and a director of the Company, will be appointed to serve as Chief Executive Officer, pending arrangement of final terms. No definitive timetable for these changes has been finalized.

The Company has been advised by 3K that it intends to appoint David Schneider and Philip Livingston to fill two vacancies in the Board created by the anticipated resignations described above:

David M. Schneider, age 42, is a consultant to 3K with 20 years of business experience, including 15 years in private equity and debt investing. Prior to joining 3K in January 2014, Mr. Schneider was with MSR Advisors Inc. (d/b/a Main Street Resources), a middle market private equity firm, from July 2001 through December 2013. As a Partner with Main Street, Mr. Schneider was responsible for all facets of the firm’s activities, including fund raising, deal sourcing and execution, and worked closely with the firm’s portfolio companies at the board and management level. Prior to Main Street, he spent time with J.H. Whitney & Co., an alternative asset investment firm, and MCG Global, a boutique merchant banking firm. Mr. Schneider started his career with Price Waterhouse LLP. He is a Certified Public Accountant (inactive) and holds a BS from Bryant College and an MBA from Bentley College. Mr. Schneider is presently a Director of The Roberts Company and has served as Director/Advisor for over a dozen companies, including Glass America, Morgan Contracting, Vertex Fasteners, Sage Parts Plus, Black Clawson, and Midasco.

Philip B. Livingston, age 57, has served as Interim Chief Executive Officer and a director of Ambassadors Group, Inc., a provider of educational travel experiences and online education research materials, since May 2014. Prior to joining Ambassadors Group, Mr. Livingston was Chief Executive Officer of LexisNexis Web Based Marketing Solutions until October 2013. He joined LexisNexis in April 2009 as Senior Vice President of Practice Management and served in executive management positions from April 2009 to October 2013. Mr. Livingston has, in the past, served as Chief Financial Officer for Celestial Seasonings, Inc., Catalina Marketing Corporation and World Wrestling Entertainment. From 1999 to 2003 he served as President of Financial Executives International, the leading professional association of chief financial officers and controllers. In that role he led the organization’s support of regulatory and corporate governance reforms culminating in the Sarbanes-Oxley Act. In the past, he has served on numerous public and private company boards including Broadsoft Corporation, Insurance Auto Auction, Cott Corporation, MSC Software and Seitel Inc.

Other than as described in this document, we currently have no plans, proposals or negotiations that relate to or would result in:

•

an extraordinary transaction, such as a merger, reorganization or liquidation, involving us or any of our subsidiaries;

•

our common stock becoming eligible for termination of registration under the Exchange Act;

•

a purchase, sale or transfer of a material amount of our assets or of the assets of our subsidiaries;

•

a material change in our present dividend rate or policy, or in our indebtedness or capitalization;

•

a change in our Board of Directors or management;

•

a material change in our corporate structure or business;

•

an acquisition or disposition by any person of our securities; or

•

a change in our Restated Certificate of Incorporation, by-laws or other governing documents or an action that could impede the acquisition of control of us.

Although we do not currently have any plans (other than as described in this document) that relate to or would result in any of the events discussed above, as we continue to evaluate opportunities for increasing stockholder value we may undertake or plan actions that relate to or could result in one or more of these events.

SECTION 5. EFFECTS OF THE OFFER.

As described above, this Offer will substantially reduce the number of issued and outstanding shares of our common stock. Accordingly, if you do not tender your shares in the Offer, upon the completion of the Offer, you (together with other non-tendering stockholders) will realize a proportionate increase in your relative ownership interest in us, and thus, in our future earnings and assets, subject to our right to issue additional shares of common stock and other equity securities in the future. The percentage ownership interest of non-tendering stockholders in us after the Offer will be greater than their percentage ownership interest before the Offer. Of course, we may issue additional shares of common stock and other securities at any time, subject to the authorization in our Restated Certificate of Incorporation, and these issuances would reduce your percentage ownership interest.

Consummation of the Offer will permit the continuing stockholders to receive the benefits that result from ownership of a proportionately greater equity interest in us. Such benefits include the benefits of the profits generated by operations and increases, if any, in our value. The continuing stockholders will also bear the risk of any decrease in our value following the Offer, and the risks associated with the additional debt that we will incur in financing the Offer. For a pro forma illustration of the effect of the Offer on our earnings per share, see Section 14.

You may be able in the future to sell shares that you do not tender or that are otherwise not purchased in the Offer. We cannot predict or assure you, however, as to the price at which you will be able to sell your shares, which may be higher or lower than the purchase price paid by us in this Offer. Consummation of the Offer will likely further reduce the liquidity of the shares, and there can be no assurance that stockholders will be able to find willing buyers for their shares after the Offer. Following the Offer, assuming 27,530,816 shares are tendered and purchased in the Offer, we estimate that we will have approximately 27,453,491 shares of common stock remaining outstanding (which number includes an estimate of the number of shares that will be issued upon the exercise of options held by executive officers or directors for purposes of tendering the underlying shares in the Offer). The reduction in our “public float” (the number of shares owned by non-affiliated stockholders and available for trading in the securities markets) may result in greater volatility in stock prices and lower liquidity in the trading markets following completion of the Offer. See Section 14.

Following completion of the Offer, we may repurchase additional shares in the open market, in privately negotiated transactions or otherwise. Future purchases may be on terms that are more or less favorable to stockholders than the terms of this Offer. SEC Rules 14e-5 and 13e-4 generally prohibit the Company from purchasing any shares outside of the Offer until at least ten (10) business days after the Expiration Date, although there are some exceptions. Any future purchases will depend on many factors, which include market conditions and the condition of our business. We currently have no plans that relate to the purchase of additional shares of our common stock following consummation of the Offer.

Shares that we acquire in the Offer will be retained as treasury stock and may be restored to the status of authorized and unissued shares. These shares will be available for us to issue without further stockholder action for purposes including, without limitation, acquisitions, raising additional capital and the satisfaction of obligations under existing or future employee benefit or compensation programs or stock plans or compensation programs for directors. We have no current plans for the reissuance of the shares purchased pursuant to the Offer.

In light of the limited liquidity available to holders of its stock options, the Board of Directors voted to accelerate, as of the commencement of the Offer, the vesting of all outstanding unvested and unexercised stock options granted under the Company’s stock option or omnibus equity compensation plans, in order to provide holders of our stock options the opportunity to participate in the decision whether or not to obtain complete or partial liquidity in our stock. The Board has also voted to permit the options to be exercised through a “net settlement” procedure. See “Treatment of Options” in Section 12 for more information. The acceleration of the vesting period of the stock options should have no effect on the status of such options as “incentive stock options”, or ISOs. Options for which the holder elects to make a “net settlement” amendment, however, will be treated as non-qualified stock options, or NQSOs. The principal effect of the “net settlement” for us is that we will be required to remit cash to the Internal Revenue Service in an amount equal to the federal tax withholding, the employee payroll tax and the employer payroll tax for exercised NQSOs. Since we will not receive any cash upon the exercise of the net settled stock options, but will rather withhold shares with the equivalent value, compliance with this withholding obligation will represent a net cash expense to us. Our Board of Directors has considered the estimated impact of this withholding obligation (estimated to be approximately $200,000) in approving the Offer and establishing the number of shares we will purchase in the Offer.

As of June 30, 2014, we had U.S. federal net operating loss carryforwards available to reduce future taxable income of approximately $30.3 million; however, $23.3 million of these carryforwards were not recognized because they are subject to annual limitations under Internal Revenue Code Section 382 and are expected to expire before being utilized. These carryforwards expire between 2014 and 2029. As of June 30, 2014, we had foreign net operating loss carryforwards of approximately $14.8 million available to reduce future taxable income. However, approximately $4.0 million of these carryforwards are expected to expire by December 1, 2014 and the balance will expire between 2028 and 2031. The Company does not believe that the changes in the ownership of our common stock that will result from the Offer are likely to materially restrict our ability to use the remaining net operating loss carryforwards that would be otherwise available to it.

Our indebtedness will be substantially higher following the completion of the Offer than prior to the Offer. This could have the effect, among other things, of substantially reducing our flexibility to respond to changing business and economic conditions, and it will have the effect of substantially increasing our interest expense. We will also be subject to the financial covenants and other restrictions of our revised debt facility. These covenants may restrict our ability to borrow additional funds in the future, to declare and pay dividends on our common stock, or to engage in other transactions that may be otherwise in our interest.

THE OFFER

SECTION 6. NUMBER OF SHARES; PRIORITY OF PURCHASES; ODD LOTS; PRORATION.

Upon the terms and subject to the conditions of the Offer, we will purchase up to 27,530,816 shares of our common stock properly tendered and not properly withdrawn in accordance with Section 7 before the Expiration Date, as defined below, at a purchase price of $1.20 per share, net to the seller in cash, less any applicable withholding taxes and without interest. If fewer than 27,530,816 shares are properly tendered and not properly withdrawn, we will buy all shares properly tendered and not properly withdrawn (upon the terms and subject to the conditions of the Offer).

The term “Expiration Date” means 5:00 p.m., New York City time, on November 3, 2014. We may, in our sole discretion, extend the period of time during which the Offer will remain open. In the event of an extension, the term “Expiration Date” will refer to the latest time and date at which the Offer, as extended by us, will expire. See Section 17 for a description of our right to extend, delay, terminate or amend the Offer.

If the Offer is over-subscribed as described below, shares properly tendered and not properly withdrawn will be subject to proration, except for Odd Lots. The proration period and, except as described herein, withdrawal rights expire at the Expiration Date. All shares tendered and not purchased in the Offer, including shares not purchased because of proration, will be returned to the tendering stockholders at our expense promptly following the Expiration Date.

If we (i) increase the maximum number of shares that we may purchase in the Offer by more than 2% of our outstanding shares or (ii) decrease the amount of shares that we may purchase in the Offer, then the Offer must remain open for at least ten business days following the date that notice of the increase or decrease is first published, sent or given in the manner specified in Section 17.

THE OFFER IS NOT CONDITIONED ON ANY MINIMUM NUMBER OF SHARES BEING TENDERED. OUR OBLIGATION TO ACCEPT AND PAY FOR SHARES PROPERLY TENDERED PURSUANT TO THE OFFER IS, HOWEVER, SUBJECT TO OTHER CONDITIONS, INCLUDING THE FINANCING CONDITION. SEE SECTION 10.

Priority of Purchases

If more than 27,530,816 shares of our common stock (or such greater value of shares as we may elect to purchase, subject to applicable law) are properly tendered and not properly withdrawn, we will purchase shares in the following order of priority:

First, we will purchase all Odd Lots of less than 100 shares from stockholders who properly tender all of their shares and who do not properly withdraw them before the Expiration Date (tenders of less than all of the shares owned, beneficially or of record, by such Odd Lot Holder will not qualify for this preference); and

Second, after purchasing all the Odd Lots that were properly tendered, we will purchase shares from all other holders who properly tender shares and who do not properly withdraw them before the Expiration Date, on a pro rata basis, with appropriate adjustments to avoid purchases of fractional shares, until we have acquired 27,530,816 shares.

Odd Lots

The term “Odd Lots” means all shares tendered by any person (an “Odd Lot Holder”) who owned beneficially or of record an aggregate of fewer than 100 shares of our common stock and so certifies in the appropriate place on the Letter of Transmittal and, if applicable, the Notice of Guaranteed Delivery. This preference is not available to partial tenders or beneficial or record holders of 100 or more shares of our common stock, even if such holders have separate accounts or certificates representing fewer than 100 shares. Odd Lots will be accepted for payment at the same time as other tendered shares.

Proration

If proration of tendered shares is required, we will determine the proration factor promptly following the Expiration Date. Proration for each stockholder tendering shares (excluding Odd Lot Holders) will be based on the ratio of the number of shares properly tendered and not properly withdrawn by the stockholder to the total number of shares properly tendered and not properly withdrawn by all stockholders (excluding Odd Lot Holders). We will announce the final proration factor and commence payment for any shares purchased pursuant to the Offer promptly after the Expiration Date. The preliminary results of any proration will be announced by press release promptly after the Expiration Date. Stockholders may obtain preliminary proration information from the Information Agent and also may be able to obtain the information from their brokers.

The Letter of Transmittal affords each stockholder who tenders shares registered in such stockholder’s name directly to the Depositary the opportunity to designate the order of priority in which shares tendered are to be purchased in the event of proration. See Section 7.

This Offer to Purchase and the related Letter of Transmittal will be mailed to record holders of the shares and will be furnished to brokers, dealers, commercial banks, trust companies or other nominee stockholders and similar persons whose names, or the names of whose nominees, appear on our stockholder list or, if applicable, who are listed as participants in a clearing agency’s security position listing for subsequent transmittal to beneficial owners of shares.

SECTION 7. PROCEDURES FOR TENDERING SHARES.

Proper Tender of Shares

For shares to be tendered properly pursuant to the Offer:

the certificates for such shares (or confirmation of receipt of such shares pursuant to the procedure for book-entry transfer set forth below), together with a properly completed and duly executed Letter of Transmittal, including any required signature guarantees, or an “Agent’s Message” (as defined below), and any other documents required by the Letter of Transmittal, must be received before 5:00 p.m., New York City time, on November 3, 2014 (or such later time to which the Offer may be extended) by the Depositary at its address set forth on the back cover of this Offer to Purchase; or

the tendering stockholder must comply with the guaranteed delivery procedure set forth below.

Stockholders holding their shares in a brokerage account or otherwise through a broker, dealer, commercial bank, trust company or other nominee, must contact their brokers or such other nominee in order to tender their shares. It is likely that the nominee has established an earlier deadline for you to act to instruct the nominee to accept the Offer on your behalf. Stockholders who hold shares through nominees are urged to consult their nominees to determine whether transaction costs may apply if stockholders tender shares through the nominees and not directly to the Depositary.

The proper tender of shares by you through one of the procedures described in this Section 7 will constitute a binding agreement between you and us on the terms of, and subject to the conditions to, the Offer.

Signature Guarantees and Method of Delivery

No signature guarantee is required if:

the Letter of Transmittal is signed by the registered holder of the shares whose name appears on a security position listing as the owner of the shares) tendered and the holder has not completed the section captioned “Special Issuance Instructions” on the Letter of Transmittal; or

shares are tendered for the account of a bank, broker, dealer, credit union, savings association or other entity which is a member in good standing of the Securities Transfer Agents Medallion Program or an “eligible guarantor institution,” as the term is defined in Rule 17Ad–15 under the Exchange Act (each of the foregoing constituting an “Eligible Institution”).

A “registered holder” of tendered shares, for purposes of this Section 7, will include any participant in the Depository Trust Company’s (“DTC’s”) system whose name appears on a security position listing as the owner of those shares, and an “eligible institution” is a “financial institution,” which term includes most commercial banks, savings and loan associations and brokerage houses, that is a participant in any of the following: (i) the Securities Transfer Agents Medallion Program; (ii) The New York Stock Exchange, Inc. Medallion Signature Program; or (iii) the Stock Exchange Medallion Program.

Except as described above, all signatures on any Letter of Transmittal for shares tendered thereby must be guaranteed by an Eligible Institution. See Instructions 1 and 5 to the Letter of Transmittal. If the certificates for shares are registered in the name of a person other than the signer of the Letter of Transmittal, or if payment is to be made or certificates for shares not tendered or not accepted for payment are to be returned to a person other than the registered holder of the certificates surrendered, then the tendered certificates must be endorsed or accompanied by appropriate stock powers, in either case signed exactly as the name or names of the registered holders or owners appear on the certificates, with the signatures on the certificates or stock powers guaranteed by an Eligible Institution. See Instructions 1, 5 and 7 to the Letter of Transmittal.

If a book-entry account system is registered in the name of a person other than the person executing a Letter of Transmittal, or if payment is to be made, or shares not purchased or tendered are to be returned, to a person other than the registered holder, then the book-entry account system must be endorsed or accompanied by an appropriate stock power, signed in either case exactly as the name of the registered holder appears on the book-entry account system, with the signature guaranteed by an Eligible Institution.

In all cases, payment for shares tendered and accepted for payment pursuant to the Offer will be made only after timely receipt by the Depositary of a properly completed and duly executed Letter of Transmittal, including any required signature guarantees, or an Agent’s Message (as defined below) in the case of a book-entry transfer, and any other documents required by the Letter of Transmittal.

Stockholders also can specify the order in which we will purchase the specified portions in the event that, as a result of the proration provisions or otherwise, we purchase some but not all of the tendered shares pursuant to the Offer. In the event the stockholder does not designate the order and fewer than all shares are purchased due to proration, the Depositary will select the order of shares purchased.

Odd Lot Holders who tender all of their shares must also complete the section captioned “Odd Lots” in the Letter of Transmittal and, if applicable, in the Notice of Guaranteed Delivery, to qualify for the priority treatment available to Odd Lot Holders as set forth in Section 6.

The method of delivery of all documents, including the Letter of Transmittal and any other required documents, including through DTC, is at the election and risk of the tendering stockholder. Shares will be deemed delivered only when actually received by the Depositary (including, in the case of a book-entry transfer, by book-entry confirmation). If delivery is by mail, then registered mail with return receipt requested, properly insured, is recommended. In all cases, sufficient time should be allowed to ensure timely delivery.

All deliveries in connection with the Offer, including a Letter of Transmittal and certificates for shares, must be made to the Depositary and not to us, the Information Agent or DTC. ANY DOCUMENTS DELIVERED TO US, THE INFORMATION AGENT OR DTC WILL NOT BE FORWARDED TO THE DEPOSITARY AND WILL NOT CONSTITUTE PROPER DELIVERY TO THE DEPOSITARY.

Book-Entry Delivery

For purposes of the Offer, the Depositary will establish an account with respect to the shares for purposes of the Offer at DTC within two business days after the date of this Offer to Purchase, and any financial institution that is a participant in DTC’s system may make book-entry delivery of the shares by causing DTC to transfer shares into the Depositary’s account in accordance with DTC’s procedures for transfer. Although delivery of shares may be effected through a book-entry transfer into the Depositary’s account at DTC, either (i) a properly completed and duly executed Letter of Transmittal, with any required signature guarantees, or an Agent’s Message, and any other required documents must be transmitted to and received by the Depositary at one of its addresses set forth on the back cover of this Offer to Purchase before the Expiration Date, or (ii) the guaranteed delivery procedure described below must be followed. Delivery of the Letter of Transmittal and any other required documents to DTC does not constitute delivery to the Depositary.

The term “Agent’s Message” means a message transmitted by DTC to, and received by, the Depositary and forming a part of a book-entry confirmation, which states that DTC has received an express acknowledgement from the DTC participant tendering shares that such DTC participant has received and agrees to be bound by the terms of the Letter of Transmittal and that the Company may enforce such agreement against such DTC participant.

Guaranteed Delivery

If a stockholder desires to tender shares pursuant to the Offer and such stockholder’s certificates for shares are not immediately available or the procedure for book-entry transfer cannot be completed before the Expiration Date, or if time will not permit all required documents to reach the Depositary before the Expiration Date, the shares still may be tendered, if all of the following conditions are satisfied:

the tender is made by or through an Eligible Institution;

the Depositary receives by mail, overnight courier, or facsimile transmission, on or before the Expiration Date, a properly completed and duly executed Notice of Guaranteed Delivery substantially in the form we have provided with this Offer to Purchase, including (where required) a signature guarantee by an Eligible Institution in the form set forth in the Notice of Guaranteed Delivery; and

the confirmation of book-entry transfer of the shares into the Depositary’s account at DTC, together with a properly completed and duly executed Letter of Transmittal, or an Agent’s Message in the case of a book-entry transfer, and any required signature guarantees and other documents required by the Letter of Transmittal, are received by the Depositary within three business days after the date of receipt by the Depositary of the Notice of Guaranteed Delivery.

Stockholders may contact the Information Agent or their broker for assistance. The contact information for the Information Agent is on the back cover page of this Offer to Purchase.

Stock Option Plans; Stock Awards

All previously unvested stock options were accelerated upon commencement of the Offer and become fully vested, as determined by the our Board of Directors. See “Treatment of Options” under Section 12. Holders of unexercised stock options, whether previously vested or unvested, may exercise such options in accordance with the terms of our Omnibus Equity Compensation Plan or, if applicable, predecessor plans and the stock option grant agreements governing such options, and may tender the shares received upon such exercise in accordance with the Offer. See “Proper Tender of Shares” above. Holders of unexercised stock options should evaluate this Offer carefully to determine if participation would be advantageous to them, based on their stock option exercise prices, the date of their stock option grants, the years left to exercise their options, the tender price and the provisions for pro rata purchases by us described in Section 6. We encourage those holders to discuss the Offer with their broker, if any, or tax or financial advisor.

Convertible Preferred Stock

We are not offering to purchase any shares of our Series D Convertible Preferred Stock or Series E Convertible Preferred Stock. Holders of shares of either our Series D Convertible Preferred Stock or our Series E Convertible Preferred Stock may convert such shares into shares of common stock in accordance with the terms of our Restated Certificate of Incorporation. Holders of the converted shares can then tender such shares of common stock in accordance with the Offer. See “Proper Tender of Shares” above. Such holders should evaluate this Offer carefully to determine if participation would be advantageous to them, based on the conversion terms and dividend rates of their preferred shares, the tender price, and the provisions for pro rata purchases by us described in Section 6. The shares of preferred stock of both series are currently convertible, in the aggregate, into approximately 2,095,177 shares of our common stock.

Return of Unpurchased Shares

If any tendered shares are not purchased or are properly withdrawn, or if less than all shares evidenced by a stockholder’s book-entry account are tendered, the shares not purchased will be credited to the appropriate account maintained by the tendering stockholder at DTC, in each case without expense to the stockholder. In the case of shares in certificate form, the Depositary will return certificates as promptly as practicable after the expiration or termination of the Offer or the proper withdrawal of the shares as applicable.

United States Federal Income Tax Withholding and Backup Withholding

Under the United States federal income tax backup withholding rules, 28% of the gross proceeds payable to a tendering U.S. Holder (as defined in Section 16) or other payee pursuant to the Offer must be withheld and remitted to the United States Treasury, unless the U.S. Holder or other payee provides his or her correct taxpayer identification number (employer identification number or social security number) to the Depositary, certifies as to no loss of exemption from backup withholding and complies with applicable requirements of the backup withholding rules, or such U.S. Holder is otherwise exempt from backup withholding. Therefore, unless an exemption exists and is proven in a manner satisfactory to the Depositary, each tendering U.S. Holder should complete and sign the Substitute Form W-9 included as part of the Letter of Transmittal so as to provide the information and certification necessary to avoid backup withholding. Certain U.S. Holders (including, among others, all corporations) are not subject to these backup withholding requirements. In addition, in order for a Non-U.S. Holder (as defined in Section 16) to avoid backup withholding, the Non-U.S. Holder must submit a statement (generally, an IRS Form W-8BEN-E or W-8ECI), signed under penalties of perjury, attesting to that individual’s exempt status. Such statements can be obtained from the Depositary. See “Substitute Form W-9” in the Letter of Transmittal.

ANY TENDERING STOCKHOLDER OR OTHER PAYEE WHO FAILS TO COMPLETE FULLY AND SIGN THE SUBSTITUTE FORM W-9 INCLUDED IN THE LETTER OF TRANSMITTAL (OR SUCH OTHER IRS FORM AS MAY BE APPLICABLE) MAY BE SUBJECT TO UNITED STATES FEDERAL INCOME TAX BACKUP WITHHOLDING OF 28% OF THE GROSS PROCEEDS PAID TO SUCH STOCKHOLDER OR OTHER PAYEE PURSUANT TO THE TENDER OFFER.

Even if a Non-U.S. Holder (as defined in Section 16) has provided the required certification to avoid backup withholding, gross proceeds payable pursuant to the Offer to the Non-U.S. Holder or his or her agent will be subject to withholding of United States federal income tax at a rate of 30%, unless we determine that a reduced rate of withholding is applicable pursuant to a tax treaty or that an exemption from withholding is applicable because such gross proceeds are effectively connected with the conduct of the Non-U.S. Holder’s trade or business within the United States. A Non-U.S. Holder may be eligible to file for a refund of such tax or a portion of such tax withheld if such stockholder meets the “complete redemption,” “substantially disproportionate” or “not essentially equivalent to a dividend” tests described in Section 16 or if such stockholder is entitled to a reduced rate of withholding pursuant to a tax treaty and we withheld at a higher rate. In order to obtain a reduced rate of withholding under a tax treaty, a Non-U.S. Holder must deliver to the Depositary before

the payment a properly completed and executed IRS Form W-8BEN-E claiming such an exemption or reduction. Such forms can be obtained from the Depositary. In order to claim an exemption from withholding on the grounds that gross proceeds paid pursuant to the Offer are effectively connected with the conduct of a trade or business within the United States, a Non-U.S. Holder must deliver to the Depositary a properly executed IRS Form W-8ECI claiming such exemption. Such forms can be obtained from the Depositary. See “Substitute Form W-9” in the Letter of Transmittal. Backup withholding generally will not apply to amounts subject to the 30% or a treaty-reduced rate of withholding. Non-U.S. Holders are urged to consult their own tax advisors regarding the application of United States federal income tax withholding, including eligibility for a withholding tax reduction or exemption and the refund procedure.

Determination of Validity; Rejection of Shares; Waiver of Defects; No Obligation to Give Notice of Defects

All questions as to the number of shares to be accepted and the validity, form, eligibility (including time of receipt) and acceptance for payment of any tender of shares will be determined by us, in our sole discretion, and our determination will be final and binding on all persons participating in the Offer, subject to such offer participants disputing such determination in a court of competent jurisdiction. We reserve the absolute right prior to the Expiration Date to reject any or all tenders of any shares that we determine are not in proper form or the acceptance for payment of or payment for which may, in the opinion of our counsel, be unlawful. We also reserve the absolute right, subject to applicable law, to waive any of the conditions of the Offer prior to the Expiration Date with respect to all tendered shares and our interpretation of the terms of the Offer will be final and binding on all persons participating in the Offer, subject to such offer participants disputing such determination in a court of competent jurisdiction. We also reserve the absolute right to waive any defect or irregularity in any tender with respect to any particular shares or any particular stockholder. No tender of shares will be deemed to have been properly made until all defects or irregularities have been cured by the tendering stockholder or waived by us. We will not be liable for failure to waive any condition of the Offer, or any defect or irregularity in any tender of shares. None of us, the Depositary, the Information Agent or any other person will be obligated to give notice of any defects or irregularities in tenders, nor will any such person incur any liability for failure to give any notice. Our interpretations of the terms of and conditions to the Offer, including the Letter of Transmittal and the instructions thereto, will be final and binding on all persons participating in the Offer, subject to such offer participants disputing such determination in a court of competent jurisdiction.

Tendering Stockholder’s Representation and Warranty; Acceptance by Us Constitutes an Agreement

A tender of shares pursuant to any of the procedures described above will constitute the tendering stockholder’s acceptance of the terms and conditions of the Offer, as well as the tendering stockholder’s representation and warranty to us that (i) the stockholder has a “net long position,” within the meaning of Rule 14e-4 promulgated by the SEC under the Exchange Act, in the shares or equivalent securities at least equal to the shares being tendered, and (ii) the tender of shares complies with Rule 14e-4. It is a violation of Rule 14e-4 for a person, directly or indirectly, to tender shares for that person’s own account unless, at the time of tender and at the end of the proration period or period during which shares are accepted by lot (including any extensions thereof), the person so tendering (i) has a net long position equal to or greater than the amount of (a) shares tendered or (b) other securities convertible into or exchangeable or exercisable for the shares tendered and will acquire the shares for tender by conversion, exchange or exercise and (ii) will deliver or cause to be delivered the shares in accordance with the terms of the Offer. Rule 14e-4 provides a similar restriction applicable to the tender or guarantee of a tender on behalf of another person. Our acceptance for payment of shares tendered pursuant to the Offer will constitute a binding agreement between the tendering stockholder and us upon the terms and conditions of the Offer.

A tender of shares made pursuant to any method of delivery set forth herein will also constitute a representation and warranty to us that the tendering stockholder has full power and authority to tender, sell, assign and transfer the shares tendered, and that, when the same are accepted for purchase by us, we will acquire good, marketable and unencumbered title thereto, free and clear of all security interests, liens, restrictions,

claims, encumbrances, conditional sales agreements and other obligations relating to the sale or transfer of the shares, and the same will not be subject to any adverse claim or right. Any such tendering stockholder will, on request by the Depositary or us, execute and deliver any additional documents deemed by the Depositary or us to be necessary or desirable to complete the sale, assignment and transfer of the shares tendered, all in accordance with the terms of the Offer.

A properly completed Letter of Transmittal and any other documents required by the Letter of Transmittal, must be delivered to the Depositary and not to us or the Information Agent. All authority conferred or agreed to be conferred by delivery of the Letter of Transmittal shall be binding on the successors, assigns, heirs, personal representatives, executors, administrators and other legal representatives of the tendering stockholder and shall not be affected by, and shall survive, the death or incapacity of such tendering stockholder.

Lost Certificates

If the share certificates which a registered holder wants to surrender have been lost, destroyed or stolen, the stockholder should follow the instructions set forth in the Letter of Transmittal. See Instruction 10 of the Letter of Transmittal.

WE WILL DECIDE, IN OUR REASONABLE DISCRETION, ALL QUESTIONS AS TO THE NUMBER OF SHARES TO BE ACCEPTED AND THE VALIDITY, FORM, ELIGIBILITY (INCLUDING TIME OF RECEIPT) AND ACCEPTANCE FOR PAYMENT OF ANY TENDER OF SHARES, AND EACH SUCH DECISION WILL BE FINAL AND BINDING ON ALL PERSONS PARTICIPATING IN THE OFFER, SUBJECT TO SUCH OFFER PARTICIPANTS DISPUTING SUCH DETERMINATION IN A COURT OF COMPETENT JURISDICTION.

CERTIFICATES FOR SHARES, TOGETHER WITH A PROPERLY COMPLETED AND DULY EXECUTED LETTER OF TRANSMITTAL, OR AN AGENT’S MESSAGE, AND ANY OTHER DOCUMENTS REQUIRED BY THE LETTER OF TRANSMITTAL, MUST BE DELIVERED TO THE DEPOSITARY AND NOT TO US OR THE INFORMATION AGENT. ANY SUCH DOCUMENTS DELIVERED TO US OR THE INFORMATION AGENT WILL NOT BE FORWARDED TO THE DEPOSITARY AND THEREFORE WILL NOT BE DEEMED TO BE PROPERLY TENDERED.

SECTION 8. WITHDRAWAL RIGHTS.

Shares tendered pursuant to the Offer may be withdrawn at any time before the Expiration Date. In addition, unless we have already accepted your tendered shares for payment, you may withdraw your tendered shares at any time after 12:00 midnight, New York City time, on December 2, 2014. Except as otherwise provided in this Section 8, tenders of shares pursuant to the Offer are irrevocable.

If we extend the period of time during which the Offer is open, are delayed in accepting for payment or paying for shares or are unable to accept for payment or pay for shares pursuant to the Offer for any reason, then, without prejudice to our rights under the Offer, the Depositary may, on our behalf, retain all shares tendered, and such shares may not be withdrawn except as otherwise provided in this Section 8, subject to Rule 13e-4(f)(5) under the Exchange Act, which provides that the issuer making the Offer shall either pay the consideration offered, or return the tendered securities, promptly after the termination or withdrawal of the Offer.

For a withdrawal to be effective, a notice of withdrawal must be in writing, must be received in a timely manner by the Depositary at one of its addresses set forth on the back cover of this Offer to Purchase and must specify the name of the person having tendered the shares to be withdrawn, the number of shares to be withdrawn and the name of the registered holder of the shares to be withdrawn, if different from the name of the person who tendered the shares. If shares have been tendered pursuant to the procedure for book-entry transfer described in Section 7, the notice of withdrawal also must specify the name and the number of the account at DTC to be credited with the withdrawn shares and must otherwise comply with DTC’s procedures.

All questions as to the form and validity, including the time of receipt, of any notice of withdrawal will be determined by us, in our sole discretion, which determination will be final and binding on all persons participating in the Offer, subject to such offer participants disputing such determination in a court of competent jurisdiction. We also reserve the absolute right to waive any defect or irregularity in the withdrawal of shares by any stockholder. However, if we waive any defect or irregularity in any withdrawal with respect to any stockholder, we also waive such defect or irregularity with respect to all stockholders. None of us, the Depositary, the Information Agent or any other person will be obligated to give notice of any defects or irregularities in any notice of withdrawal, nor will any such person incur liability for failure to give any notice.

Withdrawals may not be rescinded, and any shares properly withdrawn will be deemed not properly tendered for purposes of the Offer. However, withdrawn shares may be re-tendered before the Expiration Date by again following one of the procedures described in Section 7.

SECTION 9. PURCHASE OF SHARES AND PAYMENT OF PURCHASE PRICE.

Upon the terms and subject to the conditions of the Offer, promptly following the Expiration Date, we (i) will determine which stockholders properly tendered shares and (ii) will accept for payment and pay for (and thereby purchase) up to 27,530,816 shares (or such greater number of shares as we may elect to purchase, subject to applicable law) which are properly tendered and not properly withdrawn on or before the Expiration Date. For purposes of the Offer, we will be deemed to have accepted for payment (and therefore purchased), subject to the Odd Lot priority and proration provisions of the Offer, shares that are properly tendered and not properly withdrawn only when, as and if we give oral or written notice to the Depositary of our acceptance of the shares for payment in the Offer.

Upon the terms and subject to the conditions of the Offer, we will accept for payment and pay $1.20 for each such share promptly after the Expiration Date. In all cases, payment for shares tendered and accepted for payment in the Offer will be made promptly, subject to the possible delay in the event of proration, but only after timely receipt by the Depositary of certificates for shares or book-entry confirmation of shares into the Depositary’s account at DTC, a properly completed and duly executed Letter of Transmittal or an Agent’s Message, in the case of a book-entry transfer, and any other documents required by the Letter of Transmittal.

We will pay for shares purchased in the Offer by depositing the aggregate purchase price for the shares with the Depositary, which will act as agent for tendering stockholders for the purpose of receiving payment from us and transmitting payment to the tendering stockholders.

In the event of proration, we will determine the proration factor and pay for those tendered shares accepted for payment promptly after the Expiration Date. Unless a stockholder specified otherwise in the Letter of Transmittal, certificates for all shares tendered and not purchased, including shares not purchased due to proration, will be returned or, in the case of shares tendered by book-entry transfer, will be credited to the account maintained with DTC by the participant who delivered the shares, to the tendering stockholder at our expense promptly after the Expiration Date or termination of the Offer without expense to the tendering stockholders. Under no circumstances will we pay interest on the purchase price for any reason, including but not limited to, by reason of any delay in making payment. In addition, if certain events occur, we may not be obligated to purchase shares in the Offer. See Section 10 for a description of such conditions.

We will pay all stock transfer taxes, if any, payable on the transfer to us of shares purchased pursuant to the Offer. If, however, payment of the purchase price is to be made to, or (in the circumstances permitted by the Offer) unpurchased shares are to be registered in the name of, any person other than the registered holder, or if tendered book-entry accounts are registered in the name of any person other than the person signing the Letter of Transmittal, the amount of all stock transfer taxes, if any (whether imposed on the registered holder or the other person), payable on account of the transfer to the person will be deducted from the purchase price unless satisfactory evidence of the payment of the stock transfer taxes, or exemption from payment of the stock transfer taxes, is submitted.

Any tendering stockholder or other payee who fails to complete fully, sign and return to the Depositary the Substitute Form W-9 included with the Letter of Transmittal (and an IRS Form W-8BEN-E or other applicable form, if the tendering stockholder or other payee is a Non-U.S. Holder), may be subject to required United States federal income tax backup withholding of 28% of the gross proceeds paid to the stockholder or other payee pursuant to the Offer. See Section 16. Non-U.S. Holders are urged to consult their tax advisors regarding the application of United States federal income tax withholding, including eligibility for a withholding tax reduction or exemption, and the refund procedure.

SECTION 10. CONDITIONS OF THE OFFER.

Notwithstanding any other provision of the Offer, and subject to any applicable rules and regulations of the SEC, including Rule 13e-4(f) under the Exchange Act (relating to a purchaser’s obligation to pay for or return tendered shares promptly after termination or withdrawal of an Offer to Purchase), we will not be required to accept for payment or purchase or pay for any shares tendered, and we may terminate or amend the Offer or may postpone the acceptance for payment of, or the purchase of and the payment for, shares tendered, if, at any time on or after the commencement of the Offer and on or prior to the Expiration Date, any of the following events occur, or are determined by us to have occurred, that, in our reasonable judgment and regardless of the circumstances giving rise to the event, including any action or omission to act by us, makes it inadvisable to proceed with the Offer or with acceptance for payment or payment for the shares pursuant to the Offer:

(1) the consummation of certain financing transactions, on terms reasonably satisfactory to us, resulting in aggregate proceeds to us that are sufficient (together with approximately $9.5 million cash on hand) to fund our purchase of up to 27,530,816 shares in the Offer, which is referred to as the “Financing Condition,” has not occurred;

(2) our trailing twelve month consolidated EBITDA (defined as consolidated net income plus (i) consolidated interest expense, (ii) consolidated income tax expense, (iii) amounts attributable to depreciation and amortization, (iv) non-cash expenses associated with stock-based incentive compensation, (v) stock-based compensation and CEO compensation, (vi) certain one-time expenses and (vii) expenses arising from the sale of Rand SD, less (viii) all non-cash items of income and all extraordinary gains to the extent included in consolidated net income, all in accordance with generally accepted accounting procedures), is determined to be less than $11,800,000 for the period ended August 30, 2014;

(3) there shall have been threatened, instituted or pending before any court, agency, authority or other tribunal any action, suit or proceeding by any government or governmental, regulatory or administrative agency or authority or by any other person, domestic or foreign, or any judgment, order or injunction entered, enforced or deemed applicable by any court, authority, agency or tribunal, which directly or indirectly:

(a) challenges or seeks to make illegal, or to delay or otherwise directly or indirectly to restrain, prohibit or otherwise affect the making of the Offer or the acquisition of shares pursuant to the Offer, or is otherwise related in any manner to, or otherwise affects, the Offer; or

(b) could, in our reasonable judgment, materially affect the Company’s business, condition (financial or other), income, operations or prospects or otherwise materially impair in any way the contemplated future conduct of the Company’s business or materially impair the Offer’s contemplated benefits to us;

(4) there shall have been any action threatened, pending or taken, or any approval withheld, or any statute, rule or regulation threatened, proposed, sought, promulgated, enacted, entered, amended, enforced or deemed to be applicable to the Offer, to us or to any of our subsidiaries, by any government or governmental, regulatory or administrative authority or agency or tribunal, domestic or foreign, which, in our reasonable judgment, would or might directly or indirectly result in any of the consequences referred to in clause (a) or (b) of paragraph (3) above;

(5) the declaration of a banking moratorium or any suspension of payments with respect to banks in the United States (whether or not mandatory);

(6) any general suspension of trading in, or limitation on prices for, securities on any national securities exchange or in the over-the-counter market;

(7) the commencement or escalation of a war, armed hostilities, terrorist activity or any other national or international crisis directly or indirectly involving the United States;

(8) any limitation (whether or not mandatory) by any governmental, regulatory or administrative agency or authority on, or any event that, in our reasonable judgment, might materially affect the extension of credit by banks or other lending institutions in the United States;

(9) in the case of any of the foregoing existing at the time of the announcement of the Offer, a material acceleration or worsening thereof;

(10) any change or event occurs, is discovered, or is threatened with regard to our business, condition (financial or otherwise), income, operations, or prospects or in ownership of our shares, which in our reasonable judgment is or may be material to us;

(11) a tender or exchange offer with respect to some or all of our outstanding shares, other than the Offer, or a merger or acquisition proposal for or by us, is proposed, announced or made by another person or is publicly disclosed, or we learn that any person or “group,” within the meaning of Section 13(d)(3) of the Exchange Act (other than 3K or its affiliates), has acquired or proposes to acquire beneficial ownership of more than 50% of our outstanding shares, or any new group is formed that beneficially owns more than 50% of our outstanding shares; or

(12) any person or group shall have made a public announcement reflecting an intent to acquire us or any of our assets or securities other than in connection with a transaction authorized by our Board of Directors.

We have received a commitment letter from JPMCB on September 26, 2014 outlining the terms upon which the bank will commit to finance our purchase of shares in the Offer as outlined in clause (1) of the conditions above. We expect to obtain this financing on the terms outlined in the commitment letter.

These conditions are for our sole benefit and may be asserted by us or waived by us in whole or in part, at any time and from time to time on or prior to the expiration date of the Offer, in our sole discretion. Our failure at any time to exercise any of the foregoing rights shall not be deemed a waiver of any of these rights, and each of these rights shall be deemed an ongoing right that may be asserted by us at any time prior to the expiration of the Offer. Any determination or judgment by us concerning the events described above will be final and binding on all parties. The Exchange Act requires that all conditions to the Offer be satisfied or waived before the Expiration Date. In certain circumstances, if we waive any of the conditions described above, we may be required to extend the Expiration Date.

SECTION 11. PRICE RANGE OF SHARES; DIVIDENDS.

Our shares are not heavily traded. Trades are effected in privately-negotiated transactions and by certain broker-dealers, who make a market in the common stock through the OTCQB tier of OTC Markets Group Inc. Market information for Rand Worldwide, Inc.’s common stock may be found at the OTC Markets Group’s Internet website, www.otcmarkets.com, under the symbol “RWWI”. The information contained in or accessed through that website is not part of this Offer to Purchase or incorporated herein by reference. The following table sets forth, to the best of our knowledge, the high and low bid quotations per share, rounded to the nearest whole cent, as available through the OTCQB for each quarterly period within the two most recent fiscal years. These quotations represent prices between dealers and do not reflect retail mark-ups, mark-downs or commissions, and may not represent actual transactions. There may have been additional transactions during these periods of which we are not aware.


Fiscal Year Ended or Ending	Quarter	High		Low
June 30, 2013	First Quarter	$	0.85	$	0.67
	Second Quarter	$	0.86	$	0.68
	Third Quarter	$	0.94	$	0.70
	Fourth Quarter	$	0.95	$	0.81
June 30, 2014	First Quarter	$	1.02	$	0.91
	Second Quarter	$	1.07	$	0.96
	Third Quarter	$	1.25	$	0.99
	Fourth Quarter	$	1.19	$	1.05
June 30, 2015	First Quarter (through September 26, 2014)	$	1.19	$	1.11

We have never paid cash dividends on our common stock, during the periods reflected in the table above or otherwise, and we do not anticipate paying cash dividends in the foreseeable future. Rather, management intends to continue its strategy of retaining earnings for the foreseeable future for use in the expansion and operation of our business. The declaration and amount of any future cash dividends is at the discretion of our Board of Directors. Moreover, without the consent of our lenders, we are and will be prohibited from declaring dividends on our common stock. Accordingly, there can be no guarantee that stockholders will receive any cash dividends on their common stock in the future.

On September 26, 2014, the last trading day before we announced our intention to commence the Offer, the closing price per share of our common stock, as reported on the OTCQB, was $1.15. You are urged to obtain current market quotations for the common stock before you tender your shares.

SECTION 12. INTEREST OF DIRECTORS, EXECUTIVE OFFICERS AND PRINCIPAL STOCKHOLDERS; TRANSACTIONS AND ARRANGEMENTS CONCERNING SHARES.

General

On September 29, 2014, there were 54,491,296 shares of our common stock issued and outstanding, 3,311,745 shares issuable upon exercise of outstanding options, 2,095,177 shares issuable upon conversion of our preferred stock, and no shares held in treasury. RWWI Holdings LLC, which is majority-owned by funds affiliated with Ampersand Capital Partners, owns 25,232,682 shares, or approximately 46.3%, of our outstanding common stock. The 27,530,816 shares of common stock that we are offering to purchase pursuant to the Offer represent approximately 50.5% of the shares of common stock outstanding on September 22, 2014 (or approximately 46.0% assuming exercise of all outstanding options and conversion of all shares of preferred stock). As of September 29, 2014, our directors and executive officers as a group (6 persons) beneficially owned an aggregate of 18,969,277 shares (including 2,097,500 shares issuable to those persons upon exercise of options and 38,462 shares issuable upon conversion of Series E Convertible Preferred Stock), which constituted approximately 33.5% of our outstanding shares on that date, assuming the exercise by such persons of their options and conversion of their preferred stock.

Purchase Agreement

On September 26, 2014, our majority stockholder at the time, RWWI Holdings LLC, and an affiliate of 3K Limited Partnership entered into a Securities Purchase Agreement (the “Purchase Agreement”) in connection with the purchase of 9,000,000 shares of our common stock from RWWI Holdings LLC by the affiliate of 3K at a purchase price of $1.20 per share, for an aggregate purchase price of $10.8 million. The Purchase Agreement includes a put right, exercisable by 3K under certain circumstances, pursuant to which 3K will have the right to require RWWI Holdings LLC to repurchase all 9 million shares sold in the Purchase Agreement if (i) the Company had failed to commence this Offer by October 10, 2014, (ii) the Company withdraws or terminates this Offer without having purchased the shares tendered in it at $1.20 per share, or (iii) the Offer has not been completed by November 15, 2014, such that 3K and its affiliates own a majority of the shares then outstanding. RWWI Holdings LLC also agreed in the Purchase Agreement to tender all of its remaining shares in this Offer, and not to exercise any further board designation rights under the Existing Stockholders’ Agreement so long as that agreement may remain in effect.

Treatment of Options

In light of the limited liquidity of the shares and in order to permit holders of our stock options to benefit from the liquidity that the Offer may provide to those who wish to participate, our Board of Directors voted to accelerate all unvested stock options granted under our stock option or omnibus equity incentive plans. This will permit holders of options, if they so wish, to exercise those options, whether vested or unvested prior to the Offer, and participate in the Offer on the same terms as other stockholders. As of June 30, 2014, the last day of our most recently completed fiscal year, there were 1,960,591 vested options outstanding with a weighted average exercise price of $0.80, and 1,351,154 unvested options outstanding with a weighted average exercise price of $0.89.

Our stock option plans do not currently provide a mechanism for cashless exercise or net settlement. As a result, optionholders who otherwise may wish to participate in the Offer may be unable to exercise their stock options if they cannot obtain the cash funds necessary to pay the exercise price of their options prior to the expiration of the Offer. For this reason, the Board of Directors has agreed to permit the “net settlement” of stock options for those holders of stock options who wish to participate in the Offer. Optionholders who choose to exercise their stock options through “net settlement” will not be required to deliver payment of the exercise price of their stock options in order to exercise. Instead, upon the exercise of their stock options, we will retain the number of shares necessary to cover the cost of the required tax withholding and the exercise price of such options. Following such “net settlement,” the optionholder will hold the balance of the shares resulting from the exercise of such stock options, which will be available for participation in the tender offer. Optionholders who elect to use this net settlement alternative and to tender the underlying shares in the Offer will receive fewer shares (and thus will tender fewer shares in the Offer) than they would have through payment of the cash exercise price in full. At the same time, we will not receive any cash proceeds from the payment of the exercise price by such optionholders, and will be required to remit cash payments to the Internal Revenue Service in an amount equal to the federal tax withholding, the employee payroll tax and the employer payroll tax for the exercised non-qualified stock options. Compliance with this withholding and tax payment obligation will therefore represent a net cash expense to us. The Board of Directors has considered the estimated impact of this withholding obligation (estimated to be approximately $200,000) in approving the Offer and establishing the number of shares we will purchase in the Offer.

Based on our inquiry, we believe that our executive officers and directors intend to exercise an aggregate of approximately 1,154,400 options, with a weighted average exercise price of $0.796 per share, in order to tender the underlying shares (expected to be 291,295 shares in the aggregate after the payment of the exercise price through net settlement) in the Offer.

Participation by Executive Officers and Directors in the Offer

Our executive officers and directors are entitled to participate in the Offer on the same basis as all other stockholders. As noted above, we anticipate that certain of our directors or executive officers will participate in the Offering by tendering 291,295 shares. These directors and executive officers have advised us that they are tendering shares to obtain some liquidity or for tax planning or asset diversification purposes. Of this amount, Marc Dulude intends to tender 282,032 shares in the Offer (all of which are expected to be received upon exercise of options); and Manu Parpia, a director, intends to tender 9,263 shares in the Offer (all of which are expected to be received upon exercise of options). In addition, we believe that non-executive officers are likely to exercise options to purchase 807,795 shares of common stock and to tender the underlying shares (201,716 shares after payment of the exercise price through net settlement) in the Offer.

As discussed in Section 2, the proposal to engage in the Offer was discussed with a special committee of our Board of Directors and by our Board of Directors, a majority of both of which are non-employee directors. The Offer was proposed as means of offering liquidity to any stockholders (including RWWI Holdings LLC) who wish to tender shares of common stock in the Offer, not for the benefit of individual directors or members of management. To this end, the Board considered several factors, including the written opinion of Covington in its evaluation of the fairness of the Offer. The Special Committee and the Board deliberated the merits of the proposed transaction. Other than our Chief Executive Officer and our President and Chief Financial Officer, who are also directors, management did not vote on the proposed offer.

Assuming we purchase 27,530,816 shares pursuant to the Offer, the percentage of shares beneficially owned by our current executive officers and directors following the Offer would represent approximately 63.8% of the outstanding shares immediately after the Offer, including shares issuable upon the exercise of options held by executive officers and directors. This amount assumes the sale of shares by Messrs. Dulude and Parpia described above, without proration. It also includes the shares to be held by 3K and its affiliates following the Offer, beneficial ownership of which may be attributable to Peter Kamin, which shares alone would represent approximately 62.5% of our outstanding shares.

The following table contains common stock ownership information for persons known to us to “beneficially own” 5% or more of our common stock as of September 29, 2014. We obtained the information provided in the following table from filings with the SEC and from our own records.


Title of Class	Name and Address of Beneficial Owner	Amount and Nature of Beneficial Ownership			Percent
Common Stock	RWWI Holdings LLC c/o Ampersand Capital Partners 55 William Street, Suite 240 Wellesley, MA 02481		25,232,682			46.3	%

Common Stock	Peter H. Kamin 20 Custom House Street, Suite 610 Boston, MA 02110		16,869,215	(1)		30.9	%

(1)	Includes 5,804,361 shares owned by Mr. Kamin directly; 832,635 shares owned by a trust for members of Mr. Kamin’s family; 1,196,219 shares owned by 3K Limited Partnership, of which Mr. Kamin is managing partner; 9,000,000 shares owned by Rand Acquisition LLC; and 36,000 shares underlying options.

Security Ownership of Management. The following table shows the number of shares of our common stock beneficially owned by each director, each executive officer, and all of our directors and executive officers as a group, as of September 29, 2014, based on a total of 54,491,296 shares outstanding. Except as otherwise indicated, each person and each group shown in the table has sole voting and investment power with respect to the shares of common stock listed next to his or her name. “Voting power” is the power to vote or direct the voting of shares, and “investment power” is the power to dispose of or direct the disposition of shares.


	Common Stock					Series D Convertible Preferred Stock				Series E Convertible Preferred Stock
Beneficial Owner	Shares Beneficially Owned		Percent of Class			Shares Beneficially Owned		Percent of Class		Shares Beneficially Owned		Percent of Class
Peter H. Kamin¹		16,869,215		30.9	%		—		—		—		—
Marc L. Dulude²		1,114,200		2.0	%		—		—		—		—
Lawrence Rychlak³		945,562		1.7	%		—		—		25		2.9	%
Manu Parpia⁴		40,200		*			—		—		—		—
Richard A. Charpie		—		—			—		—		—		—
Charles D. Yie		—		—			—		—		—		—
All current directors, director nominees, and executive officers as a group (a total of 6 persons):		18,969,177		33.5	%		—		—		25		2.9	%

(*)	Less than one percent of the total outstanding shares of common stock.

(1)	Mr. Kamin is a member of the Board of Directors. The amount shown for Mr. Kamin includes 36,000 shares of Common Stock subject to exercisable options.

(2)	Mr. Dulude is Chairman of the Board of Directors and also serves as the Company’s Chief Executive Officer. The amount shown for Mr. Dulude is comprised of 1,114,200 shares of Common Stock subject to exercisable options.

(3)

Mr. Rychlak is a member of the Board of Directors and also serves as the Company’s President and Chief Financial Officer. The amount shown for Mr. Rychlak includes 907,100 shares of Common Stock subject to exercisable options and 38,462 shares of Common Stock issuable on conversion of shares of Series E Convertible Preferred Stock.

(4)	Mr. Parpia is a member of the Board of Directors and the amount shown for Mr. Parpia is comprised of 40,200 shares of Common Stock subject to options.

In general, beneficial ownership includes those shares that a person has the power to vote, sell or otherwise dispose of, including that number of shares which an individual has the right to acquire within 60 days (such as stock options). Two or more persons may be considered the beneficial owner of the same shares. The amounts reflected above includes 766,012 stock options held by Mr. Dulude that are being accelerated in connection with the commencement of the Offer and 383,006 stock options held by Mr. Rychlak that are being accelerated upon commencement of the Offer, following the determination of the Board of Directors described under “Treatment of Options” above. No other persons in the table above held options that were accelerated. Based upon our records and upon information provided to us by our directors, executive officers and subsidiaries, neither we, nor any of our subsidiaries or affiliates, nor, to the best of our knowledge, any of our directors or executive officers or their affiliates, have effected any transactions in our shares on the date of this document or during the 60 days prior to the date of this document, except for the Purchase Agreement between RWWI Holdings LLC and an affiliate of 3K described in this Section 12.

Except as otherwise described herein (including the description of the Purchase Agreement described under this Section 12 and the Existing Stockholders’ Agreement described in Section 4), neither we nor, to the best of our knowledge, any of our affiliates, directors or executive officers, is a party to any contract, arrangement, understanding or relationship with any other person relating, directly or indirectly, to the Offer or with respect to any of our securities, including, but not limited to, any contract, arrangement, understanding or relationship concerning the transfer or the voting of any such securities, joint ventures, loan or option arrangements, puts or calls, guarantees of loans, guarantees against loss or the giving or withholding of proxies, consents or authorizations.

Certain Severance Arrangements

Under his employment agreement with us dated March 23, 2011, in connection with his termination from service from us as Chief Executive Officer as described in Section 4, Mr. Dulude will be entitled to severance payments in an amount equal to twelve months’ salary and benefits continuation, without bonus, provided that he complies with certain terms of his employment agreement, including executing a general release in favor of us. Mr. Dulude’s current annual base salary is $319,000.

SECTION 13. SOURCE AND AMOUNT OF FUNDS.

If the Offer is fully subscribed, we will purchase 27,530,816 shares of common stock at an aggregate purchase price of approximately $33.0 million in the Offer. We expect to fund the purchase of these shares, and to pay related fees and expenses, through (i) cash on hand of approximately $9.5 million and (ii) borrowings under a new five year secured credit facility to be entered into with JPMCB. This facility is anticipated to include a revolving credit facility of $10,000,000 and a term loan of $25,000,000 (the “Credit Facility”). If fewer than 27,530,816 shares are tendered in the Offer, the term loan will adjust downward to an amount no greater than 75.67% of the amount necessary to fund the purchase of the shares tendered. This Offer is subject to the Financing Condition, meaning that if the Company is unable to obtain financing in an amount sufficient to fund the share purchases in the Offer by us, we will not be required to close the Offer. The Company has received a commitment letter from JPMCB outlining the terms and conditions of the Credit Facility under which JPMCB has committed to lend.

The closing of the Credit Facility is expected to be subject to certain customary and other conditions, including: (i) minimum last-twelve-month earnings before interest, taxes, depreciation and amortization (LTM EBITDA) as of August 30, 2014 of $11,800,000 (adjusted for stock based compensation, CEO compensation, certain expenses, and the sale of our Rand Secure Data business), and (ii) no additional Company indebtedness other than that contemplated in the Credit Facility.

Risks Relating to Higher Leverage

We will incur increased indebtedness in connection with the purchase of shares in the Offer and, as a result, will be more leveraged. We expect to generate the cash necessary to pay our expenses and to pay the principal and interest on all of our outstanding debt from cash flows provided by operating activities and by opportunistically using other means to repay or refinance our obligations as we determine appropriate. Our ability to pay our expenses and meet our debt service obligations depends on our future performance, which may be affected by financial, business, economic, and other factors. If we do not have enough money to pay our debt service obligations, we may be required to refinance all or part of our existing debt, sell assets, borrow more money or raise equity. In such an event, we may not be able to refinance our debt, sell assets, borrow more money or raise equity on terms acceptable to us or at all. Also, our ability to carry out any of these activities on favorable terms, if at all, may be further impacted by any financial or credit crisis which may limit access to the credit markets and increase the cost of capital.

The Credit Facility is expected to contain customary covenants, including covenants that in certain circumstances restrict our ability to incur additional indebtedness, pay dividends on and redeem capital stock, make other payments, including investments, sell assets and enter into consolidations, mergers and transfers of all or substantially all of our assets. The Credit Facility will also require us to maintain specified financial ratios and satisfy certain financial condition tests. Our ability to meet those financial ratios and tests can be affected by events beyond our control and we cannot assure you that we will meet those ratios and tests. A breach of any of these covenants, ratios, tests or restrictions could result in an event of default under the Credit Facility. If an event of default exists under the Credit Facility, the lenders could elect to cease making loans and declare all amounts outstanding thereunder to be immediately due and payable. If the lenders under the Credit Facility accelerate the payment of the indebtedness, our assets may not be sufficient to repay in full that indebtedness and any other indebtedness that would become due as a result of any acceleration.

SECTION 14. CERTAIN INFORMATION CONCERNING RAND.

Information Relating to Rand

Rand Worldwide, Inc. is a leading supplier in the design automation, facilities and data management software marketplace. We also provide value-added services, such as training, technical support and other consulting and professional services to corporations, government agencies and educational institutions worldwide.

We are organized into three divisions: IMAGINiT Technologies (“IMAGINiT”), Enterprise Applications and ASCENT—Center for Technical Knowledge (“ASCENT”).

The IMAGINiT division is one of the largest value-added resellers of Autodesk, Inc. (“Autodesk”) products in the world, providing Autodesk solutions and value-added services to customers in the manufacturing, infrastructure, building, and media and entertainment industries. IMAGINiT also specializes in computational fluid dynamics analysis consulting and thermal simulation services and sells its own proprietary software products and related services, enhancing its total client solution offerings. IMAGINiT operates in the United States and Canada.

The Enterprise Applications division is the non-Autodesk component of the business and offers various products and services including data governance solutions, facilities management solutions and 3DExperience products from Dassault Systèmes which include CATIA, ENOVIA, SIMULIA, DELMIA, and DMU. Enterprise Applications also specializes in training solutions for Dassault Systèmes and PTC products including Pro/ENGINEER, CREO, and Windchill. In December 2013, the Rand Secure Archive division within Enterprise Applications expanded its range of data governance solutions with the addition of data backup. To reflect this evolution beyond data archiving and eDiscovery, this division has changed its name to Rand Secure Data. On September 24, 2014, Rand SD was sold to a third party purchaser for a purchase price of $500,000. See “Background of the Offer” in Section 1.

ASCENT is our courseware division and is a leading developer of professional training materials and knowledge products for engineering software tools.

Our executive offices are located at 161 Worcester Road, Suite 401, Framingham, Massachusetts 01701. Our telephone number is (508) 663-1400.

A list of our directors and officers as of October 1, 2014 is attached to this Offer to Purchase as Appendix A.

Our audited financial statements for the fiscal years ended June 30, 2013 and 2014 are incorporated herein by reference to our Form 10-K for the year ended June 30, 2014 filed with the Securities and Exchange Commission on September 29, 2014.

Summary Historical and Pro Forma Condensed Consolidated Financial Data

Historical Financial Information. We incorporate by reference the financial statements and notes thereto included in Part II, Item 8 of our Annual Report on Form 10-K for the fiscal year ended June 30, 2014. Please refer to “Where You Can Find More Information” below for instructions on how you can obtain copies of our SEC filings, including filings that contain our financial statements.

Summary Historical Consolidated Financial Data. The following table sets forth our summary historical consolidated financial data for the years ended June 30, 2014 and 2013, and certain selected ratios for such periods. This financial data has been derived from, and should be read in conjunction with, our audited consolidated financial statements and the related notes filed as part of our Annual Report on Form 10-K for the year ended June 30, 2014.


	Fiscal Year Ended June 30,
Consolidated Statements of Income Data:	2014			2013
Revenue	$	91,596,000		$	82,503,000

Gross margin		45,286,000			41,681,000

Operating expense		37,728,000			37,002,000

Operating income		7,558,000			4,679,000
Interest and other expense		224,000			476,000

Income from continuing operations before income taxes		7,334,000			4,203,000

Provision for income taxes		(1,723,000	)		1,691,000

Income from continuing operations	$	9,057,000		$	2,512,000

Net earnings per share from continuing operations available to common stockholders:
Basic		0.17			0.04
Diluted		0.16			0.04
Shares used in computing earnings per share
Basic		54,210,555			53,951,438
Diluted		57,039,061			55,102,436

Other Data:
Ratio of earnings to fixed charges (a)		22.2x			9.3x

(a)	Earnings included in the calculation of this ratio consist of income before income taxes plus interest expense. Fixed charges include interest expense and pre-tax earnings amounts necessary to pay preferred stock dividends.


Consolidated Balance Sheet Data:	As of June 30, 2014
Current Assets	$	29,098,000

Total Assets		58,757,000

Current liabilities:
Short-term debt due within 1 year		188,000
All other current liabilities		15,897,000

Total current liabilities		16,085,000
Long-term debt and other liabilities		352,000

Total liabilities		16,437,000

Accumulated deficit		(25,205,000	)
Total stockholders’ equity		42,320,000

Total liabilities and stockholders’ equity	$	58,757,000

Shares outstanding—common stock		54,491,296
Book value per share (a)	$	0.78

(a)	Reflects stockholders’ equity divided by shares outstanding.

Summary Unaudited Pro Forma Consolidated Financial Data. The following table sets forth summary unaudited pro forma consolidated financial data for the year ended June 30, 2014 and certain ratios for such periods. This summary unaudited pro forma consolidated financial data gives effect to the purchase of shares by us in the Offer, as if such purchases had occurred on July 1, 2013 for the consolidated statements of income data for the year ended June 30, 2014, and on June 30, 2014 for the consolidated balance sheet data as of June 30, 2014. Such data also assumes that the purchase of shares is financed with debt on the terms described in the footnotes to the table below, and gives effect to the sale of the Rand SD business which was completed on September 24, 2014. This information should be read in conjunction with Summary Historical Consolidated Financial Data and our audited consolidated financial statements and the related notes filed as part of our Annual Report on Form 10-K for the year ended June 30, 2014. This summary unaudited pro forma consolidated financial data is not necessarily indicative of either our financial position or results of operations that actually would have been attained had the purchase of shares in the Offer, the related debt financing, and the sale of Rand SD been completed at the dates indicated, or that will be achieved in the future. Our future results are subject to prevailing economic and industry specific conditions and financial, business and other known and unknown risks and uncertainties, certain of which are beyond our control. These factors include, without limitation, those described in this Offer to Purchase under “Forward-Looking Statements.”


	Year ended June 30, 2014
Consolidated Statements of Income Data:	Actual			Adjustments				Pro Forma
Revenue	$	91,596,000		$	(2,612,000	)	(a)	$	88,984,000

Gross margin		45,286,000			(760,000	)	(a)		44,526,000

Operating expense		37,728,000			(3,308,000	)	(a)		34,420,000

Operating income		7,558,000			2,548,000		(a)		10,106,000
Interest and other expense		224,000			1,049,000		(b)		1,273,000

Income from continuing operations before income taxes		7,334,000			1,499,000				8,833,000

Provision for income taxes		(1,723,000	)		591,000				(1,132,000	)

Income from continuing operations	$	9,057,000		$	908,000			$	9,965,000

Net earnings per share from continuing operation available to common stockholders:
Basic		0.17			—				0.37
Diluted		0.16			—				0.34
Shares used in computing earnings per share:
Basic		54,210,555			(27,530,816	)			26,679,739
Diluted		57,039,061			(27,530,816	)			29,508,245

Other Data:
Ratio of earnings to fixed charges (c)		22.2x							7.3x

(a)	Reflects adjustments to effect for the disposition of the Rand SD division as if such disposition occurred at the beginning of the period presented.

(b)

Reflects interest expense on two new loan facilities including a $25 million term note at an assumed average rate of interest of 3.32% per annum and a term of 5 years, and a $10 million revolving line of credit at an assumed average rate of interest of 2.67% and a term of 5 years. Interest on the loans is based on the 30-day LIBOR rate plus a premium. For every 0.125% increase or decrease in the interest rate, the Company’s interest expense would increase $41,000 for the year ended June 30, 2014.

(c)	Earnings included in the calculation of this ratio consist of income before income taxes plus interest expense. Fixed charges include interest expense and pre-tax earnings amounts necessary to pay preferred stock dividends.


Consolidated Balance Sheet Data:	As of June 30, 2014
	Actual			Adjustments				Pro Forma
Current Assets	$	29,098,000		$	(9,917,000	)	(a)(b)	$	19,181,000

Total Assets		58,757,000			(11,076,000	)			47,681,000

Current liabilities:
Short-term debt due within 1 year		188,000			4,364,000		(b)		4,552,000
All other current liabilities		15,897,000			(1,260,000	)	(a)		14,637,000

Total current liabilities		16,085,000			3,104,000				19,189,000
Long-term debt and other liabilities		352,000			21,119,000		(b)		21,471,000

Total liabilities		16,437,000			24,223,000				40,660,000

Treasury stock		—			(33,037,000	)	(b)		(33,037,000	)
Retained earnings		(25,205,000	)		(2,262,000	)	(c)(d)		(27,467,000	)
Total stockholders’ equity (deficit)		42,320,000			(35,299,000	)			7,021,000

Total liabilities and stockholders’ deficit	$	58,757,000		$	(11,076,000	)		$	47,681,000

Shares outstanding—common stock		54,491,296			(27,530,816	)			26,960,480
Book value per share (e)	$	0.78						$	0.26

(a)	Reflects adjustments to effect for the disposition of the Rand SD division as if such transaction occurred as of the balance sheet date.

(b)	Reflects the effect of 27,530,816 shares tendered at $1.20 per share, including shares repurchased as treasury stock, use of the existing cash balance, and new debt from two new bank loans to fund the shares tendered.

(c)	Reflects expected investment banking, legal and professional fees of nearly $1.3 million related to the tender offer

(d)	Reflects an estimated loss of $1.1 million upon the disposal of the Rand SD division.

(e)	Reflects stockholders’ equity divided by shares outstanding.

Where You Can Find More Information

We are subject to the informational filing requirements of the Exchange Act and, in accordance with these requirements, are obligated to file reports and other information with the SEC relating to our business, financial condition and other matters. Information, as of particular dates, concerning our directors and officers, their compensation, stock options granted to them, the principal holders of our securities and any material interest of these persons in transactions with us is required to be disclosed in proxy statements distributed to our stockholders and filed with the SEC. We have also filed with the SEC a Tender Offer Statement on Schedule TO, which includes additional information with respect to the Offer.

The reports, proxy statements and other information we file can be inspected and copied at the public reference facilities maintained by the SEC at 100 F Street, N.E. Washington D.C. 20549. The SEC also maintains a web site at http://www.sec.gov that contains reports, proxy and information statements and other information regarding registrants that file electronically with the SEC.

The SEC allows us to “incorporate by reference” information to this Offer to Purchase. This means that we can disclose important information to you by referring you to another document filed separately with the SEC. The information incorporated by reference is considered to be a part of this Offer to Purchase, except for any information that is superseded by information that is included directly in this document. This Offer to Purchase incorporates by reference the following documents that we have previously filed with the SEC:

•

Our Annual Report on Form 10-K for the fiscal year ended June 30, 2014;

•

Our Current Report on Form 8-K, dated September 29, 2014; and

•

Any filings with the SEC pursuant to Sections 13(a), 13(c), 14 or 15(d) of the Exchange Act between the date of this Offer to Purchase and the expiration of the Offer.

You can obtain copies of any of the documents incorporated by reference in this document through us or from the SEC’s website at the address shown above. Documents incorporated by reference are available from us without charge, excluding any exhibits to those documents unless the exhibit is specifically incorporated by reference as an exhibit in this Offer to Purchase. You can obtain such documents by writing to us at: Attn: Investor Relations, 161 Worcester Road, Suite 401, Framingham, Massachusetts 01701, or by calling (508) 663-1400. Please be sure to include your complete name and address in your request.

SECTION 15. LEGAL MATTERS; REGULATORY APPROVALS.

Except as described in this document, we are not aware of any license or regulatory permit that is material to our business that might be materially and adversely affected by the acquisition of shares as contemplated by the Offer or of any approval or other action by any government or governmental, administrative or regulatory authority or agency, domestic or foreign, that would be required for the acquisition or ownership of shares by us as contemplated by the Offer. Should any approval or other action be required, we currently intend to seek that approval or other action. We are unable to predict whether we will be required to delay the acceptance for payment of or payment for shares tendered pursuant to the Offer until the outcome of that process, if necessary, is known. We cannot assure you that any approval or other action, if needed, could be obtained or would be obtained without substantial cost or conditions or that the failure to obtain the approval or other action might not result in adverse consequences to our business and financial condition.

Our obligation pursuant to the Offer to accept for payment and pay for shares is subject to conditions. See Section 10.

SECTION 16. UNITED STATES FEDERAL INCOME TAX CONSEQUENCES.

The following describes certain United States federal income tax consequences relevant to the Offer for U.S. Holders and Non-U.S. Holders (as defined below). This discussion is based upon the Internal Revenue Code of 1986, as amended (the “Code”), existing and proposed Treasury Regulations, administrative pronouncements and judicial decisions, changes to which could materially affect the tax consequences described herein and could be made on a retroactive basis.

This discussion deals only with shares of common stock held as capital assets and does not deal with all tax consequences that may be relevant to all categories of holders (including, without limitation, dealers in securities or commodities, traders in securities that elect to mark their holdings to market, financial institutions, regulated investment companies, real estate investment trusts, holders whose functional currency is not the United States dollar, insurance companies, tax-exempt organizations or persons who hold shares as part of a hedging, conversion or constructive sale transaction or as a position in a straddle). In particular, different rules may apply to shares acquired as compensation (including shares acquired upon the exercise of options or the vesting of restricted share units). This discussion does not address the consequences of the alternative minimum tax, or any state, local or foreign tax consequences of participating in the Offer. Holders of shares should consult their tax advisors as to the particular consequences to them of participation in the Offer.

As used herein, a “U.S. Holder” means a beneficial holder of shares that is for United States federal income tax purposes: (a) an individual citizen or resident of the United States, (b) a corporation (or any other entity treated as a corporation for U.S. federal income tax purposes) created or organized in or under the laws of the United States, any state thereof or the District of Columbia, (c) an estate the income of which is subject to United States federal income taxation regardless of its source, or (d) a trust if it (x) is subject to the primary supervision of a court within the U.S. and one or more U.S. persons have the authority to control all substantial decisions of the trust or (y) has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person.

Holders of shares who are neither U.S. Holders nor partnerships (or any other entity treated as a partnership for U.S. federal income tax purposes) (“Non-U.S. Holders”) should consult their tax advisors

regarding the United States federal income tax consequences and any applicable foreign tax consequences of the Offer and also should see Section 7 for a discussion of the applicable United States withholding tax rules and the potential for obtaining a refund of all or a portion of any tax withheld.

If a partnership holds shares, the tax treatment of a partner will generally depend upon the status of the partner and the activities of the partnership. Holders that are partners of a partnership holding shares should consult their own tax advisors.

Non-Participation in the Offer. Stockholders who do not participate in the Offer will not incur any tax liability as a result of the consummation of the Offer.

U.S. Holders. An exchange of shares for cash pursuant to the Offer will be a taxable transaction for United States federal income tax purposes. A U.S. Holder who participates in the Offer will be treated, depending on such U.S. Holder’s particular circumstances, either as recognizing gain or loss from the disposition of the shares or as receiving a dividend distribution from us.

Under Section 302 of the Code, a U.S. Holder will recognize gain or loss on an exchange of shares for cash if the exchange (a) results in a “complete termination” of all such U.S. Holder’s equity interest in us, (b) results in a “substantially disproportionate” redemption with respect to such U.S. Holder, or (c) is “not essentially equivalent to a dividend” with respect to the U.S. Holder (together, as described below, the “Section 302 Tests”). In applying the Section 302 Tests, a U.S. Holder must take account of stock that such U.S. Holder constructively owns under attribution rules set forth in Section 318 of the Code, pursuant to which the U.S. Holder will be treated as owning shares of stock owned by certain family members (except that in the case of a “complete termination” a U.S. Holder may waive, under certain circumstances, attribution from family members) and related entities and shares of stock that the U.S. Holder has the right to acquire by exercise of an option. An exchange of shares for cash pursuant to the Offer will be a “complete termination” of a U.S. Holder’s equity interest in us if the U.S. Holder owns none of our shares either actually or constructively (taking into account any effective waivers of attribution from family members) immediately after the exchange. An exchange of Shares for cash will be a substantially disproportionate redemption with respect to a U.S. Holder if (i) the percentage of the then outstanding shares owned by such U.S. Holder in Rand immediately after the exchange is less than 80% of the percentage of the shares owned by such U.S. Holder in Rand immediately before the exchange, and (ii) the percentage of the then outstanding voting stock owned by such U.S. Holder in Rand immediately after the exchange is less than 80% of the percentage of the voting stock owned by such U.S. Holder in Rand immediately before the exchange. If an exchange of shares for cash fails to satisfy either the “complete termination” or “substantially disproportionate” test, the U.S. Holder nonetheless may satisfy the “not essentially equivalent to a dividend” test. An exchange of shares for cash will satisfy the “not essentially equivalent to a dividend” test if it results in a “meaningful reduction” of the U.S. Holder’s equity interest in Rand. An exchange of shares for cash that results in a reduction of the proportionate equity interest in us of a U.S. Holder whose relative equity interest in us is minimal (an interest of less than one percent should satisfy this requirement) and who does not exercise any control over or participate in the management of our corporate affairs should be treated as “not essentially equivalent to a dividend.” U.S. Holders should consult their tax advisors regarding the application of the rules of Section 302 in their particular circumstances.

If a U.S. Holder is treated as recognizing gain or loss from the disposition of the shares for cash, such gain or loss will be equal to the difference between the amount of cash received and such U.S. Holder’s adjusted basis in the shares exchanged therefor. Any such gain or loss will be capital gain or loss and will be long-term capital gain or loss if the holding period of the shares exceeds one year as of the date of the exchange.

If a U.S. Holder is not treated under the Section 302 Tests as recognizing gain or loss on an exchange of shares for cash, the entire amount of cash received by such U.S. Holder pursuant to the exchange will be treated as a dividend to the extent of the portion of our current and accumulated earnings and profits allocable to such shares. Provided certain holding period requirements are satisfied, non-corporate holders generally will be

subject to United States federal income tax at a maximum rate of 15% on amounts treated as dividends, i.e., the entire amount of cash received without reduction for the tax basis of the shares exchanged. To the extent that cash received in exchange for shares is treated as a dividend to a corporate U.S. Holder, (a) it will be eligible for a dividends-received deduction (subject to applicable limitations) and (b) it will be subject to the “extraordinary dividend” provisions of the Code. U.S. Holders should consult their tax advisors concerning the rules discussed in this paragraph in light of their particular circumstances.

To the extent that amounts received pursuant to the Offer exceed a U.S. Holder’s allocable share of our current and accumulated earnings and profits, the distribution will first be treated as a non-taxable return of capital, causing a reduction in the adjusted basis of such U.S. Holder’s shares, and any amounts in excess of the U.S. Holder’s adjusted basis will constitute capital gain. Any remaining adjusted basis in the shares tendered will be transferred to any remaining shares held by such U.S. Holder.

We cannot predict whether or the extent to which the Offer will be oversubscribed. If the Offer is oversubscribed, proration of tenders pursuant to the Offer will cause us to accept fewer shares than are tendered. Therefore, a U.S. Holder can be given no assurance that a sufficient number of such U.S. Holder’s shares will be purchased pursuant to the Offer to ensure that such purchase will be treated as a sale or exchange, rather than as a dividend, for United States federal income tax purposes pursuant to the rules discussed above.

Non-U.S. Holders. The Depositary will withhold U.S. federal income taxes equal to 30% of the gross payments payable to a Non-U.S. Holder or his or her agent unless the Depositary determines that a reduced rate of withholding is available pursuant to a tax treaty or that an exemption from withholding is applicable because such gross proceeds are effectively connected with the conduct of a trade or business within the U.S. In order to obtain an exemption from withholding on the grounds that the gross proceeds paid pursuant to the Offer are effectively connected with the conduct of a trade or business within the U.S., a Non-U.S. Holder must deliver to the Depositary a properly completed and executed IRS Form W-8ECI. The Depositary will determine a holder’s status as a Non-U.S. Holder and eligibility for a reduced rate of, or exemption from, withholding by reference to any outstanding certificates or statements concerning eligibility for a reduced rate of, or exemption from, withholding (e.g. IRS Forms W-8BEN-E or W-8ECI) unless facts and circumstances indicate that such reliance is not warranted. A Non-U.S. Holder may be eligible to obtain a refund of all or a portion of any tax withheld if such Non-U.S. Holder meets one of the Section 302 Tests described above or is otherwise able to establish that no tax or a reduced amount of tax is due. Backup withholding generally will not apply to amounts subject to the 30% or a treaty-reduced rate of withholding. Non-U.S. Holders are urged to consult their own tax advisors regarding the application of U.S. federal income tax withholding, including eligibility for a withholding tax reduction or exemption, and the refund procedure.

United States Federal Income Tax Backup Withholding. See Section 7 with respect to the application of United States federal income tax backup withholding to both U.S. and Non-U.S. Holders.

The federal income tax discussion set forth above may not apply to shares acquired in connection with the exercise of stock options or pursuant to other compensation arrangements with us. The tax consequences of a sale pursuant to the Offer may vary depending upon, among other things, the particular circumstances of the tendering stockholder. No information is provided with respect to the state, local or foreign tax consequences of the transaction contemplated by the Offer. Each stockholder is urged to consult his or her own tax advisor to determine the particular tax consequences to him or her (including the applicability and effect of the constructive ownership rules and foreign, state and local tax laws and possible tax law changes) of tendering shares pursuant to the Offer.

SECTION 17. EXTENSION OF THE OFFER; TERMINATION; AMENDMENT.

We expressly reserve the right, in our sole discretion, at any time and from time to time, and regardless of whether any of the events set forth in Section 10 have occurred or are deemed by us to have occurred, to extend the period of time during which the Offer is open by giving oral or written notice of such extension to the

Depositary and making a public announcement of the extension. An extension of the Offer will delay acceptance for payment of, and payment for, any shares because we cannot accept for payment or pay for any shares until the Offer is closed. We also reserve the right, in our sole discretion, to terminate the Offer and not accept for payment or pay for any shares not already accepted for payment or paid for or, subject to applicable law, to postpone payment for shares upon the occurrence of any of the conditions specified in Section 10 by giving oral or written notice of such termination or postponement to the Depositary and making a public announcement of the termination or postponement. Our reservation of the right to delay acceptance for payment and to delay payment for shares which we have accepted for payment is limited by Rule 13e-4(f)(5) under the Exchange Act, which requires that we must pay the consideration offered or return the shares tendered promptly after termination or withdrawal of the Offer.

Subject to compliance with applicable law, we also reserve the right, in our sole discretion, and regardless of whether any of the events set forth in Section 10 have occurred or are deemed by us to have occurred, to amend the Offer in any respect, including, without limitation, by decreasing or increasing the consideration offered to holders of shares or by decreasing or increasing the number of shares being sought pursuant to the Offer. Amendments to the Offer may be made at any time and from time to time by public announcement. The announcement, in the case of an extension, shall be issued no later than 9:00 a.m., New York City time, on the next business day after the last previously scheduled or announced expiration date. Material changes to information previously provided to stockholders in this Offer or in documents furnished subsequent thereto will be disseminated to stockholders in compliance with Rule 13e-4(e)(2) under the Exchange Act.

Any public announcement made pursuant to the Offer will be disseminated promptly to stockholders in a manner reasonably designed to inform stockholders of that change. Without limiting the manner in which we may choose to make any public announcement, except as provided by applicable law, we have no obligation to publish, advertise or otherwise communicate any such public announcement other than by making a release through PR Newswire or another comparable news service.

If we materially change the terms of the Offer or the information concerning the Offer, or if we waive a material condition of the Offer, we will extend the Offer to the extent required by Rule 13e-4 promulgated under the Exchange Act. This rule and certain related releases and interpretations of the SEC provide that the minimum period during which a tender offer must remain open following material changes in the terms of the Offer or information concerning the Offer (other than a change in price, change in dealer’s soliciting fee or change in percentage of securities sought) will depend on the facts and circumstances, including the relative materiality of such terms or information. In a published release, the SEC has stated that, in its view, an offer should remain open for a minimum of five business days from the date that notice of a material change is first published, sent or given.

If (1) we increase or decrease the price to be paid for the shares, increase the number of shares being sought pursuant to the Offer (and such increase exceeds 2% of our outstanding shares) or decrease the number of shares being sought pursuant to the Offer, and (2) the Offer is scheduled to expire at any time earlier than the expiration of a period ending on the tenth business day from, and including, the date that notice of such an increase or decrease is first published, sent or given to security holders in the manner specified in this Section 17, then the Offer will be extended until the expiration of such period of ten business days. For the purposes of the Offer, a “business day” means any day other than a Saturday, Sunday or federal holiday and consists of the time period from 12:01 a.m. through 12:00 midnight, New York City time.

SECTION 18. FEES AND EXPENSES.

We have retained Georgeson, Inc. to act as Information Agent and American Stock Transfer & Trust Company, LLC to act as Depositary in connection with the Offer. The Information Agent may contact stockholders by mail, telephone, telegraph and in person and may request brokers, dealers, commercial banks, trust companies and other nominee stockholders to forward materials relating to the Offer to beneficial owners.

We have agreed to pay the Information Agent upon acceptance for and payment of shares pursuant to the Offer, a total of $6,500 plus certain expenses. In addition, we have agreed to pay Covington a fee of $200,000 for delivering its fairness opinion. Covington will also receive a fee from us upon completion of the Offer for acting as our financial advisor in connection with the Offer. The Depositary will receive reasonable and customary compensation for its services. We will reimburse the Information Agent, our financial advisor and the Depositary for certain reasonable out-of-pocket expenses and will indemnify them against certain liabilities in connection with the Offer, including certain liabilities under the federal securities laws.

We will pay all expenses related to the printing and mailing of this Offer to Purchase and related materials, attorneys’ fees and expenses and other miscellaneous fees and expenses incurred in connection with the Offer. We will also pay or cause to be paid all stock transfer taxes, if any, on our purchase of shares except as otherwise provided in this document and Instruction 7 in the related Letter of Transmittal.

We will not be obligated to pay fees or commissions to brokers, dealers, commercial banks or trust companies (other than fees described above) for soliciting tenders of shares pursuant to the Offer. Stockholders holding shares through brokers or banks are urged to consult the brokers or banks to determine whether transaction costs are applicable if stockholders tender shares through such brokers or banks and not directly to the Depositary. We will, however, upon request, reimburse brokers, dealers, commercial banks and trust companies for customary mailing and handling expenses incurred by them in forwarding the Offer to Purchase and related materials to the beneficial owners of shares held by them as a nominee or in a fiduciary capacity. We have not authorized any broker, dealer, commercial bank or trust company to act as our agent or the agent of the Information Agent or the Depositary for purposes of the Offer.

SECTION 19. MISCELLANEOUS.

We are not aware of any jurisdiction where the making of the Offer is not in compliance with applicable law. If we become aware of any jurisdiction where the making of the Offer or the acceptance of shares pursuant thereto is not in compliance with any applicable law, we will make a good faith effort to comply with such law. If, after good faith efforts, we cannot comply with the applicable law, we will not make the Offer to, nor will we accept tenders from or on behalf of, the holders of shares residing in that jurisdiction.

In accordance with Rule 13e-4 under the Exchange Act, we have filed with the SEC a Tender Offer Statement on Schedule TO that contains additional information with respect to the Offer. The Schedule TO, including the exhibits and any amendments thereto, may be examined, and copies may be obtained, at the same places and in the same manner as is set forth in Section 14 with respect to information concerning us.

We have not authorized any person to make any recommendation on our behalf regarding whether you should tender or refrain from tendering your shares pursuant to the Offer, and we have not authorized any person to provide any information or make any representation in connection with the Offer, other than those contained in this Offer to Purchase or in the Letter of Transmittal. You must not rely upon any such recommendation, information or representation that is given or made to you as having been authorized by us or the Information Agent.

October 3, 2014

APPENDIX A

DIRECTORS AND EXECUTIVE OFFICERS OF RAND WORLDWIDE, INC.

The following table sets forth the name, present principal occupation or employment and 5-year employment history of the directors and executive officers of Rand Worldwide, Inc. The business address of each director and executive officer is c/o Rand Worldwide, Inc., 161 Worcester Road, Suite 401, Framingham, Massachusetts 01701. Except as noted below, each of our directors and executive officers is a United States citizen.

RICHARD A. CHARPIE, PhD—Dr. Charpie joined the Board in connection with the Company’s August 2010 merger with Avatech Solutions, Inc. (the “Merger”), at which time he was also elected Chairman of the Board and remained in that role until September 2013. He has more than 30 years of private equity experience and is a Managing Partner of Ampersand Capital Partners, which is currently the largest equity owner of Rand. Dr. Charpie joined Ampersand’s predecessor in 1980 and led its activities beginning in 1983. He has served as a director of more than 35 companies and as Chairman of more than 10 companies. He holds an M.S. degree in Physics and a Ph.D. in Economics and Finance, both from the Massachusetts Institute of Technology. He served on the board of directors of the pre-merger Rand Worldwide immediately prior to the Merger.

MARC L. DULUDE—Mr. Dulude became a director and Chief Executive Officer of the Company in connection with the Merger and became Chairman of the Board in September 2013. From April 1, 2009 through the date of the Merger, Mr. Dulude was the President, Chief Executive Officer, and Chairman of the Board of the pre-merger Rand Worldwide. Prior to joining Rand Worldwide, Mr. Dulude was a General Partner with Ampersand Capital Partners, a private equity firm he joined in 2002. Before Ampersand, Mr. Dulude spent six years at Moldflow Corporation, a product design simulation software company, where he was Chairman, President and CEO. Mr. Dulude has nearly two decades of experience as a senior information technology executive, including serving as Senior VP of Marketing at Parametric Technology Corporation (NASDAQ: PMTC), a product lifecycle management company, and in various positions at Nortel, a telecommunications company. Mr. Dulude holds a M.Eng. Degree in Mechanical Engineering from Carleton University. Mr. Dulude is on the board of directors of Kortec, Inc., a PET packaging equipment manufacturing company. Mr. Dulude is a citizen of the United States and Canada.

PETER H. KAMIN—Mr. Kamin joined the Board of Directors in March 2012. He is the founder and Managing Partner of 3K Limited Partnership. For the previous 11 years, Mr. Kamin was a founding member and Managing Partner of ValueAct Capital. Prior to founding ValueAct Capital in 2000, Mr. Kamin founded and managed Peak Investment L.P. Peak was a limited partnership, organized to make investments in a select number of domestic public and private companies. Mr. Kamin is presently a Director of Ambassadors Group, Inc., MAM Software Group, Inc., Tile Shop Holdings and several privately held companies. Mr. Kamin has previously served as a Director of a number of public and private companies. Mr. Kamin holds a BA from Tufts University and an MBA from Harvard’s Graduate School of Business.

MANU PARPIA—Mr. Parpia joined the Board of Directors in March 2011. Mr. Parpia was Chief Executive of the Electronic Business Equipment Division of Godrej & Boyce from the mid-1980s to 1999. During this period, he also founded Godrej Pacific, and served as its Managing Director from 1995 to 1999. In his activities with Godrej, he oversaw the design, development, manufacture and distribution of a variety of high-tech products. After his time at Godrej, he founded Geometric Ltd. and assumed the position of Managing Director, serving Geometric in that role until 2006. Today he sits on many boards including Geometric Ltd., 3d PLM Software Solutions Ltd., Virgo Engineers Ltd. and Godrej Infotech Ltd. In addition he is a Charter Member of The Indus Entrepreneurs (TiE)—Mumbai Chapter where he chairs their mentoring efforts. Mr. Parpia is a citizen of India.

LAWRENCE RYCHLAK—Mr. Rychlak joined the Board of Directors in September 2013. Mr. Rychlak was hired by Avatech in May 2005 as Chief Financial Officer and was appointed President in October 2009.

Appendix A-1

Following the Merger, Mr. Rychlak continued as the President and Chief Financial Officer of Rand Worldwide, Inc. Prior to joining the Company, he worked for Environmental Elements Corporation, where he served as interim president and Senior Vice President and Chief Financial Officer from 2001 to May 2005. Mr. Rychlak’s background also includes several senior financial positions in both for profit and not-for-profit organizations, business consulting with a regional consulting firm and eight years with an international accounting and consulting firm. He is a Certified Public Accountant and holds a Bachelor of Arts degree in Accounting and a Master’s degree in Business Administration from Loyola University Maryland.

Appendix A-2

APPENDIX B

FAIRNESS OPINION OF COVINGTON ASSOCIATES

September 29, 2014

Special Committee of the Board of Directors of Rand Worldwide, Inc.

161 Worcester Rd

Suite 401

Framingham, MA 01701

Ladies and Gentlemen:

The Special Committee of the Board of Directors (the “Special Committee”) of Rand Worldwide, Inc. (the “Company”) has engaged Covington Associates, LLC (“Covington”) to serve as an independent financial advisor to the Special Committee and to provide an opinion to the Special Committee (the “Opinion”) as to the fairness, from a financial point of view, of the consideration to be received by certain holders of the Company’s common stock, $.01 par value (the “Common Stock”) tendering their Common Stock (the “Tendering Stockholders”) in the contemplated transaction described below (the “Proposed Transaction”).

Description of the Proposed Transaction

The terms of the Proposed Transaction will be more specifically set forth in a Tender Offer Statement on Schedule TO, including the Offer to Purchase to be filed as Exhibit (a)(1)(i) and the associated Letter of Transmittal (collectively, the “Tender Offer Materials”), to be filed with the Securities and Exchange Commission upon commencement of the Offer (as defined below). It is Covington’s understanding that the Tender Offer Materials provide for, among other things, a tender offer (the “Offer”) for up to 27,530,816 shares of Common Stock by the Company, pursuant to which the Company will pay $1.20 per share in cash, without interest (the “Offer Consideration”), subject to applicable withholding requirements, for each share of Common Stock accepted in the Offer. Under the Tender Offer Materials, the Company will commit (subject to the conditions described therein) to purchase up to 27,530,816 shares of Common Stock. In the event a greater number of shares are tendered, the Company will accept shares from Tendering Stockholders on a pro rata basis.

Scope of Analysis

In connection with this Opinion, Covington has made such reviews, analyses and inquiries as we have deemed necessary and appropriate under the circumstances. Covington also took into account its assessment of the general economic market and financial conditions, as well as its experience in securities and business valuations in general, and with respect to similar transactions in particular. Among other things, Covington’s procedures, investigations and financial analysis with respect to the preparation of this Opinion included but were not limited to, the items summarized below;

Reviewed the draft of the Tender Offer Materials received from the Company on September 26, 2014;

Reviewed certain publicly available business and financial information relating to the Company that we deemed to be relevant including but not limited to the Company’s annual reports and audited financial statements on Form 10-K filed with the Securities and Exchange Commission (the “SEC”) for the years ended June 30, 2013 and 2012 and the Company’s unaudited interim financial statements for the nine month period ended March 31, 2014, included with the Company’s Form 10-Q filed with the SEC on May 15, 2014 and the substantially final draft of the Company’s Form 10-K for the year ending September 30, 2014;

Appendix B-1

Reviewed certain information relating to the historical, current and future operations, financial condition and prospects of the Company made available to us by the Company, including financial projections (and adjustments thereto) prepared by the management of the Company relating to the Company for the fiscal years ending June 30, 2015 through June 30, 2017 (the “Financial Projections”);

Spoken with certain members of the management of the Company regarding the business, operations, financial condition and prospects of the Company, the Offer and related matters;

Compared the financial and operating performance of the Company with that of certain other public companies that Covington deemed to be relevant;

Considered the publicly available financial terms of certain transactions in the industry in which the Company operates that Covington deemed to be relevant;

Reviewed the current and historical market prices and trading volume for the Common Stock, and the historical market prices and certain financial data of the publicly traded securities of certain other companies that Covington deemed to be relevant;

Conducted such other financial studies, analyses and inquiries, including a discounted cash flow analysis, and considered such other information and factors as Covington deemed appropriate; and

Considered a review of the financial condition of the Company with respect to its liquidity and capital position as of the date hereof.

Assumptions, Qualifications and Limiting Conditions

In performing its analyses and rendering this Opinion with respect to the Proposed Transaction, Covington, with the Company’s consent:

Relied upon and assumed, without independent verification, the accuracy and completeness of all data, material and other information furnished, or otherwise made available, to us, and Covington does not

assume any responsibility with respect to such data, material and other information nor did Covington independently verify such information;

Relied upon representations by management of the Company, which has advised Covington, and Covington has assumed, that any estimates, evaluations, forecasts and the Financial Projections reviewed by Covington have been reasonably prepared in good faith and based on the best currently available estimates and good faith judgments of such management or anyone else furnishing the same as to the future financial results and condition of the Company, and Covington expresses no opinion or view with respect to such projections or the assumptions on which they are based;

Relied upon and assumed, without independent verification, that the historical financial statements of the Company provided to Covington have been prepared in accordance with United States generally accepted accounting principles, that there has been no change in the business, assets, liabilities, financial condition, results of operations, cash flows or prospects of the Company since the date of the most recent financial statements provided to Covington that would be material to Covington’s analyses or this Opinion, and that there is no information or any facts, either contained therein or omitted therefrom, that would make any of the information reviewed by Covington inaccurate, incomplete or misleading;

Relied upon and assumed, without independent verification, that (a) the representations and warranties of all parties in the Tender Offer Materials and all other related documents and instruments that are referred to therein, are true, correct and complete, (b) each party referenced in the Tender Offer Materials and such other related documents and instruments will fully and timely perform all of the covenants and agreements required to be performed by such party, (c) all conditions to the consummation of the Offer will be timely

Appendix B-2

satisfied without waiver thereof, and (d) the Offer will be consummated in a timely manner in accordance with the terms described in the Tender Offer Materials and such other related documents, without any amendments or modifications thereto;

Relied upon and assumed, without independent verification, that (i) the Offer will be consummated in a manner that complies in all respects with all applicable federal and state statutes, rules and regulations, and (ii) all governmental, regulatory, and other consents and approvals necessary for the consummation of the Offer will be obtained and that no delay, limitations, restrictions or conditions will be imposed or amendments, modifications or waivers made that would have an effect on the Company or the consummation of the Offer that would be material to Covington’s analyses or this Opinion;

Relied upon and assumed, without independent verification, that the final form of the Tender Offer Materials will not differ in any material respect from the draft thereof identified above;

Relied upon the fact that the Special Committee and the Company have been advised by counsel as to the legal matters with respect to the Proposed Transaction, including whether all procedures required by law to be taken in connection with the Proposed Transaction have been duly, validly and timely taken;

Has not been requested to make, and has not made, any physical inspection or independent appraisal or evaluation of any of the assets, properties or liabilities (fixed, contingent, derivative, off-balance-sheet or otherwise) of the Company or any other party, nor was Covington provided with any such appraisal or evaluation;

10.

Did not estimate, and expresses no opinion regarding, the liquidation value of any entity or business under any laws relating to bankruptcy, insolvency or similar matters; and

11.

Has not undertaken any independent analysis of any potential or actual litigation, regulatory action, possible unasserted claims or other contingent liabilities, to which the Company is or may be a party or is or may be subject, or of any governmental investigation of any possible unasserted claims or other contingent liabilities to which the Company is or may be a party or is or may be subject.

This Opinion is necessarily based on financial, regulatory, economic, market and other conditions as in effect on, and the information made available to Covington as of, the date hereof. It is understood that subsequent developments may affect this Opinion, and that Covington has not undertaken, and is under no obligation, and affirmatively disclaims any obligation to update, revise, reaffirm or withdraw this Opinion, or otherwise comment on or consider events occurring or coming to Covington’s attention after the date hereof.

This Opinion is furnished for the use and benefit of the Special Committee in connection with their consideration of the Proposed Transaction and may not be reproduced, summarized, referred to, provided to third parties, or used for any other purpose without the prior written consent of an authorized officer of Covington, except that this Opinion may be reproduced and included in its entirety in any filing made by the Company with the Securities and Exchange Commission and any disclosure document distributed to the Company’s stockholders in connection with the Offer. At your request, it is further understood that this opinion may be relied on by those members of the Board of Directors of the Company who are not members of the Special Committee (other than those members of the Board of Directors who recused themselves from voting on the approval of the Proposed Transaction) as if the opinion had also been addressed to them. This Opinion should not be construed as creating any fiduciary duty on the part of Covington to any party. This Opinion is not intended to be, and does not constitute, a recommendation to the Special Committee, any security holder or any other person, as to how to act with respect to any matter relating to the Offer.

To the extent that any of the foregoing assumptions or any of the facts on which this Opinion is based prove to be untrue in any material respect, this Opinion cannot and should not be relied upon. Furthermore, in Covington’s analysis and in connection with the preparation of this Opinion, Covington has made numerous assumptions with respect to industry performance, general business, market and economic conditions and other matters, many of

Appendix B-3

which are beyond the control of any party involved in the Proposed Transaction and as to which Covington does not express any view or opinion in this Opinion including as to the reasonableness of such assumptions.

Covington is not expressing any opinion as to the market price or value of the Common Stock after announcement of the Proposed Transaction and this Opinion is not to be relied upon by and stockholders of the Company other than the Tendering Stockholders. This Opinion should not be construed as a valuation opinion, a credit rating, a solvency opinion, an analysis of the Company’s credit worthiness, tax advice, or accounting advice. Covington has not made, and assumes no responsibility to make, any representation, or render any opinion, as to any legal matter.

Covington will receive a fee from the Company for rendering this Opinion, which is not contingent upon the successful completion of the Offer. Covington will also receive a fee from the Company upon the closing of the Offer, which is contingent upon the successful completion of the Offer. The Company has agreed to reimburse certain of Covington’s expenses and to indemnify Covington and certain related parties for certain potential liabilities arising out of this engagement.

This Opinion is solely that of Covington Associates, and Covington’s liability in connection with this letter shall be limited in accordance with the terms set forth in the engagement letter between Covington and the Company dated February 13, 2014 (the “Engagement Letter”). This letter is confidential, and its use and disclosure is strictly limited in accordance with the terms set forth in the Engagement Letter.

Covington has not been requested to opine as to, and this Opinion does not express an opinion as to or otherwise address, among other things: (i) the underlying business decision of the Company, its security holders or any other party to proceed with or effect the Offer, (ii) the terms of any arrangements, understandings, agreements or documents related to, or the form or any other portion or aspect of, the Offer or otherwise, (iii) the fairness, advisability or impact of any portion or aspect of the Offer to the holders of any class of securities, creditors or other constituencies of the Company, or to any other party, except if and only to the extent expressly set forth in the last sentence of this Opinion, (iv) the relative merits of the Offer as compared to any alternative business strategies that might exist for the Company or any other party or the effect of any other transaction in which the Company or any other party might engage, (v) the fairness, advisability or impact of any portion or aspect of the Offer to any one class or group of the Company’s or any other party’s security holders vis-à-vis any other class or group of the Company’s or such other party’s security holders (including, without limitation, the allocation of any consideration among or within such classes or groups of security holders), (vi) whether or not the Company, its security holders or any other party is receiving or paying reasonably equivalent value in the Offer, (viii) the solvency, creditworthiness or fair value of the Company or any other participant in the Offer, or any of their respective assets, under any applicable laws relating to bankruptcy, insolvency, fraudulent conveyance or similar matters, or (ix) the fairness, financial or otherwise, of the amount, nature or any other aspect of any compensation to or consideration payable to or received by any officers, directors or employees of any party to the Offer, any class of such persons or any other party, relative to the Offer to Purchase or otherwise. Furthermore, no opinion, counsel or interpretation is intended in matters that require legal, regulatory, accounting, insurance, tax or other similar professional advice. It is assumed that such opinions, counsel or interpretations have been or will be obtained from the appropriate professional sources. Furthermore, Covington has relied, with your consent, on the assessments by the Company and its advisers, as to all legal, regulatory, accounting, insurance and tax matters with respect to the Company and the Offer. The issuance of this Opinion was approved by the persons within Covington authorized to approve opinions of this nature.

Disclosure of Prior Relationships

During the two years preceding the date of this Opinion, Covington has not had any material relationship with any party to the Proposed Transaction for which compensation has been received or is intended to be received, nor is any such material relationship or related compensation mutually understood to be contemplated.

Appendix B-4

Conclusion

Based upon and subject to the foregoing, and in reliance thereon, it is Covington’s opinion that, as of the date hereof, the Offer Consideration to be received by Tendering Stockholders for their tendered Common Stock pursuant to the Offer to Purchase is fair to such holders from a financial point of view (without giving effect to any impact of the Proposed Transaction on any Tendering Stockholder other than in its capacity as a Tendering Stockholder).

Very truly yours,

COVINGTON ASSOCIATES, LLC

Appendix B-5

RAND WORLDWIDE, INC.

161 Worcester Road, Suite 401

Framingham, Massachusetts 01701

(508) 663-1400

October 3, 2014

Facsimile copies of the Letter of Transmittal, properly completed and duly executed, will be accepted. The Letter of Transmittal, certificates for shares and any other required documents should be sent or delivered by each stockholder of Rand Worldwide, Inc. or his or her bank, broker, dealer, trust company or other nominee to the Depositary as follows:

The Depositary for the Offer is:

LOGO

Phone: Toll-free (877) 248-6417 and (718) 921-8317

Fax: 718 234-5001


If delivering by mail:		If delivering by hand, express mail, courier or any other expedited service:

American Stock Transfer & Trust Company, LLC Operations Center Attn: Reorganization Department P.O. Box 2042 New York, New York 10272-2042		American Stock Transfer & Trust Company, LLC Operations Center Attn: Reorganization Department 6201 15^th Avenue Brooklyn, New York 11219

DELIVERY OF THE LETTER OF TRANSMITTAL TO AN ADDRESS OTHER THAN AS SET FORTH ABOVE WILL NOT CONSTITUTE A VALID DELIVERY TO THE DEPOSITARY.

Questions and requests for assistance or for additional copies of this Offer to Purchase, the Letter of Transmittal and the Notice of Guaranteed Delivery may be directed to the Information Agent at the telephone number and location listed below. You may also contact your bank, broker, dealer, trust company or other nominee for assistance concerning the Offer.

The Information Agent for the Offer is:

LOGO

480 Washington Blvd., - 26^th Floor

Jersey City, NJ 07310

Stockholders, Banks and Brokers

Call Toll-Free: (866) 357-4029

Exhibit (a)(1)(ii)

Letter of Transmittal To Tender Shares of Common Stock

RAND WORLDWIDE, INC.

at $1.20 Per Share in Cash Pursuant to the Offer to Purchase dated October 3, 2014 by

Rand Worldwide, Inc.

The undersigned represents that I (we) have full authority to surrender without restriction the certificate(s) listed below. You are hereby authorized and instructed to deliver to the address indicated below (unless otherwise instructed in the boxes on the following pages) a check representing a cash payment for shares of common stock, par value $0.01 per share, of Rand Worldwide, Inc. (the “Issuer”) (collectively, the “Shares”) tendered pursuant to this Letter of Transmittal, at a price of $1.20 per share, net to the seller in cash, without interest and less any applicable withholding taxes, upon the terms and subject to the conditions set forth in the Offer to Purchase, dated October 3,2014 (as it may be amended or supplemented from time to time, the “Offer to Purchase” and, together with this Letter of Transmittal, as it may be amended or supplemented from time to time, the “Offer”).

THE OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON MONDAY, NOVEMBER 3, 2014, UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS IT MAY BE EXTENDED, THE “EXPIRATION DATE”) OR EARLIER TERMINATED.

Method of delivery of the certificate(s) is at the option and risk of the owner thereof. See Instruction 2.

Mail or deliver this Letter of Transmittal, together with the certificate(s) representing your shares, to:

LOGO

Phone: Toll-free (877) 248-6417 and (718) 921-8317

Fax: 718 234-5001


If delivering by mail:		If delivering by hand, express mail, courier or any other expedited service:

American Stock Transfer & Trust Company, LLC Operations Center Attn: Reorganization Department P.O. Box 2042 New York, New York 10272-2042		American Stock Transfer & Trust Company, LLC Operations Center Attn: Reorganization Department 6201 15^th Avenue Brooklyn, New York 11219

Pursuant to the offer of Rand Worldwide, Inc., (the “Issuer”) to purchase up to 27,530,816 of the outstanding Shares of the Issuer, the undersigned encloses herewith and surrenders the following certificate(s) representing Shares of the Issuer:


DESCRIPTION OF SHARES TENDERED – See Instructions 3 and 4
Name(s) and Address(es) of Registered Owner(s) (Please fill in exactly as name(s) appear(s) on certificate(s))	Shares Tendered (attach additional list if necessary)
	Certificate Number(s)*	Number of Shares Represented by Certificate(s)*	Number of Shares Represented by Book Entry (electronic form)	Number of Shares Tendered**










	Total Shares


		*		Need not be completed if Shares are delivered by book-entry transfer.
		**		Unless otherwise indicated, it will be assumed that all Shares represented by any certificates delivered to the Depositary are being tendered. See Instruction 4.

PLEASE READ THE INSTRUCTIONS ACCOMPANYING THIS LETTER OF TRANSMITTAL CAREFULLY BEFORE COMPLETING THIS LETTER OF TRANSMITTAL.

FOR THIS LETTER OF TRANSMITTAL TO BE PROPERLY DELIVERED, IT MUST BE RECEIVED BY THE DEPOSITARY AT ONE OF THE ADDRESSES ABOVE BEFORE THE OFFER EXPIRES (IN ADDITION TO THE OTHER REQUIREMENTS DETAILED IN THIS LETTER OF TRANSMITTAL AND ITS INSTRUCTIONS). DELIVERY OF THIS INSTRUMENT TO AN ADDRESS OTHER THAN EITHER OF THOSE SHOWN ABOVE DOES NOT CONSTITUTE A VALID DELIVERY. DELIVERIES TO THE COMPANY, THE INFORMATION AGENT, OR THE DEPOSITORY TRUST COMPANY (“DTC”) WILL NOT CONSTITUTE A VALID DELIVERY.

You have received this Letter of Transmittal in connection with the offer of Rand Worldwide Inc., a Delaware corporation (the “Issuer”), to purchase 27,530,816 of the outstanding shares of common stock, par value $0.01 per share, of the Issuer (collectively, the “Shares”), at a price of $1.20 per Share, net to the seller in cash, without interest and less any applicable withholding taxes, as described in the Offer to Purchase, dated October 3, 2014 (as it may be amended or supplemented from time to time, the “Offer to Purchase” and, together with this Letter of Transmittal, as it may be amended or supplemented from time to time, the “Offer”).

This Letter of Transmittal is to be used if certificates for the Shares are to be forwarded herewith or, unless an Agent’s Message (defined below) is utilized, if delivery of the Shares is to be made by book-entry transfer to an account maintained by American Stock Transfer & Trust Company, LLC (the “Depositary”) at DTC.

If certificates for your Shares are not immediately available or you cannot deliver your certificates and all other required documents to the Depositary prior to the Expiration Date, or you cannot complete the book-entry transfer procedures prior to the Expiration Date, you may nevertheless tender your Shares according to the guaranteed delivery procedures set forth in Section 7 of the Offer to Purchase.

Your attention is directed in particular to the following:

If you want to retain your shares, you do not need to take any action.

If you want to participate in the Offer, you should complete the appropriate portions of this Letter of Transmittal.

We urge stockholders who hold Shares through a broker, dealer, commercial bank, trust company or other nominee to consult their nominee to determine whether transaction costs are applicable if they tender Shares through their nominee and not directly to the Depositary.

ANY QUESTIONS OR REQUESTS FOR ASSISTANCE OR FOR ADDITIONAL COPIES OF THE OFFER TO PURCHASE OR THIS LETTER OF TRANSMITTAL MAY BE DIRECTED TO THE INFORMATION AGENT SET FORTH AT THE END OF THIS LETTER OF TRANSMITTAL.

Additional Information if Shares Have Been Lost, Are Being Delivered By Book-Entry Transfer

or Are Being Delivered Pursuant to a Previous Notice of Guaranteed Delivery

If any certificate representing the Shares that you are tendering with this Letter of Transmittal has been lost, stolen, destroyed or mutilated, please contact the Depositary immediately at (877) 248-6417 or (718) 921-8317 to obtain instructions as to the steps that must be taken in order to replace the certificate(s). This Letter of Transmittal and related documents cannot be processed until the procedures for replacing lost or destroyed certificates have been followed. Please contact the Depositary immediately to permit timely processing of the replacement documentation. See Instruction 10.


¨		LOST CERTIFICATES: My certificate(s) for shares have been lost, stolen, destroyed or mutilated, and I require assistance in replacing shares. See Instruction 10.

¨		CHECK HERE IF TENDERED SHARES ARE BEING DELIVERED BY BOOK-ENTRY TRANSFER TO THE ACCOUNT MAINTAINED BY THE DEPOSITARY WITH DTC AND COMPLETE THE FOLLOWING (ONLY FINANCIAL INSTITUTIONS THAT ARE PARTICIPANTS IN DTC MAY DELIVER SHARES BY BOOK-ENTRY TRANSFER):


Name of Tendering Institution:



DTC Participant Number:



DTC Account Number:



Transaction Code Number:


¨		CHECK HERE IF TENDERED SHARES ARE BEING DELIVERED PURSUANT TO A NOTICE OF GUARANTEED DELIVERY PREVIOUSLY SENT TO THE DEPOSITARY AND COMPLETE THE FOLLOWING (PLEASE ENCLOSE A PHOTOCOPY OF SUCH NOTICE OF GUARANTEED DELIVERY):


Name(s) of Registered Owner(s):



Window Ticket Number (if any) or DTC Participant Number:



Date of Execution of Notice of Guaranteed Delivery:



Name of Institution that Guaranteed Delivery:

NOTE: SIGNATURES MUST BE PROVIDED BELOW.

PLEASE READ THE ACCOMPANYING INSTRUCTIONS CAREFULLY.

ODD LOTS

(See Instruction 12)

As described in Section 6 of the Offer to Purchase, under certain conditions, stockholders holding fewer than 100 Shares may have their Shares accepted for payment before any proration of other tendered Shares. This preference is not available to partial tenders, or to beneficial or record holders of an aggregate of 100 or more Shares, even if such holders have separate accounts or certificates representing fewer than 100 Shares. Accordingly, this section is to be completed ONLY if Shares are being tendered by or on behalf of a person owning, beneficially or of record, an aggregate of fewer than 100 Shares.

The undersigned either (check one box):


¨		owns, whether beneficially or of record, an aggregate of fewer than 100 Shares and is tendering all such Shares; or

¨		is a broker, dealer, commercial bank, trust company, or other nominee that (a) is tendering for the beneficial owner(s), Shares with respect to which it is the record holder, and (b) believes, based upon representations made to it by the beneficial owner(s), that each such person is the beneficial owner of an aggregate of fewer than 100 Shares and is tendering all such Shares.

ORDER OF PURCHASE IN EVENT OF PRORATION

(See Instruction 13)

Indicate below the order (by certificate number) in which Shares are to be purchased in the event of proration (attached additional signed list, if necessary). If you do not designate an order and if less than all Shares tendered are purchased due to proration, Shares to be purchased will be selected by the Depositary.


1st:

2nd:

3rd:

4th:

5th:

6th:

Ladies and Gentlemen:

The undersigned hereby tenders to Rand Worldwide Inc., a Delaware corporation (the “Issuer”), the above-described shares of common stock of the Issuer, par value $0.01 per share (the “Shares”), at a price of $1.20 per Share, net to the seller in cash, without interest and less any applicable withholding taxes, on the terms and subject to the conditions set forth in the Offer to Purchase, receipt of which is hereby acknowledged, and this Letter of Transmittal (as it may be amended or supplemented from time to time, this “Letter of Transmittal” and, together with the Offer to Purchase, as it may be amended or supplemented from time to time, the “Offer”).

On the terms and subject to the conditions of the Offer (including, if the Offer is extended or amended, the terms and conditions of such extension or amendment), subject to, and effective upon, acceptance for payment and payment for the Shares validly tendered herewith, and not properly withdrawn, prior to the Expiration Date, in accordance with the terms of the Offer, the undersigned hereby sells, assigns and transfers to, or upon the order of, the Issuer, all right, title and interest in and to all of the Shares being tendered hereby and hereby irrevocably appoints American Stock Transfer & Trust Company, LLC (the “Depositary”) the true and lawful agent and attorney-in-fact and proxy of the undersigned with respect to such Shares with full power of substitution (such proxies and power of attorney being deemed to be an irrevocable power coupled with an interest in the tendered shares) to the full extent of such stockholder’s rights with respect to the Shares (a) to deliver certificates representing the Shares (the “Share Certificates”), or transfer of ownership of such Shares on the account books maintained by DTC, together, in either such case, with all accompanying evidence of transfer and authenticity, to or upon the order of the Issuer, (b) to present such Shares for transfer on the books of the Issuer, and (c) to receive all benefits and otherwise exercise all rights of beneficial ownership of such Shares, all in accordance with the terms and subject to the conditions of the Offer.

The undersigned hereby represents and warrants that the undersigned has full power and authority to tender, sell, assign and transfer the Shares tendered hereby and, when the same are accepted for payment by the Issuer, the Issuer will acquire good, marketable and unencumbered title thereto, free and clear of all liens, restrictions, charges and encumbrances and the same will not be subject to any adverse claim. The undersigned hereby represents and warrants that the undersigned is the registered owner of the Shares, or the Share Certificate(s) have been endorsed to the undersigned in blank, or the undersigned is a participant in DTC whose name appears on a security position listing as the owner of the Shares. The undersigned will, upon request, execute and deliver any additional documents deemed by the Depositary or the Issuer to be necessary or desirable to complete the sale, assignment and transfer of the Shares tendered hereby.

It is understood that the undersigned will not receive payment for the Shares unless and until the Shares are accepted for payment and until the Share Certificate(s) owned by the undersigned are received by the Depositary at the address set forth above, together with such additional documents as the Depositary may require, or, in the case of Shares held in book-entry form, ownership of the Shares is validly transferred on the account books maintained by DTC, and until the same are processed for payment by the Depositary.

IT IS UNDERSTOOD THAT THE METHOD OF DELIVERY OF THE SHARES, THE SHARE CERTIFICATE(S) AND ALL OTHER REQUIRED DOCUMENTS (INCLUDING DELIVERY THROUGH DTC) IS AT THE OPTION AND RISK OF THE UNDERSIGNED AND THAT THE RISK OF LOSS OF SUCH SHARES, SHARE CERTIFICATE(S) AND OTHER DOCUMENTS SHALL PASS ONLY AFTER THE DEPOSITARY HAS ACTUALLY RECEIVED THE SHARES OR SHARE CERTIFICATE(S) (INCLUDING, IN THE CASE OF A BOOK-ENTRY TRANSFER, BY BOOK-ENTRY CONFIRMATION (AS DEFINED BELOW)). IF DELIVERY IS BY MAIL, IT IS RECOMMENDED THAT ALL SUCH DOCUMENTS BE SENT BY PROPERLY INSURED REGISTERED MAIL WITH RETURN RECEIPT REQUESTED. IN ALL CASES, SUFFICIENT TIME SHOULD BE ALLOWED TO ENSURE TIMELY DELIVERY.

All authority conferred or agreed to be conferred pursuant to this Letter of Transmittal shall not be affected by, and shall survive, the death or incapacity of the undersigned and any obligation of the undersigned hereunder shall be binding upon the heirs, executors, administrators, trustees in bankruptcy, personal representatives, successors and assigns of the undersigned. Except as stated in the Offer to Purchase, this tender is irrevocable.

The undersigned understands that the acceptance for payment by the Issuer of the Shares tendered pursuant to one of the procedures described in Section 7 of the Offer to Purchase and in the instructions hereto will constitute a binding agreement between the undersigned and the Issuer upon the terms and subject to the conditions of the Offer. The undersigned further understands that it is a violation of Rule 14e-4 promulgated under the Securities Exchange Act of 1934, as amended, for a person acting alone or in concert with others, directly or indirectly, to tender Shares for such person’s own account unless at the time of tender and until 5:00 p.m. midnight, New York City time, on the Expiration Date, such person has a “net long position” in (a) the Shares that is equal to or greater than the amount tendered and will deliver or cause to be delivered such Shares for the purpose of tender to the Issuer within the period specified in the Offer, or (b) other securities immediately convertible into, exercisable for or exchangeable into the Shares (“Equivalent Securities”) that is equal to or greater than the amount tendered and, upon the acceptance of such tender, will acquire such Shares by conversion, exchange or exercise of such Equivalent Securities to the extent required by the terms of the Offer and will deliver or cause to be delivered such Shares so acquired for the purpose of tender to the Issuer within the period specified in the Offer.

Rule 14e-4 also provides a similar restriction applicable to the tender or guarantee of a tender on behalf of another person. A tender of Shares made pursuant to any method of delivery set forth in this Letter of Transmittal will constitute the tendering stockholder’s representation and warranty to the Issuer that (y) such stockholder has a “net long position” in Shares or Equivalent Securities being tendered within the meaning of Rule 14e-4, and (z) such tender of Shares complies with Rule 14e-4.

The undersigned understands that all shares properly tendered and not properly withdrawn will be purchased at the purchase price, without interest, upon the terms and subject to the conditions of the Offer, including its proration provisions, “odd lot” provisions and conditional tender provisions, and that the Issuer will return at its expense all other shares including shares not purchased because of proration or conditional tenders, promptly following the Expiration Time.

Under the circumstances set forth in the Offer to Purchase, the Issuer expressly reserves the right, in its sole discretion, to terminate the Offer at any time and from time to time, upon the occurrence of any of the events set forth in Section 10 of the Offer to Purchase and to extend the period of time during which the Offer is open and thereby delay acceptance for payment of, and payment for, any Shares by giving oral or written notice of such extension to the Depositary and making a public announcement thereof. During any such extension, all Shares previously tendered and not properly withdrawn will remain subject to the Offer and to the rights of a tendering stockholder to withdraw such stockholder’s Shares.

The Issuer has advised the undersigned to consult with the undersigned’s own advisors as to the consequences of tendering Shares pursuant to the Offer. THE UNDERSIGNED UNDERSTANDS THAT THE OFFER IS NOT BEING MADE TO (NOR WILL TENDERS OF SHARES BE ACCEPTED FROM OR ON BEHALF OF) HOLDERS IN ANY JURISDICTION WITHIN THE UNITED STATES IN WHICH THE MAKING OR ACCEPTANCE OF THE OFFER WOULD NOT BE IN COMPLIANCE WITH THE LAWS OF THAT JURISDICTION.

Unless otherwise indicated herein under “Special Payment Instructions,” please issue the check for the purchase price in the name(s) of, and/or return any Share Certificates representing Shares not tendered or accepted for payment to, the registered owner(s) appearing under “Description of Shares Tendered.” Similarly, unless otherwise indicated under “Special Delivery Instructions,” please mail the check for the purchase price and/or return any Share Certificates representing Shares not tendered or accepted for payment (and accompanying documents, as appropriate) to the address(es) of the registered owner(s) appearing under “Description of Shares Tendered.” In the event that both the Special Delivery Instructions and the Special Payment Instructions are completed, please issue the check for the purchase price and/or issue any Share Certificates representing Shares not tendered or accepted for payment (and any accompanying documents, as appropriate) in the name of, and deliver such check and/or return such Share Certificates (and any accompanying documents, as appropriate) to, the person or persons so indicated. Unless otherwise indicated herein in the box titled “Special Payment Instructions,” please credit any Shares tendered hereby or by an Agent’s Message and delivered by book-entry transfer, but which are not purchased, by crediting the account at DTC designated above. The undersigned recognizes that Issuer has no obligation pursuant to the Special Payment Instructions to transfer any Shares from the name of the registered owner thereof if the Issuer does not accept for payment any of the Shares so tendered.

NOTE: SIGNATURES MUST BE PROVIDED BELOW.

SPECIAL PAYMENT INSTRUCTIONS

(See Instructions 1, 4, 5 and 7)

To be completed ONLY if Share Certificate(s) not tendered or not accepted for payment and/or the check for the purchase price in consideration of the Shares accepted for payment are to be issued in the name of someone other than the undersigned or if Shares tendered by book-entry transfer which are not accepted for payment are to be returned by credit to an account maintained at DTC other than that designated above.

Issue: ¨ Check ¨ Share Certificates to:


Name (Please Print):



Address (Include Zip Code):



Tax Identification or Social Security Number (See Enclosed Substitute Form W-9):

¨ Credit Shares tendered by book-entry transfer that are not accepted for payment to the DTC account set forth below.


DTC Account Number:

SPECIAL DELIVERY INSTRUCTIONS

(See Instructions 1, 4, 5 and 7)

To be completed ONLY if Share Certificate(s) not tendered or not accepted for payment and/or the check for the purchase price of Shares accepted for payment are to be sent to someone other than the undersigned or to the undersigned at an address other than that shown in the box titled “Description of Shares Tendered” above.

Deliver: ¨ Check(s) and/or ¨ Share Certificates to:


Name (Please Print):



Address (Include Zip Code):

IMPORTANT—SIGN HERE

(U.S. Holders Please Also Complete the Enclosed Substitute Form W-9)

(Non-U.S. Holders Please Obtain and Complete IRS Form W-8BEN-E or Other Applicable IRS Form W-8)

By signing below, the undersigned expressly agrees to the terms and conditions set forth above:


Signature(s):



Name(s):

Dated: , 2014

(Must be signed by registered owner(s) exactly as name(s) appear(s) on Share Certificate(s) or on a security position listing or by person(s) authorized to become registered owner(s) by certificates and documents transmitted herewith. If signature is by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, please set forth full title and see Instruction 5. For information concerning signature guarantees, see Instruction 1.)

Please Print:


Capacity (See Instruction 5):



Address (Include Zip Code):



Area Code and Telephone Number:



Tax Identification or Social Security Number (See Enclosed Substitute Form W-9):

GUARANTEE OF SIGNATURE(S)

(For use by Eligible Institutions only; See Instructions 1 and 5)


Authorized Signature:

Please Print:


Name(s):



Name of Firm:



Area Code and Telephone Number:

Dated: , 2014

Place medallion guarantee in space below:

INSTRUCTIONS

Forming Part of the Terms and Conditions of the Offer

1. Guarantee of Signatures. Signatures on this Letter of Transmittal need not be guaranteed (a) if this Letter of Transmittal is signed by the registered owner(s) (which term, for purposes of this document, includes any participant in any of DTC’s systems whose name appears on a security position listing as the owner of the Shares) of the Shares tendered herewith and such registered owner has not completed the box titled “Special Payment Instructions” or the box titled “Special Delivery Instructions” on this Letter of Transmittal or (b) if such Shares are tendered for the account of an Eligible Institution. See Instruction 5. Except as otherwise provided in the preceding sentence, all signatures on this Letter of Transmittal must be guaranteed by a financial institution (including most commercial banks, savings and loan associations and brokerage houses) that is a member in good standing of a recognized Medallion Program approved by the Securities Transfer Association, Inc., including the Security Transfer Agents Medallion Program, the New York Stock Exchange Medallion Signature Program and the Stock Exchanges Medallion Program (each, an “Eligible Institution”). If you have any questions regarding the need for a signature guarantee, please call the Information Agent at (866) 357-4029.

2. Delivery of Letter of Transmittal and Certificates or Book-Entry Confirmations. This Letter of Transmittal is to be completed by stockholders if Share Certificates are to be forwarded herewith. If tenders are to be made pursuant to the procedures for tender by book-entry transfer set forth in Section 7 of the Offer to Purchase, an Agent’s Message must be utilized. A manually executed facsimile of this document may be used in lieu of the original. Share Certificates representing all physically tendered Shares, or confirmation of any book-entry transfer into the Depositary’s account at DTC of Shares tendered by book-entry transfer (“Book Entry Confirmation”), as well as this Letter of Transmittal properly completed and duly executed with any required signature guarantees, or an Agent’s Message in the case of a book-entry transfer, and any other documents required by this Letter of Transmittal, must be received by the Depositary at its address set forth herein prior to the Expiration Date. Please do not send your Share Certificates directly to the Issuer.

Stockholders whose Share Certificates are not immediately available or who cannot deliver all other required documents to the Depositary prior to the Expiration Date or who cannot complete the procedures for book-entry transfer prior to the Expiration Date may nevertheless tender their Shares by properly completing and duly executing a Notice of Guaranteed Delivery pursuant to the guaranteed delivery procedure set forth in Section 7 of the Offer to Purchase. Pursuant to such procedure: (a) such tender must be made by or through an Eligible Institution, (b) a properly completed and duly executed Notice of Guaranteed Delivery substantially in the form provided by the Issuer must be received by the Depositary prior to the Expiration Date (or prior to the expiration of the Subsequent Offering Period, as applicable), and (c) Share Certificates representing all tendered Shares, in proper form for transfer (or a Book Entry Confirmation with respect to such Shares), this Letter of Transmittal (or facsimile thereof), properly completed and duly executed with any required signature guarantees (or, in the case of a book-entry transfer, an Agent’s Message), and all other documents required by this Letter of Transmittal, if any, must be received by the Depositary within three business days after the date of execution of such Notice of Guaranteed Delivery.

A properly completed and duly executed Letter of Transmittal (or facsimile thereof) must accompany each such delivery of Share Certificates to the Depositary.

The term “Agent’s Message” means a message, transmitted through electronic means by DTC to, and received by, the Depositary and forming part of a Book-Entry Confirmation, which states that DTC has received an express acknowledgment from the participant in DTC tendering the Shares which are the subject of such Book-Entry Confirmation that such participant has received and agrees to be bound by the terms of this Letter of Transmittal and that the Issuer may enforce such agreement against the participant. The term “Agent’s Message” also includes any hard copy printout evidencing such message generated by a computer terminal maintained at the Depositary’s office.

THE METHOD OF DELIVERY OF THE SHARES, THIS LETTER OF TRANSMITTAL AND ALL OTHER REQUIRED DOCUMENTS, INCLUDING DELIVERY THROUGH DTC, IS AT THE ELECTION AND RISK OF THE TENDERING STOCKHOLDER. DELIVERY OF ALL SUCH DOCUMENTS WILL BE DEEMED MADE AND RISK OF LOSS OF THE SHARE CERTIFICATES SHALL PASS ONLY WHEN ACTUALLY RECEIVED BY THE DEPOSITARY (INCLUDING, IN THE CASE OF A BOOK-ENTRY TRANSFER, BY BOOK-ENTRY CONFIRMATION). IF SUCH DELIVERY IS BY MAIL, IT IS RECOMMENDED THAT ALL SUCH DOCUMENTS BE SENT BY PROPERLY INSURED REGISTERED MAIL WITH RETURN RECEIPT REQUESTED. IN ALL CASES, SUFFICIENT TIME SHOULD BE ALLOWED TO ENSURE TIMELY DELIVERY.

No alternative, conditional or contingent tenders will be accepted and no fractional Shares will be purchased. All tendering stockholders, by execution of this Letter of Transmittal (or facsimile thereof), waive any right to receive any notice of the acceptance of their Shares for payment.

All questions as to validity, form and eligibility (including time of receipt) of the surrender of any Share Certificate hereunder, including questions as to the proper completion or execution of any Letter of Transmittal, Notice of Guaranteed Delivery or other required documents and as to the proper form for transfer of any certificate of Shares, will be determined by the Issuer in its sole and absolute discretion (which may delegate power in whole or in part to the Depositary) which determination will be final and binding. The Issuer reserves the absolute right to reject any and all tenders determined by it not to be in proper form or the acceptance for payment of or payment for which may be unlawful. The Issuer also reserves the absolute right to waive any defect or irregularity in the surrender of any Shares or Share Certificate(s) whether or not similar defects or irregularities are waived in the case of any other stockholder. A surrender will not be deemed to have been validly made until all defects and irregularities have been cured or waived. The Issuer and the Depositary shall make reasonable efforts to notify any person of any defect in any Letter of Transmittal submitted to the Depositary.

3. Inadequate Space. If the space provided herein is inadequate, the certificate numbers and/or the number of Shares should be listed on a separate schedule attached hereto and separately signed on each page thereof in the same manner as this Letter of Transmittal is signed.

4. Partial Tenders (Not Applicable to Stockholders Who Tender By Book-Entry). If fewer than all the Shares evidenced by any Share Certificate delivered to the Depositary are to be tendered, fill in the number of Shares which are to be tendered in the column titled “Number of Shares Tendered” in the box titled “Description of Shares Tendered.” In such cases, new certificate(s) for the remainder of the Shares that were evidenced by the old certificate(s) but not tendered will be sent to the registered owner, unless otherwise provided in the appropriate box on this Letter of Transmittal, as soon as practicable after the Expiration Date. All Shares represented by Share Certificates delivered to the Depositary will be deemed to have been tendered unless otherwise indicated.

5. Signatures on Letter of Transmittal; Stock Powers and Endorsements. If this Letter of Transmittal is signed by the registered owner(s) of the Shares tendered hereby, the signature(s) must correspond with the name(s) as written on the face of the Share Certificate(s) without alteration or any other change whatsoever.

If any Shares tendered hereby are owned of record by two or more joint owners, all such owners must sign this Letter of Transmittal.

If any tendered Shares are registered in the names of different holder(s), it will be necessary to complete, sign and submit as many separate Letters of Transmittal (or facsimiles thereof) as there are different registrations of such Shares.

If this Letter of Transmittal or any certificates or stock powers are signed by trustees, executors, administrators, guardians, attorneys-in-fact, officers of corporations or others acting in a fiduciary or representative capacity, such persons should so indicate when signing, and proper evidence satisfactory to the Issuer of their authority so to act must be submitted with this Letter of Transmittal.

If this Letter of Transmittal is signed by the registered owner(s) of the Shares listed and transmitted hereby, no endorsements of Share Certificates or separate stock powers are required unless payment is to be made to, or Share Certificates representing Shares not tendered or accepted for payment are to be issued in the name of, a person other than the registered owner(s), in which case the Share Certificates representing the Shares tendered by this Letter of Transmittal must be endorsed or accompanied by appropriate stock powers, in either case, signed exactly as the name(s) of the registered owner(s) or holder(s) appear(s) on the Share Certificates. Signatures on such Share Certificates or stock powers must be guaranteed by an Eligible Institution.

If this Letter of Transmittal is signed by a person other than the registered owner(s) of the Share(s) listed, the Share Certificate(s) must be endorsed or accompanied by the appropriate stock powers, in either case, signed exactly as the name or names of the registered owner(s) or holder(s) appear(s) on the Share Certificate(s). Signatures on such Share Certificates or stock powers must be guaranteed by an Eligible Institution.

6. Transfer Taxes. The Issuer will pay any transfer taxes with respect to the transfer and sale of Shares to it or to its order pursuant to the Offer (for the avoidance of doubt, transfer taxes do not include United States federal income or backup withholding taxes). If, however, payment of the purchase price is to be made to, or (in the circumstances permitted hereby) if Share Certificates not tendered or accepted for payment are to be registered in the name of, any person other than the registered owner(s), or if tendered Share Certificates are registered in the name of any person other than the person signing this Letter of Transmittal, the amount of any transfer taxes (whether imposed on the registered owner(s) or such person) payable on account of the transfer to such person will be deducted from the purchase price unless satisfactory evidence of the payment of such taxes, or exemption therefrom, is submitted with this Letter of Transmittal.

Except as provided in this Instruction 6, it will not be necessary for transfer tax stamps to be affixed to the Share Certificates listed in this Letter of Transmittal.

7. Special Payment and Delivery Instructions. If a check for the purchase price is to be issued, and/or Share Certificates representing Shares not tendered or accepted for payment are to be issued or returned to, a person other than the signer(s) of this Letter of Transmittal or to an address other than that shown in the box titled “Description of Shares Tendered” above, the appropriate boxes on this Letter of Transmittal should be completed. Stockholders delivering Shares tendered hereby or by Agent’s Message by book-entry transfer may request that Shares not purchased be credited to an account maintained at DTC as such stockholder may designate in the box titled “Special Payment Instructions” herein. If no such instructions are given, all such Shares not purchased will be returned by crediting the same account at DTC as the account from which such Shares were delivered.

8. Requests for Assistance or Additional Copies. Questions or requests for assistance may be directed to the Information Agent at its respective address and telephone number set forth below or to your broker, dealer, commercial bank or trust company. Additional copies of the Offer to Purchase, this Letter of Transmittal, the Notice of Guaranteed Delivery and other tender offer materials may be obtained from the Information Agent as set forth below, and will be furnished at the Issuer’s expense.

9. Backup Withholding. Under U.S. federal income tax laws, the Depositary will be required to withhold a portion of the amount of any payments made to certain stockholders pursuant to the Offer, as applicable. In order to avoid such backup withholding, each tendering stockholder or payee that is a United States person (for U.S. federal income tax purposes), must provide the Depositary with such stockholder’s or payee’s correct taxpayer identification number (“TIN”) and certify that such stockholder or payee is not subject to such backup withholding by completing the attached Form W-9. Certain stockholders or payees (including, among others, corporations, non-resident foreign individuals and foreign entities) are not subject to these backup withholding and reporting requirements. A tendering stockholder who is a foreign individual or a foreign entity should complete, sign, and submit to the Depositary the appropriate Form W-8. A Form W-8BEN-E may be obtained from the Depositary or downloaded from the Internal Revenue Service’s website at the following address: http://www.irs.gov. Failure to complete the Form W-9 will not, by itself, cause Shares to be deemed invalidly tendered, but may require the Depositary to withhold a portion of the amount of any payments made of the Offer Price pursuant to the Offer.

NOTE: FAILURE TO COMPLETE AND RETURN THE FORM W-9 MAY RESULT IN BACKUP WITHHOLDING OF A PORTION OF ANY PAYMENTS MADE TO YOU PURSUANT TO THE OFFER. PLEASE REVIEW THE “IMPORTANT TAX INFORMATION” SECTION BELOW.

10. Lost, Destroyed, Mutilated or Stolen Share Certificates. If any Share Certificate has been lost, destroyed, mutilated or stolen, the stockholder should promptly notify the Issuer’s stock transfer agent, American Stock Transfer & Trust Company, LLC at (877) 248-6417 or (718) 921-8317. The stockholder will then be instructed as to the steps that must be taken in order to replace the Share Certificate. This Letter of Transmittal and related documents cannot be processed until the procedures for replacing lost, mutilated, destroyed or stolen Share Certificates have been followed.

11. Waiver of Conditions; Irregularities. All questions as to the number of Shares to be accepted and the validity, form, eligibility (including time of receipt) and acceptance for payment of any tender of Shares, or as to the validity (including time of receipt) and form of any notice of withdrawal of tendered Shares, will be determined by the Issuer, in its sole discretion, and its determination will be final and binding on all persons participating in the Offer, subject to such Offer participants disputing such determination in a court of competent jurisdiction. The Issuer may delegate power in whole or in part to the Depositary. The Issuer reserves the absolute right prior to the Expiration Date to reject any or all tenders of any Shares that the Issuer determines are not in proper form or the acceptance for payment of or payment for which may, in the opinion of the Issuer’s counsel, be unlawful. The Issuer reserves the absolute right to reject any notices of withdrawal that it determines are not in proper form. The Issuer also reserves the absolute right, subject to the applicable rules and regulations of the Securities and Exchange Commission, to waive any of the conditions of the Offer prior to the Expiration Date, or any defect or irregularity in any tender or withdrawal with respect to any particular Shares or any particular stockholder, and the Issuer’s interpretation of the terms of the Offer (including these instructions) will be final and binding on all persons participating in the Offer, subject to such Offer participants disputing such determination in a court of competent jurisdiction. No tender or withdrawal of Shares will be deemed to have been properly made until all defects or irregularities have been cured by the tendering or withdrawing stockholder or waived by the Issuer. The Issuer will not be liable for failure to waive any condition of the Offer, or any defect or irregularity in any tender or withdrawal of Shares. None of the Issuer, the Information Agent, the Depositary or any other person will be obligated to give notice of any defects or irregularities in any tender or withdrawal, nor will any of the foregoing incur any liability for failure to give any such notice.

12. Odd Lots. As described in Section 6 of the Offer to Purchase, if the Issuer is to purchase fewer than all Shares tendered before the Expiration Date and not properly withdrawn, the Shares purchased first will consist of all Odd Lots of less than 100 Shares from stockholders who properly tender all of their Shares and who do not properly withdraw them before the Expiration Date (tenders of less than all of the Shares owned, beneficially or of record, by such Odd Lot Holder will not qualify for this preference). This preference will not be available unless the section captioned “Odd Lots” in this Letter of Transmittal is completed.

13. Order of Purchase in Event of Proration. As described in Section 6 of the Offer to Purchase, stockholders may designate the order in which their Shares are to be purchased in the event of proration. The order of purchase may have an effect on the U.S. federal income tax classification and the amount of any gain or loss on the Shares purchased. See Section 6 and Section 16 of the Offer to Purchase.

IMPORTANT: THIS LETTER OF TRANSMITTAL (OR A MANUALLY EXECUTED FACSIMILE COPY THEREOF) OR AN AGENT’S MESSAGE, TOGETHER WITH SHARE CERTIFICATE(S) OR BOOK-ENTRY CONFIRMATION OR A PROPERLY COMPLETED AND DULY EXECUTED NOTICE OF GUARANTEED DELIVERY AND ALL OTHER REQUIRED DOCUMENTS, MUST BE RECEIVED BY THE DEPOSITARY PRIOR TO THE EXPIRATION DATE.

IMPORTANT TAX INFORMATION

Under U.S. federal income tax law, a stockholder that is a non-exempt U.S. person (for U.S. federal income tax purposes) whose tendered Shares are accepted for payment is required by law to provide the Depositary (as payer) with such stockholder’s correct TIN on Form W-9 below. If such stockholder is an individual, the TIN is such stockholder’s social security number. If the Depositary is not provided with the correct TIN, the stockholder may be subject to penalties imposed by the Internal Revenue Service (“IRS”) and payments that are made to such stockholder with respect to Shares purchased pursuant to the Offer, may be subject to backup withholding.

If backup withholding applies, the Depositary is required to withhold 28% of any payments of the purchase price made to the stockholder. Backup withholding is not an additional tax. Rather, the tax liability of persons subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund or credit may be obtained from the IRS provided that the required information is furnished to the IRS.

Form W-9

To prevent backup withholding on payments that are made to a U.S. stockholder with respect to Shares purchased pursuant to the Offer, as applicable, the stockholder is required to notify the Depositary of such stockholder’s correct TIN by completing Form W-9 certifying, under penalties of perjury, (i) that the TIN provided on Form W-9 is correct (or that such stockholder is awaiting a TIN), (ii) that such stockholder is not subject to backup withholding because (a) such stockholder has not been notified by the IRS that such stockholder is subject to backup withholding as a result of a failure to report all interest or dividends, (b) the IRS has notified such stockholder that such stockholder is no longer subject to backup withholding or (c) such stockholder is exempt from backup withholding, and (iii) that such stockholder is a U.S. person.

What Number to Give the Depositary

Each United States stockholder is generally required to give the Depositary its social security number or employer identification number. If the tendering stockholder has not been issued a TIN and has applied for a number or intends to apply for a number in the near future, the stockholder should write “Applied For” in Part I, sign and date the Form W-9. Notwithstanding that “Applied For” is written in Part I, the Depositary will withhold 28% of all payments of the purchase price to such stockholder until a TIN is provided to the Depositary. Such amounts will be refunded to such surrendering stockholder if a TIN is provided to the Depositary within 60 days. We note that your Form W-9, including your TIN, may be transferred from the Depositary to the Paying Agent, in certain circumstances.

Please consult your accountant or tax advisor for further guidance regarding the completion of IRS Form W-9, IRS Form W-8BEN-E, or another version of IRS Form W-8 to claim exemption from backup withholding, or contact the Depositary.

Payer’s Name: American Stock Transfer & Trust Company, LLC



SUBSTITUTE FORM W-9 Department of the Treasury Internal Revenue Service	Part 1 — PLEASE PROVIDE YOUR TIN IN THE BOX AT RIGHT AND CERTIFY BY SIGNING AND DATING BELOW		Social Security Number
			OR

			Employer Identification Number
	Part 2 — FOR PAYEES EXEMPT FROM BACKUP WITHHOLDING
	(See Page 2 of enclosed Guidelines)

	Part 3 — Certification Under Penalties of Perjury, I certify that:

	(1)	The number shown on this form is my current taxpayer identification number (or I am waiting for a number to be issued to me),	Part 4 — Awaiting TIN ¨
Payer’s Request for Taxpayer Identification Number (TIN) and Certification	(2)	I am not subject to backup withholding either because I have not been notified by the Internal Revenue Service (the “IRS”) that I am subject to backup withholding as a result of failure to report all interest or dividends, or the IRS has notified me that I am no longer subject to backup withholding and
	(3)	I am a U.S. person (including a U.S. resident alien).
	Certification instructions — You must cross out item (2) in Part 3 above if you have been notified by the IRS that you are subject to backup withholding because of underreporting interest or dividends on your tax return. However, if after being notified by the IRS that you are subject to backup withholding you receive another notification from the IRS stating that you are no longer subject to backup withholding, do not cross out item (2).
	SIGNATURE DATE
	NAME
	ADDRESS
	CITY STATE ZIP CODE

NOTE: FAILURE TO COMPLETE AND RETURN THIS FORM MAY RESULT IN BACKUP WITHHOLDING OF 28% OF ANY PAYMENTS MADE TO YOU PURSUANT TO THE OFFER. PLEASE REVIEW THE ENCLOSED GUIDELINES FOR CERTIFICATION OF TAXPAYER IDENTIFICATION NUMBER ON SUBSTITUTE FORM W-9 FOR ADDITIONAL DETAILS.

IMPORTANT TAX INFORMATION

Under current U.S. federal income tax law, a stockholder whose Shares are accepted for payment may be subject to backup withholding. In order to avoid such backup withholding, the stockholder must provide the Depositary with such stockholder’s correct taxpayer identification number and certify that such stockholder is not subject to such backup withholding by completing the Substitute Form W-9 provided herewith. In general, if a stockholder is an individual, the taxpayer identification number is the Social Security number of such individual. If the Depositary is not provided with the correct taxpayer identification number, the stockholder may be subject to a $50 penalty imposed by the IRS. For further information concerning backup withholding and instructions for completing the Substitute Form W-9 (including how to obtain a taxpayer identification number if you do not have one and how to complete the Substitute Form W-9 if your certificates are held in more than one name), consult the enclosed Guidelines for Certification of Taxpayer Identification Number on Substitute Form W-9.

Certain stockholders (including, among others, all corporations and certain foreign individuals) are not subject to these backup withholding and reporting requirements. In order to satisfy the Exchange Agent that a foreign individual qualifies as an exempt recipient, such stockholder must submit a statement, signed under penalties of perjury, attesting to that individual’s exempt status, on a properly completed Form W-8BEN-E, or successor form. Such statements can be obtained from the Depositary.

Failure to complete the Substitute Form W-9 will not, by itself, cause the stock certificates to be deemed invalidly tendered, but may require the Depositary to withhold a portion of the amount of any payments made pursuant to the Offer. Backup withholding is not an additional federal income tax. Rather, the federal income tax liability of a person subject to backup withholding will be reduced by the amount of tax withheld. If withholding results in an overpayment of taxes, a refund may be obtained provided that the required information is furnished to the Internal Revenue Service.

GUIDELINES FOR CERTIFICATION OF TAXPAYER IDENTIFICATION

NUMBER ON SUBSTITUTE FORM W-9

Guidelines for Determining the Proper Identification Number to Give the Payer — Social Security Numbers have nine digits separated by two hyphens: i.e., 000-00-0000. Employer Identification Numbers have nine digits separated by only one hyphen: i.e., 00-0000000. The table below will help determine the number to give the payer.

For this type of account:

Give the SOCIAL

SECURITY number of —

For this type of account:

Give the EMPLOYER

IDENTIFICATION number of —

An individual’s account

The individual

Sole proprietorship account

The owner(4)

Two or more individuals (joint account)

The actual owner of the account or, if combined funds, the first individual on the account(1)

A valid trust, estate or pension trust

The legal entity(5)

Husband and wife (joint account)

The actual owner of the account or, if joint funds, the first individual on the account (1)

10.

Corporate account

The corporation

Custodian account of a minor (Uniform Gift to Minors Act)

The minor(2)

11.

Religious, charitable, or educational organization account

The organization

Adult and minor (joint account)

The adult or, if the minor is the only contributor, the minor(1)

12.

Partnership account held in the name of the business

The partnership

Account in the name of guardian or committee for a designated ward, minor, or incompetent person

The ward, minor, or incompetent person(3)

13.

Association, club, or other tax-exempt organization

The organization

The usual revocable savings trust account (grantor is also trustee)

The grantor-trustee(1)

14.

A broker or registered nominee

The broker or nominee

So-called trust account that is not a legal or valid trust under state law

The actual owner(1)

15.

Account with the Department of Agriculture in the name of a public entity (such as a state or local government, school district, or prison) that receives agricultural program payments

The public entity

(1)	List first and circle the name of the person whose number you furnish. If only one person on a joint account has a social security number, that person’s number must be furnished.

(2)	Circle the minor’s name and furnish the minor’s social security number.

(3)	Circle the ward’s, minor’s or incompetent person’s name and furnish such person’s social security number.

(4)	You must show your individual name, but you may also enter your business or “doing business as” name. You may use either your social security number or employer identification number (if you have one).

(5)	List first and circle the name of the legal trust, estate, or pension trust. Do not furnish the taxpayer identification number of the personal representative or trustee unless the legal entity itself is not designated in the account title.

Note:

If no name is circled when there is more than one name, the number will be considered to be that of the first name listed.

GUIDELINES FOR CERTIFICATION OF TAXPAYER IDENTIFICATION

NUMBER ON SUBSTITUTE FORM W-9

Page 2

Obtaining a Number

If you do not have a taxpayer identification number or if you do not know your number, obtain Form SS-5, Application for Social Security Card, or Form SS-4, Application for Employer Identification Number, at the local office of the Social Security Administration or the Internal Revenue Service (the “IRS”) and apply for a number. Section references in these guidelines refer to sections under the Internal Revenue Code of 1986, as amended.

Payees specifically exempted from backup withholding include:

•

An organization exempt from tax under Section 501(a), an individual retirement account (IRA), or a custodial account under Section 403(b)(7), if the account satisfies the requirements of Section 401(f)(2).

•

The United States or a state thereof, the District of Columbia, a possession of the United States, or a political subdivision or wholly-owned agency or instrumentality of any one or more of the foregoing.

•

An international organization or any agency or instrumentality thereof.

•

A foreign government or any political subdivision, agency or instrumentality thereof.

Payees that may be exempt from backup withholding include:

•

A corporation.

•

A financial institution.

•

A dealer in securities or commodities required to register in the United States, the District of Colombia, or a possession of the United States.

•

A real estate investment trust.

•

A common trust fund operated by a bank under Section 584(a).

•

An entity registered at all times during the tax year under the Investment Company Act of 1940, as amended.

•

A middleman known in the investment community as a nominee or custodian.

•

A futures commission merchant registered with the Commodity Futures Trading Commission.

•

A foreign central bank of issue.

•

A trust exempt from tax under Section 664 or described in Section 4947.

Payments of dividends and patronage dividends not generally subject to backup withholding include the following:

•

Payments to nonresident aliens subject to withholding under Section 1441.

•

Payments to partnerships not engaged in a trade or business in the U.S. and which have at least one nonresident alien partner.

•

Payments of patronage dividends where the amount received is not paid in money.

•

Payments made by certain foreign organizations.

•

Section 404(k) payments made by an ESOP.

Payments of interest not generally subject to backup withholding include the following:

•

Payments of interest on obligations issued by individuals. Note: You may be subject to backup withholding if this interest is $600 or more and is paid in the course of the payer’s trade or business and you have not provided your correct taxpayer identification number to the payer.

•

Payments of tax-exempt interest (including exempt-interest dividends under Section 852).

•

Payments described in Section 6049(b)(5) to nonresident aliens.

•

Payments on tax-free covenant bonds under Section 1451.

•

Payments made by certain foreign organizations.

•

Mortgage or student loan interest paid to you.

Exempt payees described above should file Form W-9 to avoid possible erroneous backup withholding. FILE THIS FORM WITH THE PAYER, FURNISH YOUR TAXPAYER IDENTIFICATION NUMBER, WRITE “EXEMPT” IN PART 2 OF THE FORM, SIGN AND DATE THE FORM AND RETURN IT TO THE PAYER.

Certain payments other than interest, dividends, and patronage dividends, which are not subject to information reporting are also not subject to backup withholding. For details, see the regulations under Sections 6041, 6041A, 6045, 6050A and 6050N.

Privacy Act Notice. — Section 6109 requires most recipients of dividend, interest, or certain other income to give taxpayer identification numbers to payers who must report the payments to the IRS. The IRS uses the numbers for identification purposes and to help verify the accuracy of tax returns. The IRS may also provide this information to the Department of Justice for civil and criminal litigation and to cities, states and the District of Columbia to carry out their tax laws. The IRS may also disclose this information to other countries under a tax treaty, or to Federal and state agencies to enforce Federal nontax criminal laws and to combat terrorism. Payers must be given the numbers whether or not recipients are required to file tax returns. Payers must generally withhold a portion of taxable interest, dividend, and certain other payments to a payee who does not furnish a taxpayer identification number to a payer. Certain penalties may also apply.

Penalties

(1) Penalty for Failure to Furnish Taxpayer Identification Number. — If you fail to furnish your taxpayer identification number to a payer, you are subject to a penalty of $50 for each such failure unless your failure is due to reasonable cause and not to willful neglect.

GUIDELINES FOR CERTIFICATION OF TAXPAYER IDENTIFICATION

NUMBER ON SUBSTITUTE FORM W-9

Page 3

(2) Civil Penalty for False Information With Respect to Withholding. — If you make a false statement with no reasonable basis which results in no imposition of backup withholding, you are subject to a penalty of $500.

(3) Criminal Penalty for Falsifying Information. — Willfully falsifying certifications or affirmations may subject you to criminal penalties including fines and/or imprisonment.

(4) Misuse of Taxpayer Identification Numbers. — If the requester discloses or uses taxpayer identification numbers in violation of federal law, the requester may be subject to civil and criminal penalties.

FOR ADDITIONAL INFORMATION CONTACT YOUR TAX CONSULTANT OR THE INTERNAL REVENUE SERVICE.

The Depositary for the Offer is:

LOGO

Phone: Toll-free (877) 248-6417 and (718) 921-8317

Fax: 718 234-5001

If delivering by mail:

If delivering by hand, express mail, courier

or any other expedited service:

American Stock Transfer & Trust Company, LLC

Operations Center

Attn: Reorganization Department

P.O. Box 2042

New York, New York 10272-2042

American Stock Transfer & Trust Company, LLC

Operations Center

Attn: Reorganization Department

6201 15^th Avenue

Brooklyn, New York 11219

DELIVERY OF THIS LETTER OF TRANSMITTAL TO AN ADDRESS OTHER THAN AS SET FORTH ABOVE WILL NOT CONSTITUTE A VALID DELIVERY TO THE DEPOSITARY.

Any questions or requests for assistance may be directed to the Information Agent at its telephone number and location listed below. Requests for additional copies of this Offer to Purchase and the Letter of Transmittal may be directed to the Information Agent at its respective telephone number and location listed below. You may also contact your broker, dealer, commercial bank or trust company or other nominee for assistance concerning the Offer.

The Information Agent for the Offer is:

LOGO

480 Washington Blvd., — 26^th Floor

Jersey City, NJ 07310

Stockholders, Banks and Brokers

Call Toll-Free: (866) 357-4029

Exhibit (a)(1)(iii)

NOTICE OF GUARANTEED DELIVERY

TO TENDER SHARES OF COMMON STOCK

RAND WORLDWIDE, INC.

Pursuant to its Offer to Purchase Dated October 3, 2014

THE OFFER, PRORATION PERIOD AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON NOVEMBER 3, 2014, UNLESS THE OFFER IS EXTENDED (SUCH DATE AND TIME, AS THEY MAY BE EXTENDED, THE “EXPIRATION DATE”).

As set forth in Section 7 of the Offer to Purchase (as hereinafter defined), this Notice of Guaranteed Delivery, or one substantially in the form hereof, must be used to accept the Offer (as hereinafter defined) if (a) the certificates for Shares are not immediately available, (b) the procedure for book-entry transfer described in the Offer to Purchase and the related Letter of Transmittal cannot be completed on a timely basis or (c) time will not permit all required documents, including a properly completed and duly executed Letter of Transmittal, to reach the Depositary prior to the Expiration Date.

This Notice of Guaranteed Delivery, properly completed and duly executed, may be delivered by mail, overnight courier or other expedited service to the Depositary on or before the Expiration Date. See Section 7 of the Offer to Purchase.

The Depositary for the Offer is:

LOGO

Phone: Toll-free (877) 248-6417 and (718) 921-8317

Fax: 718 234-5001

If delivering by mail:

If delivering by hand, express mail, courier

or any other expedited service:

American Stock Transfer & Trust Company, LLC

Operations Center

Attn: Reorganization Department

P.O. Box 2042

New York, New York 10272-2042

American Stock Transfer & Trust Company, LLC

Operations Center

Attn: Reorganization Department

6201 15^th Avenue

Brooklyn, New York 11219

DELIVERY OF THIS INSTRUMENT TO AN ADDRESS OTHER THAN THE ONE ABOVE DOES NOT CONSTITUTE A VALID DELIVERY.

THIS FORM IS NOT TO BE USED TO GUARANTEE SIGNATURES. IF A SIGNATURE ON THE LETTER OF TRANSMITTAL IS REQUIRED TO BE GUARANTEED BY AN ELIGIBLE INSTITUTION (AS DEFINED IN THE OFFER TO PURCHASE) UNDER THE INSTRUCTIONS TO THE LETTER OF TRANSMITTAL, SUCH SIGNATURE GUARANTEE MUST APPEAR IN THE APPLICABLE SPACE PROVIDED IN THE SIGNATURE BOX ON THE LETTER OF TRANSMITTAL.

Ladies and Gentlemen:

The undersigned hereby tenders to Rand Worldwide, Inc., a Delaware corporation (the “Company”), on the terms and subject to the conditions set forth in the Offer to Purchase dated October 3, 2014 (the “Offer to Purchase”), and the related Letter of Transmittal (which, together with any amendments or supplements thereto, collectively constitute the “Offer”), receipt of which is hereby acknowledged, the number of shares set forth below, all pursuant to the guaranteed delivery procedures set forth in Section 7 of the Offer to Purchase. Unless the context otherwise requires, all references to the shares shall refer to the common stock of the Company.

Number of shares to be tendered: shares*

Unless otherwise indicated, it will be assumed that all shares held by the undersigned are to be tendered.

ODD LOTS

(See Instruction 12 of the Letter of Transmittal)

The undersigned either (check one box):

owns, whether beneficially or of record, an aggregate of fewer than 100 Shares and is tendering all such Shares; or

is a broker, dealer, commercial bank, trust company, or other nominee that (a) is tendering for the beneficial owner(s), Shares with respect to which it is the record holder, and (b) believes, based upon representations made to it by the beneficial owner(s), that each such person is the beneficial owner of an aggregate of fewer than 100 Shares and is tendering all such Shares.


Certificate Number(s):
(if available)

Name(s) of Record Holders(s):



Address(es):
(include zip code)

Telephone(s):
(include area code)

Signature(s):


Dated:

If shares will be tendered by book-entry transfer, check this box: ¨ and provide the following information:


Name of Tendering Institution:



Account Number at Book-Entry Transfer Facility:

THE GUARANTEE SET FORTH BELOW MUST BE COMPLETED

GUARANTEE OF DELIVERY

(not to be used for signature guarantee)

The undersigned, a firm that is a member in good standing of a recognized Medallion Program approved by the Securities Transfer Association, Inc., including the Securities Transfer Agents Medallion Program, the New York Stock Exchange, Inc. Medallion Signature Program or the Stock Exchange Medallion Program, or is otherwise an “eligible guarantor institution,” as that term is defined in Rule 17Ad-15 under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), hereby guarantees (1) that the above named person(s) “own(s)” the shares tendered hereby within the meaning of Rule 14e-4 under the Exchange Act, (2) that such tender of shares complies with Rule 14e-4 under the Exchange Act and (3) to deliver to the Depositary either the certificates representing the shares tendered hereby, in proper form for transfer, or a book-entry confirmation with respect to such shares, in any such case together with a properly completed and duly executed Letter of Transmittal (or a facsimile thereof), with any required signature guarantees, or an Agent’s Message (as defined in the Offer to Purchase) in the case of a book-entry delivery, and any other required documents, within three business days after the date hereof.

The eligible institution that completes this form must communicate the guarantee to the Depositary and must deliver the Letter of Transmittal and certificates for shares to the Depositary within the time period shown herein. Failure to do so could result in financial loss to such eligible institution.



Name of Firm				Authorized Signature


Address				Name


City, State, Zip Code				Title


Area Code and Telephone Number:


Date:

NOTE: DO NOT SEND CERTIFICATES FOR SHARES WITH THIS NOTICE.

CERTIFICATES FOR SHARES SHOULD BE SENT WITH YOUR LETTER OF TRANSMITTAL.

Exhibit (a)(1)(iv)

LOGO

To Stockholders of Rand Worldwide, Inc.:

Enclosed for your consideration are the Offer to Purchase, dated October 3, 2014 (the “Offer to Purchase”), and the related Letter of Transmittal (which, together with any amendments or supplements thereto, collectively constitute the “Offer”), in connection with the offer by Rand Worldwide, Inc. (“Rand”, “we” or “us”) to purchase for cash up to 27,530,816 shares of the common stock of Rand, $0.01 par value per share, at a price, less any applicable withholding taxes and without interest, of $1.20 per share, on the terms and subject to the conditions of the Offer. Unless the context otherwise requires, all references to the shares shall refer to the common stock of Rand. The last reported sale price for our common stock on September 26, 2014, the last trading day before our intention to make the offer was announced, was $1.15 per share.

We will purchase shares on the terms and subject to the conditions of the Offer, including the proration provisions and “odd lot” provisions contained therein. We will purchase up to 27,530,816 shares pursuant to the Offer. We also reserve the right, in our sole discretion, to increase the number of shares we purchase by an amount that does not exceed 2% of our outstanding shares.

If the number of shares properly tendered is less than or equal to 27,530,816 shares (or such greater number of shares as we may elect to purchase pursuant to the Offer, subject to applicable law and the Offer to Purchase), we will, on the terms and subject to the conditions of the Offer, purchase all shares so tendered.

On the terms and subject to the conditions of the Offer, if at the expiration of the Offer more than 27,530,816 shares (or such greater number of shares as we may elect to purchase, subject to applicable law) are properly tendered, we will buy shares first, from all stockholders who own beneficially or of record, an aggregate of fewer than 100 shares (an “Odd Lot Holder”) who properly tender all their shares, and second, on a pro rata basis from all other stockholders who properly tender shares. Shares that are tendered but not purchased because of proration provisions will be returned to the tendering stockholders at our expense promptly after the expiration of the Offer. See Section 6 and Section 7 of the Offer to Purchase.

We believe that the repurchase of shares is consistent with our long-term goal of maximizing stockholder value. Further, we are making the Offer to provide all stockholders liquidity in our common stock, which is not heavily traded. Our largest stockholder, RWWI Holdings, LLC, which is majority-owned by funds affiliated with Ampersand Capital Partners, sold 9,000,000 of shares of its Rand common stock to 3K Limited Partnership (“3K”), an existing stockholder, on September 26, 2014, and has indicated its intention to tender the remainder of its shares (25,232,682) in the Offer, subject to proration.

The offer is explained in detail in the enclosed Offer to Purchase and Letter of Transmittal. This letter is only a summary, and I encourage you to read these documents carefully before making any decision with respect to the offer. The instructions on how to tender shares are explained in detail in the accompanying materials. Neither Rand nor its Board of Directors makes any recommendation to stockholders as to whether to tender their shares in the Offer.

The offer will expire at 5:00 P.M., New York City time, on Monday, November 3, 2014, unless the Offer is extended. Questions and requests for assistance may be directed to Georgeson, Inc., the information agent for the offer, at the telephone number and address set forth on the back cover of the Offer to Purchase. You may request additional copies of the Offer to Purchase and other offer documents from the information agent at the telephone number and address on the back cover of the Offer to Purchase.

Very truly yours,

Marc L. Dulude

Chairman and Chief Executive Officer

Exhibit (a)(1)(v)

OFFER TO PURCHASE FOR CASH

RAND WORLDWIDE, INC.

UP TO 27,530,816 SHARES OF COMMON STOCK OF RAND WORLDWIDE, INC.

AT A PURCHASE PRICE OF $1.20 PER SHARE

To Brokers, Dealers, Commercial Banks, Trust Companies and Other Nominees:

Please furnish copies of the enclosed materials to those of your clients for whom you hold shares registered in your name or in the name of your nominee.

We have been appointed by Rand Worldwide Inc., a Delaware corporation (“Rand” or the “Company”), to act as Information Agent in connection with its offer to purchase for cash up to 27,530,816 shares of its common stock, $0.01 par value per share, at a price, less any applicable withholding taxes and without interest, of $1.20 per share, upon the terms and subject to the conditions set forth in the Company’s Offer to Purchase, dated October 3, 2014 (the “Offer to Purchase”), and in the related Letter of Transmittal (which together, as they may be supplemented or amended from time to time, constitute the “Offer”). Unless the context requires otherwise, all references to “shares” shall refer to the shares of common stock of the Company. All capitalized terms used and not defined herein shall have the meanings ascribed to such terms in the Offer to Purchase.

Only shares properly tendered and not properly withdrawn will be purchased. The Company will purchase shares on the terms and subject to the conditions of the Offer, including the proration provisions and “odd lot” provisions contained therein. The Company reserves the right, in its sole discretion, to increase the number of shares it purchases by an amount that does not exceed 2% of its outstanding shares.

If the number of shares properly tendered is less than or equal to 27,530,816 shares (or such greater number of shares as the Company may elect to purchase pursuant to the Offer, subject to applicable law and the Offer to Purchase), the Company will, on the terms and subject to the conditions of the Offer, purchase all shares so tendered.

On the terms and subject to the conditions of the Offer, if at the expiration of the Offer more than 27,530,816 shares (or such greater number of shares as the Company may elect to purchase, subject to applicable law) are properly tendered, the Company will buy shares first, from all stockholders who own beneficially or of record, an aggregate of fewer than 100 shares (an “Odd Lot Holder”) who properly tender all their shares, and second, on a pro rata basis from all other stockholders who properly tender shares. Shares that are tendered but not purchased because of proration provisions will be returned to the tendering stockholders at the Company’s expense promptly after the expiration of the Offer. See Section 6 and Section 7 of the Offer to Purchase.

For your information and for forwarding to those of your clients for whom you hold shares registered in your name or in the name of your nominee, we are enclosing the following documents:

1. The Offer to Purchase dated October 3, 2014;

2. The Letter of Transmittal (including Guidelines of the Internal Revenue Service for Certification of Taxpayer Identification Number on Substitute Form W-9) for your use and for the information of your clients, together with the accompanying Substitute Form W-9;

3. The Notice of Guaranteed Delivery to be used to accept the Offer and tender shares pursuant to the Offer if the procedure for book-entry transfer cannot be completed by the Expiration Date or if all other required documents cannot be delivered to the Depositary by the Expiration Date;

4. A printed form of letter which you may send to your clients for whose accounts you hold shares registered in your name or in the name of your nominee, with an instruction form provided for obtaining the clients’ instructions with regard to the Offer;

5. Letter to stockholders, dated October 3, 2014; and

6. A return envelope addressed to American Stock Transfer and Trust Company, LLC, as Depositary for the Offer.

Certain conditions of the Offer are described in Section 10 of the Offer to Purchase.

Your prompt action is requested. We urge you to contact your clients as promptly as possible. Please note that the Offer and withdrawal rights will expire at 5:00 P.M., New York City time, on November 3, 2014, unless the Offer is extended.

For shares to be tendered properly pursuant to the Offer:

(a) the certificates for such shares (or confirmation of receipt of such shares pursuant to the procedure for book-entry transfer set forth in the Offer to Purchase, together with a properly completed and duly executed Letter of Transmittal, including any required signature guarantees, or (in the case of book-entry transfer) an “Agent’s Message” (as defined in the Offer to Purchase), and any other documents required by the Letter of Transmittal, must be received before the Expiration Date by the Depositary; or

(b) the tendering stockholder must comply with the guaranteed delivery procedures, all in accordance with the Offer to Purchase and Letter of Transmittal.

Under no circumstances will interest be paid on the purchase price of the shares regardless of any extension of, or amendment to, the Offer or any delay in paying for such shares.

The Company will not pay any fees or commissions to any broker or dealer or other person (other than the information agent and the depositary, as described in the Offer to Purchase) in connection with the solicitation of tenders of shares pursuant to the Offer. However, the Company will, on request, reimburse you for customary mailing and handling expenses incurred by you in forwarding copies of the enclosed Offer materials to your clients.

Questions and requests for additional copies of the enclosed material may be directed to the information agent at its address and telephone number set forth on the back cover of the Offer to Purchase.

Very truly yours,

Georgeson, Inc.

NOTHING CONTAINED IN THIS DOCUMENT OR IN THE ENCLOSED DOCUMENTS WILL MAKE YOU OR ANY OTHER PERSON AN AGENT OF THE COMPANY, THE INFORMATION AGENT OR THE DEPOSITARY OR ANY AFFILIATE OF ANY OF THE FOREGOING, OR AUTHORIZE YOU OR ANY OTHER PERSON TO USE ANY DOCUMENT OR MAKE ANY STATEMENT ON BEHALF OF ANY OF THEM IN CONNECTION WITH THE OFFER OTHER THAN THE DOCUMENTS ENCLOSED AND THE STATEMENTS CONTAINED IN THEREIN.

Exhibit (a)(1)(vi)

OFFER TO PURCHASE FOR CASH

RAND WORLDWIDE, INC.

UP TO 27,530,816 SHARES OF COMMON STOCK OF RAND WORLDWIDE, INC.

AT A PURCHASE PRICE OF $1.20 PER SHARE

To Our Clients:

Enclosed for your consideration are the Offer to Purchase, dated October 3, 2014 (the “Offer to Purchase”), and the related Letter of Transmittal (which, together with any amendments or supplements thereto, collectively constitute the “Offer”), in connection with the offer by Rand Worldwide, Inc. (“Rand” or the “Company”) to purchase for cash up to 27,530,816 shares of its common stock, $0.01 par value per share, at a price, less any applicable withholding taxes and without interest, of $1.20 per share, on the terms and subject to the conditions of the Offer. Unless the context otherwise requires, all references to the shares shall refer to the common stock of the Company.

The Company will purchase shares on the terms and subject to the conditions of the Offer, including the proration provisions and “odd lot” provisions contained therein. The Company reserves the right, in its sole discretion, to increase the number of shares it purchases by an amount that does not exceed 2% of its outstanding shares.

WE ARE THE OWNER OF RECORD OF SHARES HELD FOR YOUR ACCOUNT. AS SUCH, WE ARE THE ONLY ONES WHO CAN TENDER YOUR SHARES, AND THEN ONLY PURSUANT TO YOUR INSTRUCTIONS. WE ARE SENDING YOU THE LETTER OF TRANSMITTAL FOR YOUR INFORMATION ONLY; YOU CANNOT USE IT TO TENDER SHARES WE HOLD FOR YOUR ACCOUNT.

Please instruct us as to whether you wish us to tender any or all of the shares we hold for your account on the terms and subject to the conditions of the Offer.

Please note the following:

1. You may tender your shares at a price of $1.20 per share, as indicated in the attached Instruction Form, without interest.

2. You should consult with your broker or other financial or tax advisor on the possibility of designating the priority in which your shares will be purchased in the event of proration.

3. The Offer is not conditioned on any minimum number of shares being tendered. However, the Offer is subject to certain other conditions. See Section 10 of the Offer to Purchase.

4. The Offer, withdrawal rights and proration period will expire at 5:00 p.m., New York City time, on Monday, November 3, 2014, unless the Company extends the Offer.

5. The Offer is for 27,530,816 shares, constituting approximately 50.5% of the total number of outstanding shares of the common stock of Rand.

6. Tendering stockholders who are registered stockholders or who tender their shares directly to American Stock Transfer & Trust Company, LLC (the “Depositary”) will not be obligated to pay any brokerage commissions or fees to the Company, solicitation fees, or, except as set forth in the Offer to Purchase and the Letter of Transmittal, stock transfer taxes on the Company’s purchase of shares under the Offer. Shareholders holding shares in a brokerage account or otherwise through brokers, dealers, commercial banks, trust companies or other nominees are urged to consult their brokers or such other nominees to determine whether transaction costs may apply if shareholders tender shares through such brokers or other nominees and not directly to the Depositary.

7. If you are an Odd Lot Holder and you instruct us to tender on your behalf all of the shares that you own before the expiration of the Offer and check the box captioned “Odd Lots” on the attached Instruction Form, the Company will, on the terms and subject to the conditions of the Offer, accept all such shares for purchase before proration, if any, of the purchase of other shares properly tendered and not properly withdrawn.

If you wish to have us tender any or all of your shares, please so instruct us by completing, executing, detaching and returning to us the attached instruction form. If you authorize us to tender your shares, we will tender all such shares unless you specify otherwise on the attached Instruction Form.

YOUR PROMPT ACTION IS REQUESTED. YOUR INSTRUCTION SHEET SHOULD BE FORWARDED TO US IN AMPLE TIME TO PERMIT US TO SUBMIT A TENDER ON YOUR BEHALF BEFORE THE EXPIRATION OF THE TENDER OFFER. PLEASE NOTE THAT THE TENDER OFFER AND WITHDRAWAL RIGHTS WILL EXPIRE AT 5:00 P.M., NEW YORK CITY TIME, ON NOVEMBER 3, 2014, UNLESS THE OFFER IS EXTENDED.

The Offer is being made solely under the Offer to Purchase and the related Letter of Transmittal and is being made to all record holders of shares of common stock of Rand. The Offer is not being made to, nor will tenders be accepted from or on behalf of, holders of shares of common stock of the Company residing in any jurisdiction in which the making of the Offer or acceptance thereof would not be in compliance with the securities, blue sky or other laws of such jurisdiction.

RAND’S BOARD OF DIRECTORS HAS APPROVED MAKING THE OFFER. HOWEVER, NEITHER RAND NOR ANY MEMBER OF ITS BOARD OF DIRECTORS, THE INFORMATION AGENT OR THE DEPOSITARY MAKES ANY RECOMMENDATION TO STOCKHOLDERS AS TO WHETHER THEY SHOULD TENDER OR REFRAIN FROM TENDERING THEIR SHARES. STOCKHOLDERS MUST MAKE THEIR OWN DECISION AS TO WHETHER TO TENDER THEIR SHARES AND, IF SO, HOW MANY SHARES TO TENDER. IN DOING SO, STOCKHOLDERS SHOULD READ CAREFULLY THE INFORMATION IN THE OFFER TO PURCHASE AND IN THE RELATED LETTER OF TRANSMITTAL, INCLUDING THE COMPANY’S REASONS FOR MAKING THE OFFER. SEE SECTION 2 OF THE OFFER TO PURCHASE. STOCKHOLDERS SHOULD DISCUSS WHETHER TO TENDER THEIR SHARES WITH THEIR BROKER OR OTHER FINANCIAL OR TAX ADVISOR. SEVERAL OF RAND’S DIRECTORS AND EXECUTIVE OFFICERS HAVE ADVISED RAND THAT THEY INTEND TO TENDER UP TO A SPECIFIED AMOUNT OF SHARES BENEFICIALLY OWNED BY THEM IN THE OFFER. SEE SECTION 12 OF THE OFFER TO PURCHASE.

INSTRUCTION FORM

WITH RESPECT TO

OFFER TO PURCHASE FOR CASH

RAND WORLDWIDE, INC.

UP TO 27,530,816 SHARES OF COMMON STOCK OF RAND WORLDWIDE, INC.

AT A PURCHASE PRICE OF $1.20 PER SHARE

The undersigned acknowledge(s) receipt of your letter and the enclosed Offer to Purchase, dated October 3, 2014 (the “Offer to Purchase”), and the related Letter of Transmittal (which, together with any amendments or supplements thereto, collectively constitute the “Offer”), in connections with the offer by Rand Worldwide, Inc. (“Rand” or the “Company”) to purchase for cash up to 27,530,816 shares of its common stock, $0.01 par value per share, at a price, less any applicable withholding taxes and without interest, of $1.20 per share, on the terms and subject to the conditions of the Offer. Unless the context otherwise requires, all references to the shares shall refer to the common stock of the Company.

The undersigned hereby instruct(s) you to tender to the Company the number of shares indicated below or, if no number is indicated, all shares you hold for the account of the undersigned, on the terms and subject to the conditions of the Offer.

Number of shares to be tendered by you for the account of the undersigned:

shares*

* Unless otherwise indicated, it will be assumed that all shares held by us for your account are to be tendered.

ODD LOTS

(See Instruction 12 of the Letter of Transmittal)

To be completed only if shares are being tendered by or on behalf of a person owning, beneficially or of record, an aggregate of fewer than 100 shares.

¨ By checking this box, the undersigned represents that the undersigned owns, beneficially or of record, an aggregate of fewer than 100 shares and is tendering all of those shares.


Account Number:



Signature(s):


Print Name(s):



Address(es):



Area Code and Telephone Number:



Taxpayer Identification or Social Security Number:



Date:

Exhibit (a)(5)

FOR IMMEDIATE RELEASE

Rand Worldwide Announces Commencement of Self-Tender Offer

For Shares of its Common Stock

FRAMINGHAM, MA – October 3, 2014 – Rand Worldwide, Inc. (OTCBB: RWWI), a global provider of technology solutions to organizations with engineering design and information technology requirements, announced today the commencement of its previously announced tender offer to repurchase up to 27,530,816 shares of its common stock at a purchase price of $1.20 per share. The number of shares sought in the tender offer represents approximately 50.5% of the Company’s shares currently outstanding, or approximately 46% on a fully diluted basis. On September 26, 2014, the last trading day before the Company announced its intention to conduct the Offer, the closing price per share of the Company’s common stock was $1.15.

Participation in the tender offer by Company stockholders is voluntary and stockholders will not be required to tender any shares. If Company stockholders tender more than 27,530,816 shares, the Company will purchase shares from all stockholders who properly tendered shares, on a pro rata basis based on the aggregate number of shares tendered. If individual stockholders holding fewer than 100 shares tender all of their shares, the Company will accept those shares first, without proration.

The Company expects to enter into a new credit facility in connection with the tender offer, which is expected to include a revolving credit facility of $10 million and a term loan of $25 million, with approximately $25 million expected to be used to repurchase shares together with cash on hand of approximately $9.5 million. The Company has received a commitment letter from the lending bank relating to the new credit facility, and the Company is currently negotiating the terms of the credit facility. The tender offer will not be conditioned upon any minimum number of shares being tendered, but will be subject to the completion of the new credit facility and other customary conditions that are described in the tender offer documents.

The tender offer documents also contain tendering instructions and a complete explanation of the tender offer’s terms and conditions. Such documents, including the Offer to Purchase and the related Letter of Transmittal, are being distributed to Company stockholders. Company stockholders may also obtain copies of the Offer to Purchase, related materials filed by the Company as part of the statement on Schedule TO, and other documents filed with the Securities and Exchange Commission through the SEC’s website at www.sec.gov without charge. Stockholders may also obtain a copy of these documents, as well as any other documents the Company has filed with the SEC, without charge, by contacting the Company or through the Company’s website at www.rand.com. Stockholders are urged to carefully read these materials prior to making any decision with respect to the tender offer.

The Company is making the offer for the purpose of maximizing shareholder value and providing its shareholders an opportunity for liquidity in its common stock, which is not heavily traded. The Company’s largest stockholder, RWWI Holdings LLC, sold 9,000,000 of its shares of Company common stock to another existing stockholder on September 26, 2014 at a price of $1.20 per share and has indicated that it plans to tender its remaining shares in the tender offer, subject to proration if applicable.

The tender offer will expire at 5:00 p.m., New York City time, on Monday, November 3, 2014, unless extended or earlier terminated by the Company. Company stockholders who wish to tender their shares must properly tender their shares on or prior to the expiration of the tender offer. Tendered shares may be withdrawn at any time on or prior to the expiration of the tender offer.

The information agent for the tender offer is Georgeson, Inc. The depositary is American Stock Transfer & Trust Company, LLC. The Offer to Purchase, Letter of Transmittal and related documents are being mailed to stockholders of record and also will be made available for distribution to beneficial owners of the Company’s common stock. For questions and information, please call the Information Agent toll free at (866) 357-4029.

None of the Company, its directors, the information agent, or the depositary makes any recommendation as to whether to tender shares. Stockholders are urged to carefully review the tender offer documents prior to making any decision with respect to the tender offer.

THIS PRESS RELEASE IS FOR INFORMATIONAL PURPOSES ONLY AND DOES NOT CONSTITUTE AN OFFER TO BUY OR THE SOLICITATION OF AN OFFER TO SELL SHARES OF RAND WORLDWIDE, INC. COMMON STOCK. THE TENDER OFFER IS BEING MADE ONLY PURSUANT TO THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS THAT RAND IS DISTRIBUTING TO ITS STOCKHOLDERS AND FILING WITH THE SECURITIES AND EXCHANGE COMMISSION. STOCKHOLDERS AND INVESTORS SHOULD READ CAREFULLY THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND RELATED MATERIALS BECAUSE THEY CONTAIN IMPORTANT INFORMATION, INCLUDING THE VARIOUS TERMS OF, AND CONDITIONS TO, THE TENDER OFFER. STOCKHOLDERS AND INVESTORS MAY OBTAIN A FREE COPY OF THE TENDER OFFER STATEMENT ON SCHEDULE TO, THE OFFER TO PURCHASE, LETTER OF TRANSMITTAL AND OTHER DOCUMENTS THAT RAND FILES WITH THE SECURITIES AND EXCHANGE COMMISSION AT THE COMMISSION’S WEBSITE AT WWW.SEC.GOV OR BY CALLING GEORGESON, INC., THE INFORMATION AGENT FOR THE TENDER OFFER, TOLL-FREE AT (866) 357-4029. STOCKHOLDERS ARE URGED TO CAREFULLY READ THESE MATERIALS PRIOR TO MAKING ANY DECISION WITH RESPECT TO THE TENDER OFFER.

Forward-looking Statement

This press release contains forward-looking statements about the expectations, beliefs, plans, intentions, and strategies of Rand Worldwide, Inc. There are a number of important factors that could cause actual results to differ materially from those anticipated by any forward-looking information. Statements that are not historical in nature, including those that include the words “goal,” “expect,” “anticipate,” “estimate,” “should,” “believe,” “intend,” and similar expressions, are based on current expectations, estimates and projections about, among other things, the industry and the markets in which Rand Worldwide operates, and they are not guarantees of future performance. Whether actual results will conform to expectations and predictions is subject to known and unknown risks and uncertainties, including risks and uncertainties discussed in this report; general economic, market, or business conditions; changes in interest rates, and demand for our products and services; changes in our competitive position or competitive actions by other companies; the ability to manage growth; changes in laws or regulations or policies of federal and state regulators and agencies; and other circumstances beyond our control. Consequently, all of the forward-looking statements made in this document are qualified by these cautionary statements, and there can be no assurance that the actual results anticipated will be realized, or, if substantially realized, will have the expected consequences on our business or operations.

About Rand Worldwide

Rand Worldwide is one of the world’s leading professional services and technology companies for the engineering community, targeting organizations in the building, infrastructure, and manufacturing industries. The company advances the way organizations design, develop, and manage building, infrastructure, and manufacturing projects. Fortune 500 and Engineering News Record’s Top 100

companies work with Rand Worldwide to gain a competitive advantage through technology consulting, implementation, training, and support services. One of the world’s largest integrators of Autodesk software, the company also provides facilities management software from ARCHIBUS, CAD and PLM courseware through their ASCENT division and provides training and support solutions on Dassault Systèmes and PTC products. For more information, visit rand.com

Rand Worldwide Company Contact

Chantale Marchand

Rand Worldwide

Phone +1 (508) 663-1411

cmarchand@rand.com

Any and all trademarks making reference to or related to Rand Worldwide, IMAGINiT, ASCENT or ProductivityNOW are registered and/or owned by Rand Worldwide, Inc., and/or its subsidiaries, affiliates, and/or other legal holders under the Rand Worldwide, Inc. name.

Exhibit (b)(1)

LOGO

September 26, 2014

Rand Worldwide, Inc.

Senior Secured Credit Facility

Commitment Letter

Rand Worldwide, Inc.

11201 Dolfield Blvd.

Owings Mills, MD 21117

Attention: Lawrence Rychlak, President and Chief Financial

Officer Ladies and Gentlemen:

Rand Worldwide, Inc. (the “Borrower” or “you”) has requested that JPMorgan Chase Bank, National Association (“JPMCB”), agree to structure and arrange a senior secured credit facility consisting of a revolving credit facility in an aggregate amount of up to $10,000,000 (the “Revolving Facility”) and a term loan facility in the amount of $25,000,000 (the “Term Facility” and together with the Revolving Facility, the “Facility”), and that JPMCB commit to provide all of the Facility and to serve as administrative agent for the Facility.

JPMCB is pleased to advise you that it is willing to act as exclusive arranger for the Facility and of its commitment to fund the Facility upon the terms and subject to the conditions set forth or referred to in this commitment letter (the “Commitment Letter”) and in the Summary of Terms and Conditions attached hereto as Exhibit A (the “Term Sheet”).

You agree that, other than with respect to JPMCB, no other agents, co-agents or arrangers will be appointed, no other titles will be awarded and no compensation (other than that expressly contemplated by the Term Sheet and the Fee Letter referred to below) will be paid in connection with the Facility unless you and we shall so agree.

To assist JPMCB in its diligence efforts, you agree promptly to prepare and provide to JPMCB and its subsidiaries all information with respect to Borrower and the transactions contemplated hereby, including all financial information and projections (the “Projections”), as JPMCB may reasonably request in connection with its diligence. You hereby represent and covenant that (a) all information, other than the Projections, forward looking statements and other information of a general economic or industry nature (the “Information”), that has been or will be made available to JPMCB by you or any of your representatives on your behalf in connection with the transactions contemplated hereby, when taken as a whole, is or will be, when furnished, complete and correct in all material respects and does not or will not, when furnished, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein not misleading in light of the circumstances under which such statements were or are made and (b) the Projections that have been or will be made available to JPMCB by you or any of your representatives have been or will be prepared in good faith based upon assumptions believed by you to be reasonable when made; it being understood that the Projections are as to future events and are not to be viewed as facts or a guarantee of financial performance or achievement, the

Rand Worldwide, Inc.

September 26, 2014

Page 2

Projections are subject to significant uncertainties and contingencies, many of which are beyond your control, that no assurance can be given that any particular Projections will be realized and that actual results during the period or periods covered by any such Projections may differ significantly from the projected results and such differences may be material. You agree that if at any time prior to the consummation of transactions contemplated by this Commitment Letter, you become aware that any of the foregoing representations would be incorrect in any material respect if the Information and Projections were being furnished, and such representations were being made, at such time, then you will promptly supplement, or cause to be supplemented, the Information and Projections so that such representations will be correct in all material respects under those circumstances. You understand that in arranging and underwriting the Facility we may use and rely on the Information and Projections without independent verification thereof.

As consideration for JPMCB’s commitment hereunder, you agree to pay to JPMCB the nonrefundable fees set forth in the Fee Letter dated the date hereof and delivered herewith (the “Fee Letter”) at the times and subject to the conditions specified therein.

JPMCB’s commitment hereunder is subject to (a) there not occurring or becoming known to us any material adverse condition or material adverse change in or affecting the business, operations, property or condition (financial or otherwise) of Borrower and its subsidiaries, taken as a whole, since the date of the most recent audited financial statements, (b) our not becoming aware after the date hereof of any information or other matter affecting Borrower or the transactions contemplated hereby which is inconsistent in a material and adverse manner with any such information or other matter disclosed to us prior to the date hereof, (c) there not having occurred a material disruption of or material adverse change in financial, banking, or capital market conditions, (d) the negotiation, execution and delivery on or before November 14, 2014 of definitive agreements and documentation including a credit agreement, security and pledge agreement and other loan documentation (collectively the “Loan Documentation”) consistent with the Term Sheet and otherwise mutually satisfactory to JPMCB, its counsel and you, and (e) the other conditions set forth or referred to in the Term Sheet. The terms and conditions of JPMCB’s commitment hereunder and of the Facility are not limited to those set forth herein and in the Term Sheet. Those matters that are not covered by the provisions hereof and of the Term Sheet are subject to the approval and agreement of JPMCB and Borrower.

You agree (a) to indemnify and hold harmless JPMCB and its affiliates’ respective officers, directors, employees, advisors, representatives, and agents (each, an “indemnified person”) from and against any and all losses, claims, damages and liabilities to which any such indemnified person may become subject arising out of or in connection with this Commitment Letter, the Information, the Facility, the use of the proceeds thereof or any related transaction or any claim, litigation, investigation or proceeding relating to any of the foregoing, regardless of whether any indemnified person is a party thereto, and to reimburse each indemnified person upon demand for reasonable legal expenses and other expenses incurred in connection with investigating or defending any of the foregoing, provided that the foregoing indemnity will not, as to any indemnified person, apply to losses, claims, damages, liabilities or related expenses to the extent they are found by a final judgment of a court to arise from the willful misconduct or gross negligence of such indemnified person or the material breach in bad faith by such indemnified person of its express obligations under this commitment letter, and (b) to reimburse an indemnified person on demand for all reasonable and documented out-of-pocket expenses (including reasonable and documented due diligence expenses, travel expenses, and reasonable fees, charges and disbursements of counsel) incurred in connection with the Facility and any related documentation (including this Commitment Letter, the Term Sheet, the Fee Letter and the Loan Documentation) or the

Rand Worldwide, Inc.

September 26, 2014

Page 3

administration, amendment, modification or waiver thereof. No indemnified person shall be liable for any damages arising from the use by others of Information or other materials obtained through electronic, telecommunications or other information transmission systems other than as a result of the willful misconduct or gross negligence of such indemnified person, or for any special, indirect, consequential or punitive damages in connection with the Facilities. No indemnified person shall be liable for any indirect or consequential damages in connection with its activities related to the Facility.

This Commitment Letter shall not be assignable by you without the prior written consent of JPMCB (and any purported assignment without such consent shall be null and void ab initio), is intended to be solely for the benefit of the parties hereto and is not intended to confer any benefits upon, or create any rights in favor of, any person other than the parties hereto. In the event JPMCB assigns any portion of its commitment under the Facility on or prior to November 14, 2014, JPMCB shall remain liable for funding any such assigned commitment to the extent that the assignee does not fund such assigned commitment. This Commitment Letter may not be amended or waived except by an instrument in writing signed by you and JPMCB. This Commitment Letter may be executed in any number of counterparts, each of which shall be an original, and all of which, when taken together, shall constitute one agreement. Delivery of an executed signature page of this Commitment Letter by facsimile or electronic transmission shall be effective as delivery of a manually executed counterpart hereof. This Commitment Letter and the Fee Letter are the only agreements that have been entered into among us with respect to the Facility and set forth the entire understanding of the parties as of the date hereof with respect thereto.

This Commitment Letter shall be governed by, and construed in accordance with, the laws of the State of New York. Borrower consents to the nonexclusive jurisdiction and venue of the state or federal courts located in the City of New York. Borrower and JPMCB each irrevocably waive, to the fullest extent permitted by applicable law, (a) any right each may have to trial by jury in any suit, action, proceeding, claim or counterclaim brought by or on behalf of any party related to or arising out of the this Commitment Letter, the transactions contemplated by this Commitment Letter or the performance of services hereunder, the Term Sheet or the Fee Letter (whether based on contract, tort or any other theory) and (b) any objection that each may now or hereafter have to the laying of venue of any such legal proceeding in the state or federal courts located in the City of New York.

This Commitment Letter is delivered to you on the understanding that neither this Commitment Letter, the Term Sheet or the Fee Letter nor any of their terms or substance shall be disclosed, directly or indirectly, to any other person without prior written approval of JPMCB (such approval not to be unreasonably withheld or delayed) except (a) to your officers, directors, agents, employees, attorneys, accountants and advisors, controlling persons or equity holders on a confidential basis who are directly involved in the consideration of this matter and for whom you shall be responsible for any breach by any one of them of this confidentiality undertaking; (b) pursuant to the order of any court or administrative agency in any pending legal, judicial or administrative proceeding, or otherwise as required by applicable law or compulsory legal process or to the extent requested or required by governmental and/or regulatory authorities (in which case you agree to inform us promptly thereof, to the extent permitted by applicable law) or (c) to the extent advised by securities counsel to Borrower that filing this Commitment Letter is required under U.S. federal securities law, Borrower may file this Commitment Letter, and not the Fee Letter, with the U.S. Securities and Exchange Commission as an exhibit to an appropriate periodic report, registration statement or tender offer schedule.

JPMCB and its affiliates will use all proprietary and financial information provided to them by or on behalf of you solely for the purpose of providing the financing which is the subject of this

Rand Worldwide, Inc.

September 26, 2014

Page 4

Commitment Letter and shall not disclose, and shall treat confidentially, all such information; provided that nothing herein shall prevent them from disclosing any such information (i) to any lenders under the Facility (“Lenders”) or participants or prospective Lenders or participants via electronic or any other means, (ii) in any legal, judicial, administrative proceeding or other compulsory process or otherwise as required by applicable law or regulations (in which case we agree to inform you promptly thereof, to the extent permitted by applicable law), (iii) upon the request or demand of any regulatory authority having jurisdiction over JPMCB or its affiliates, (iv) to the employees, legal counsel, independent auditors, professionals and other experts or agents of JPMCB or its affiliates who are informed of the confidential nature of such information and are or have been advised of their obligation to keep such information confidential and who are directly involved in the consideration of this matter and for whom JPMCB shall be responsible for any breach by any one of them of this confidentiality undertaking, (v) in connection with the enforcement of this Commitment Letter, (vi) known by other means to JPMCB or its affiliates at the time of receipt, and (vii) to the extent any such information becomes publicly available other than by reason of disclosure by JPMCB or its affiliates in breach of this Commitment Letter.

You acknowledge that JPMCB and its affiliates may be providing debt financing, equity capital or other services (including financial advisory services) to other companies in respect of which you may have conflicting interests. Neither JPMCB nor its affiliates will use confidential information obtained from you by virtue of the transactions contemplated by this letter or their other relationships with you in connection with the performance by JPMCB of services for other companies, and neither JPMCB nor its affiliates will furnish any such information to other companies. You also acknowledge that JPMCB and its affiliates have no obligation to use in connection with the transactions contemplated by this Commitment Letter, or to furnish to you, confidential information obtained from others.

The compensation, reimbursement, indemnification and confidentiality provisions contained herein and in the Fee Letter shall remain binding and in full force and effect regardless of whether definitive financing documentation shall be executed and delivered and notwithstanding the termination of this Commitment Letter or JPMCB’s commitment hereunder; provided that the various parties’ obligations under such sections of this Commitment Letter shall be superseded by any corresponding provisions of the Loan Documentation addressing the matters which are the subject of such sections of this Commitment Letter.

JPMCB hereby notifies you that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26, 2001) (the “PATRIOT Act”), JPMCB is required to obtain, verify and record information that identifies Borrower, which information includes the name, address, tax identification number and other information regarding Borrower that will allow JPMCB to identify Borrower in accordance with the PATRIOT Act. This notice is given in accordance with the requirements of the PATRIOT Act. Borrower shall, promptly following a request by JPMCB, whether in its capacity as Administrative Agent or otherwise, provide all documentation and other information that it requests in order to comply with its ongoing obligations under applicable “know your customer” and anti-money laundering rules and regulations, including the PATRIOT Act.

Notwithstanding anything herein to the contrary, any party to this Commitment Letter (and any employee, representative or other agent of such party) may disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of the transactions contemplated by this Commitment Letter and the Fee Letter and all materials of any kind (including opinions or other tax analyses) that are provided to it relating to such tax treatment and tax structure, except that (i) tax treatment and tax structure shall not include the identity of any existing or future party (or any affiliate of such party)

Rand Worldwide, Inc.

September 26, 2014

Page 5

to this Commitment Letter or the Fee Letter and (ii) no party shall disclose any information relating to such tax treatment and tax structure to the extent nondisclosure is reasonably necessary in order to comply with applicable securities laws. For this purpose, the “tax treatment” of the transactions contemplated by this Commitment Letter and the Fee Letter is the purported or claimed U.S. federal income tax treatment of such transactions and the “tax structure” of such transactions is any fact that may be relevant to understanding the purported or claimed U.S. federal income tax treatment of such transactions.

If the foregoing correctly sets forth our agreement, please indicate your acceptance of the terms hereof and of the Term Sheet and the Fee Letter by returning to us executed counterparts hereof and of the Fee Letter not later than 5:00 p.m., New York City time, on September 29, 2014. JPMCB’s commitment herein will expire at such time if JPMCB has not received such executed counterparts in accordance with the immediately preceding sentence.

[signatures follow on the next page]

Rand Worldwide, Inc.

September 26, 2014

Page 6

JPMCB is pleased to have been given the opportunity to assist you in connection with this important financing.


Very truly yours,

JPMORGAN CHASE BANK,
NATIONAL ASSOCIATION

By:		/s/ Joan Morgan Higgins
Name:		Joan Morgan Higgins
Title:		Underwriter II

Accepted and agreed to as of the date first written above by:


RAND WORLDWIDE, INC.

By:	/s/ Lawrence Rychlak
	Name:	Lawrence Rychlak
	Title:	President and Chief Financial Officer

Signature page to commitment letter September 26, 2014

CREDIT FACILITY

Summary of Terms and Conditions

September 26, 2014


I.	Parties

	Borrower:	Rand Worldwide, Inc. (the “Borrower”).

	Guarantors:	See below.

	Administrative Agent:	JPMorgan Chase Bank, National Association (“JPMCB” and, in such capacity, the “Administrative Agent”).

	Lender(s):	JPMCB.

II.	Revolving Credit Facility

	Type and Amount of Facility:	Five (5)- year revolving credit facility (the “Revolving Credit Facility”) in the amount of Ten Million United States Dollars ($10,000,000) (the “Aggregate Revolver Commitment”) and the loans thereunder, the “Revolving Credit Loans”).

	Amortization:	No principal will be required to be repaid under the Revolving Credit Facility until the Revolving Credit Termination Date (defined below), when, at such time, all outstanding principal under the Revolving Credit Loans shall be immediately due and payable.

	Interest:	LIBOR plus 250 bps; “LIBOR” means the rate at which eurodollar deposits in the London interbank market for one, two, three or six months (as selected by Borrower) are quoted on the Telerate screen, as adjusted for statutory reserve requirements for eurocurrency liabilities. Administrative Agent may convert LIBOR to ABR if unavailable or infeasible. “ABR” means the greater of JPMCB’s prime rate or the federal funds effective rate plus 50 bps.

	Availability:	The Revolving Credit Facility shall be available on a revolving basis during the period commencing on the Closing Date and ending on the fifth anniversary of the Closing Date unless earlier terminated (the “Revolving Credit Termination Date”).

	Borrowing Base:	Availability under the Revolving Credit Facility shall be subject to satisfying Borrowing Base requirements based on an 85% advance rate against eligible receivables established by Credit Documentation validated by periodic field exams and other reviews. Advances in excess of the Borrowing Base shall be immediately due and payable.



		Commitment Fee:		A commitment fee equal to 25 bps shall apply against the average daily unused portion of the Aggregate Revolver Commitment, payable quarterly in arrears from the Closing Date until termination of the Aggregate Revolver Commitment.

		Letters of Credit:		A portion of the Revolving Credit Facility not in excess of One Million Dollars ($1,000,000) shall be available for the issuance of letters of credit (the “Letters of Credit”) by JPMCB (in such capacity, the “Issuing Lender”). No Letter of Credit shall have an expiration date after the earlier of (a) one year after the date of issuance and (b) five (5) business days prior to the Revolving Credit Termination Date, provided that any Letter of Credit with a one-year tenor may provide for the renewal thereof for additional one-year periods (which shall in no event extend beyond the date referred to in clause (b) above unless cash collateralized). The commitment to issue any Letter of Credit shall terminate thirty (30) days before the Revolving Credit Termination Date.

				Any drawing under any Letter of Credit shall be reimbursed by Borrower (whether with its own funds or with the proceeds of Revolving Credit Loans) on the same business day as the drawing. To the extent that the Borrower does not so reimburse the Issuing Lender, such drawing shall be deemed a request by the Borrower for the funding of a Revolving Credit Loan in such amount, provided that all conditions to an on-going borrowing under the Revolving Credit Facility are satisfied.

		Letter of Credit Fees:		Borrower shall pay a commission on all outstanding Letters of Credit at a per annum rate equal to 150 bps on the face amount of each such Letter of Credit. Such commission shall be shared ratably among the Lenders in accordance with their respective Revolving Facility commitment and shall be payable quarterly in arrears.

		Maturity:		The Revolving Credit Termination Date (five years after the Closing Date).

		Purpose:		The proceeds of the Revolving Credit Loans shall be used to finance the working capital needs, and for the general corporate purposes, of Borrower and its subsidiaries and to pay fees in connection with the Credit Facility (defined below) closing.


III.	Term Loan Facility

	Type and Amount of Facility:	Five (5)- year amortizing term loan facility (the “Term Loan Facility” and together with the Revolving Credit Facility, the “Credit Facility”) in the amount of up to Twenty-Five Million United States Dollars ($25,000,000) subject to reduction in connection with a Tender Offer Proration (defined below) (the “Term Commitment”) and the loans thereunder, the “Term Loans”).

	Amortization:	Term Loan principal shall be repaid pursuant to the following amortization schedule: for the first year following the Closing Date, 15% of original Term Loan principal to be paid in quarterly installments; for the second year following the Closing Date, 15% of original Term Loan principal to be paid in quarterly installments; for the third year following the Closing Date, 20% of original Term Loan principal to be paid in quarterly installments; for the fourth year following the Closing Date, 25% of original Term Loan principal to be paid in quarterly installments and for the fifth year following the Closing Date, 25% of original Term Loan principal to be paid in quarterly installments.

	Interest:	LIBOR plus 315 bps.

	Maturity:	The Term Loans shall mature on the fifth anniversary of the Closing Date.

	Purpose:	The proceeds of the Term Loans shall be used to repurchase 27,530,816 shares of Borrower’s outstanding common stock in an issuer tender offer (the “Tender Offer”). If holders of Borrower’s equity securities tender less than 27,530,816 shares of Borrower’s outstanding common stock in connection with the Tender Offer, the Term Commitment shall adjust downward to an amount no greater than 75.67% of the amount necessary to fund the repurchase of the Borrower’s common stock actually tendered (the “Tender Offer Proration”).

* * *

COLLATERAL AND OTHER CREDIT SUPPORT

	Collateral:	The Facility will be secured by a first priority perfected security interest in and mortgage on all of the assets of the Borrower and the Guarantors (as defined below), whether owned on the Closing Date or thereafter acquired, and whether consisting of personal, tangible or intangible property, (including all of the outstanding shares of capital stock of the Borrower’s domestic subsidiaries and no more than 65% of the outstanding voting equity interests of any non-U.S. subsidiary to the extent that the pledge of a greater


				percentage would result in adverse tax consequences for the Borrower) (together with the Pledged Stock, but excluding the Excluded Assets (as defined below), collectively, the “Collateral”). The Collateral will also secure all cash management products and interest rate and foreign currency hedging obligations owing to any Lender or an affiliate of any Lender.

				Notwithstanding anything herein to the contrary, the Collateral shall exclude the following: (i) pledges and security interests prohibited by applicable law, rule or regulation or which would require governmental (including regulatory) consent, approval, license or authorization with respect to such pledge unless such consent, approval, license or authorization has been received; and (ii) any lease, license or other agreement or any property subject to a purchase money security interest, capital lease obligation or similar arrangements, in each case, to the extent permitted under the Revolving Credit Facility, or to the extent that a grant of a security interest in such lease, license or other agreement would require a third party consent that would violate or invalidate such lease, license or agreement, purchase money, capital lease or a similar arrangement or create a right of termination in favor of any other party thereto (other than Borrower or any subsidiary) (the foregoing described in clauses (i) and (ii) collectively, the “Excluded Assets”).

				All the above-described pledges, security interests and mortgages shall be created on terms, and pursuant to documentation, reasonably satisfactory to Administrative Agent and Lender (including, in the case of real property acquired after the Closing (it being understood that neither Borrower nor any of its subsidiaries owns any real property), by customary items such as satisfactory title insurance and surveys), and none of the Collateral shall be subject to any other liens (other than liens expressly permitted by the Credit Documentation).

		Guaranties:		The Borrower’s direct and indirect domestic subsidiaries (and, to the extent that no adverse tax consequences to the Borrower would result therefrom, foreign subsidiaries) (collectively, the “Guarantors”) shall unconditionally guarantee all of the indebtedness, obligations and liabilities of the Borrower arising under or in connection with the loan documents; provided that the Guarantors shall not include, (a) any subsidiary that either (i)(A) does not conduct any business operations, (B) has assets with a total book value not in excess of $50,000 and (C) does not have any indebtedness outstanding, or (b) is a direct or indirect subsidiary of the Borrower formed for purposes of effecting an acquisition which subsidiary is formed with the intention of meeting, and within one year after the consummation of such acquisition meets, the criteria set forth in clause (a)


		above; provided that at no time shall this clause (b) include any such subsidiary holding 5% or more individually and 10% in the aggregate of the consolidated assets, revenue or Consolidated EBITDA of the Borrower or be used for circumventing the Collateral requirements of the Credit Documentation.

III.	Certain Payment Provisions

	Fees:	As set forth in Fee Letter.

	Interest Payment Dates:	In the case of Loans bearing interest based upon the ABR (“ABR Loans”), quarterly in arrears.

		In the case of Loans bearing interest based upon the adjusted LIBOR (“Eurodollar Loans”), on the last day of each relevant interest period and, in the case of any interest period longer than three months or 90 days, as the case may be, on each successive date three months or 90 days, as the case may be, after the first day of such interest period.

	Default Rate:	At any time when a payment default or other default, in the Lender’s discretion, is continuing under the Facility, the applicable interest rate on principal obligations under the Term Loan Facility shall increase to 2% above the rate otherwise applicable thereto. Overdue interest under either the Revolving Facility or the Term Facility, fees and other amounts shall bear interest at 2% above the rate applicable to ABR Loans.

	Rate and Fee Basis:	All per annum rates shall be calculated on the basis of a year of 360 days (or 365/366 days, in the case of ABR Loans the interest rate payable on which is then based on the Prime Rate) for actual days elapsed.

	Voluntary Prepayments:	Voluntary prepayments of borrowings under the Revolving Credit Facility, in whole or in part, will be permitted at any time, without premium or penalty other than customary breakage costs, to the extent applicable.

	Mandatory Prepayments:	Mandatory Term Loan principal pre-payment equal to (i) 50% of Excess Cash Flow, subject to reduction to 0.00% of Excess Cash Flow when actual total leverage is less than 1.50 to 1.00 and when the total leverage covenant is set at 2.25 to 1.00, and (ii) 100% of net proceeds of asset sales other than assets sold in the ordinary course of business and proceeds from asset sales to the extent such proceeds are reinvested within 180 days agreed upon baskets and exceptions, and (iii) 100% of net proceeds from issuances of any equity of Borrower or any guarantor, subject to mutually agreed upon baskets and exceptions.


IV.	Certain Conditions

	Initial Conditions:	The availability of the Revolving Credit Facility shall be conditioned upon satisfaction of, among other things, the following conditions precedent (the date upon which all such conditions precedent shall be satisfied, the “Closing Date”) on or before November 14, 2014:

		(a) The Borrower shall have executed and delivered definitive financing documentation with respect to the Credit Facility consistent with this Term Sheet and otherwise mutually satisfactory to JPMCB and Borrower (the “Credit Documentation”).

		(b) The Lender(s) and the Administrative Agent shall have received all fees required to be paid, and all expenses for which invoices have been presented, on or before the Closing Date.

		(c) All governmental and third party approvals necessary in connection with the financing contemplated hereby and the continuing operations of Borrower and its subsidiaries (except those which the failure to so obtain would not result in a material adverse effect on Borrower and its subsidiaries taken as a whole) shall have been obtained and be in full force and effect.

		(d) The Lender(s) shall have received (i) satisfactory audited consolidated financial statements of Borrower for the fiscal year ended June 30, 2014 (to the extent delivered to Borrower by its auditors before the Closing Date) and (ii) satisfactory unaudited interim consolidated financial statements of the Borrower for each fiscal month and quarterly period (to the extent available to Borrower’s management before the Closing Date) ended subsequent to the date of the latest financial statements delivered pursuant to clause (i) of this paragraph as to which such financial statements are available including September 30 financial statements in the event that the Tender Offer is extended beyond October 31, 2014.

		(e) Borrower shall have maintained a trailing twelve month Consolidated EBITDA to Administrative Agent’s satisfaction of no less than $[11.8 million] for the period ended August 30, 2014.

		(f) Administrative Agent is satisfied with the pro-forma ownership structure of Borrower. Borrower shall have incurred no indebtedness other than in connection with the loans contemplated by this Term Sheet to close the transactions to reorganize its capital structure. Borrower shall have not effected any restructuring to its capital structure including any stock splits other than the Tender Offer.


		(g) 3K Limited Partnership shall have purchased no less than 9,000,000 shares of Borrower’s common stock from Ampersand Capital Partners.

		(h) All conditions to the consummation of the Tender Offer, other than the funding of the loans and use of proceeds contemplated hereby, have been satisfied or waived. Purchase price in connection with such Tender Offer shall not exceed $1.20 per share.

		(i) Administrative Agent and Lender(s) shall have received such legal opinions, documents and other instruments as are customary for transactions of this type.

	On-Going Conditions:	The making of each extension of credit shall be conditioned upon (a) the accuracy in all material respects of all representations and warranties in the Credit Documentation (including, without limitation, the material adverse change and litigation representations) as of the date of such extension of credit (except to the extent that such representation and warranty is made as of an earlier date, in which case such representation and warranty shall be true and correct in all material respects as of such earlier date) and (b) there being no default or Event of Default in existence at the time of, or after giving effect to the making of, such extension of credit. As used herein and in the Credit Documentation a “material adverse change” shall mean any event, development or circumstance that has had or would reasonably be expected to have a material adverse change on (a) the business, assets, property or condition (financial or otherwise) of the Borrower and its subsidiaries taken as a whole, or (b) the validity or enforceability of any of the Credit Documentation or the rights or remedies of the Administrative Agent and the Lenders thereunder.

V.	Certain Documentation Matters

		The Credit Documentation shall contain representations, warranties, covenants and Events of Default customary for financings of this type (which shall be subject to materiality thresholds, exceptions and grace periods, as agreed upon, and such other terms as agreed upon, including, without limitation:

	Representations and Warranties:	Financial statements; absence of undisclosed liabilities; no material adverse change; corporate existence; compliance with law, except where the failure to comply with would not reasonably be expected to have a material adverse change; corporate power and authority; enforceability of Credit Documentation; no conflict with law or contractual obligations; no litigation that would reasonably be expected to result in a material adverse effect; no default; ownership of property; liens; intellectual property; no burdensome restrictions; taxes; Federal Reserve regulations; ERISA; Investment Company Act; subsidiaries; environmental matters; labor matters; accuracy of disclosure.


		Affirmative Covenants:		Delivery of financial statements, reports, accountants’ letters, projections, officers’ certificates and other information reasonably requested by the Lenders; payment of other obligations; continuation of business and maintenance of existence and material rights and privileges; compliance with laws and material contractual obligations; maintenance of property (subject to casualty, condemnation and normal wear and tear) and insurance; maintenance of books and records; right of the Lenders to inspect property and books and records (subject to no more than once per year at the Borrower’s expense so long as there is no Event of Default); notices of defaults, material litigation and other material events; and compliance with environmental laws.

		Financial Covenants:		Financial covenants shall be limited to minimum fixed charge coverage (1.25 to 1.0), maximum total leverage (2.75 to 1.0 stepping down to 2.50 to 1.0 at 9/30/2015 and stepping down to 2.25 to 1.0 at 9/30/2016), and minimum trailing twelve month Consolidated EBITDA tested quarterly of (A) $10,000,000 and (B) $11,000,000 for the quarter ended 9/30/15 and thereafter until actual leverage declines below 1.50 to 1.00 and the total leverage covenant is then no greater than 2.25 to 1.00.

		Consolidated EBITDA:		Consolidated net income plus (i) consolidated interest expense, (ii) consolidated income tax expense, (iii) amounts attributable to depreciation and amortization, (iv) non-cash expenses associated with common stock based incentive compensation; (v) stock based compensation and CEO compensation, (vi) certain one-time expenses determined in the Credit Documentation, and (vii) expenses arising from divestiture of Rand Secure Data or other expenses to be mutually agreed upon less (a) all non-cash items of income and all extraordinary gains to the extent included in consolidated net income (all accounting treatment to be in accordance with US-GAAP).

		Negative Covenants:		Customary including limitations on indebtedness (including preferred stock of subsidiaries); liens, with customary exceptions; guarantee obligations, mergers, consolidations, liquidations and dissolutions; sales of assets; leases; dividends and other payments in respect of or repurchases of capital stock (excluding permitted preferred dividends not to exceed $125,000 in any one fiscal year); capital expenditures; investments, loans and advances and intercompany investments to support foreign subsidiaries, in each case, subject to limitations and customary exceptions to be mutually agreed; optional payments and modifications of subordinated and other debt instruments; transactions with affiliates; sale and leasebacks; charter provisions restricting dividends; changes in fiscal year; negative pledge clauses; and changes in lines of business.


		Events of Default:		Customary events of default including, without limitation, nonpayment of principal when due; nonpayment of interest, fees or other amounts after agreed grace period; material inaccuracy of representations and warranties; violation of covenants; cross-default and cross-acceleration to other material indebtedness; bankruptcy and insolvency events; certain ERISA events; material judgments not discharged or stayed within 60 days; change of control (the definition of which is to be agreed and, in any event, shall recognize an IPO); and actual or asserted invalidity of guarantees or security arrangements.

		Assignment		The Lender(s) shall be permitted to assign all or a portion of their loans and commitments with the consent, not to be unreasonably withheld, of (a) the Borrower, unless (i) the assignee is a Lender, an affiliate of a Lender or an approved fund or (ii) an Event of Default has occurred and is continuing, (b) the Administrative Agent and (c) the Issuing Bank.

				The Lenders shall also be permitted to sell participations in their Loans. Participants shall have derivative benefits through the Lenders with respect to yield protection and increased cost provisions. Participants shall have no direct voting rights under the Credit Documentation but may have derivative voting rights with respect to matters requiring approval of the Lenders to the extent such participant is directly and adversely affected thereby as described under “Voting” above. Pledges of Loans in accordance with applicable law shall be permitted without restriction.

		Yield Protection:		The Credit Documentation shall contain customary provisions (a) protecting the Lenders against increased costs or loss of yield resulting from changes in reserve, tax, capital adequacy and other requirements of law and from the imposition of or changes in withholding or other taxes and (b) indemnifying the Lenders for “breakage costs” incurred in connection with, among other things, any prepayment of a Eurodollar Loan on a day other than the last day of an interest period with respect thereto.

		Expenses and Indemnification:		The Borrower shall pay (a) all out-of-pocket expenses of the Administrative Agent associated with the preparation, execution, delivery and administration of the Credit Documentation and any amendment or waiver with respect thereto (including the reasonable and documented out-of- pocket fees, disbursements and other charges of counsel) and (b) all out-of-pocket expenses of the Administrative Agent and the Lenders (including the reasonable and documented fees, disbursements and other charges of counsel) in connection with the enforcement of the Credit Documentation.


				The Administrative Agent and the Lenders (and their affiliates and their respective officers, directors, employees, advisors and agents) will have no liability for, and will be indemnified and held harmless against, any loss, liability, cost or expense incurred in respect of the financing contemplated hereby or the use or the proposed use of proceeds thereof (except to the extent resulting from the gross negligence or willful misconduct of the indemnified party).

		Governing Law and Forum:		State of New York and will include customary jury waiver provisions.

		Counsel to the Administrative Agent:		Holland & Knight LLP.

* * *

Exhibit (d)(2)

RAND WORLDWIDE, INC.

Re:

Optionholder Notice and Acknowledgment

Acceleration of Options and Net Settlement

Dear Optionholder:

This letter relates to your stock option agreement(s) with Rand Worldwide, Inc. (the “Company”), each of which sets forth the terms of an option (each an “Option” and collectively, the “Options”) granted to you pursuant to the Company’s Omnibus Equity Compensation Plan or a predecessor plan that provides you the right to purchase the respective number of shares (each an “Option Share”) of the Company’s common stock at the respective exercise price per share set forth in such stock option agreement(s).

The Company is offering to repurchase shares of its common stock in a self-tender offer. The details of that tender offer are described in an Offer to Purchase document, which has been made available to you and can be found in the “Investor Center” section of the Company’s website or on the Securities and Exchange Commission’s website at www.sec.gov under “Filings.”

In connection with the tender offer, this letter serves as notice to you that the Company’s board of directors (the “Board”) has voted to accelerate the vesting schedule of all unvested Options effective September 29, 2014.

If you wish to participate in the tender offer by selling the Option Shares subject to your Options, you must exercise your Options and then tender the Option Shares.

To assist you in participating in this tender offer if you desire to do so, the Board has voted to allow option holders who wish to exercise their Options and participate in the tender offer to modify their Options to allow for payment of the Option exercise price pursuant to a net settlement program. Under the net settlement program, you will not be required to deliver payment of the exercise price of your Options in cash or by personal check in order to exercise your Options. Instead, upon the exercise of your Options, the Company will retain the number of Option Shares necessary to cover the cost of the exercise price and required tax withholding associated with the exercise of your Options. For the purposes of covering the cost of the exercise price and required tax withholding, the fair market value of your Option Shares will be deemed to be $1.20 per share, which is the same price per share at which the Company is offering to repurchase its shares in the tender offer. Following such net settlement, you will be issued the balance of the Option Shares, which will be available for participation in the tender offer.

Your ability to utilize a net settlement program to exercise your Options is conditioned on your tender of the balance of your Option Shares in the tender offer. To use a net settlement program you must: (i) agree to tender the balance of your Option Shares in the tender offer by signing the attached election form, (ii) exercise your Options as described below, and (iii) deliver a Letter of Transmittal tendering the balance of your Option Shares to the depositary for the tender offer as described in the Offer to Purchase.

You should understand that, with respect to any Options that are intended to qualify as Incentive Stock Options (“ISO”), the ability to use a net settlement program to exercise your Options will be considered a modification of the stock option, which will disqualify your Option from being treated as an ISO. We recommend you consult with your tax or financial advisor regarding any tax implications of this modification.

You are not required to use a net settlement program to exercise your Options to participate in the tender offer. You may pay the Option exercise price in cash or by personal check. You also may choose not to exercise your Options or participate in the tender offer. We urge you to read the Offer to Purchase document carefully when deciding whether to exercise your Options and participate in the tender offer.

If you choose to exercise options to participate in the tender offer, there can be no assurance that any such acquired shares you tender will be accepted by the Company and purchased for cash. The tender offer is subject to certain conditions, which may not be satisfied or waived, as outlined in Section 10 of the Offer to Purchase. Furthermore, in the event that more than 27,530,816 shares of the Company’s common stock are validly tendered in the tender offer, the Company will purchase only 27,530,816 shares in the aggregate, on a pro rata basis from all stockholders who have tendered shares. Thus, even if the tender offer is completed, the Company may not purchase all of the shares of common stock that you tender.

If you wish to modify your Options to pay the option exercise price through the use of a net settlement program, you must indicate your intent below and sign this agreement and return it to David Hummel in the Owings Mills office before October 24, 2014. If you do not sign and deliver this letter before October 24, 2014, you will have agreed NOT to modify your Options to permit payment of the Option exercise price pursuant to a net settlement program.

If you wish to modify your Options to pay the option exercise price through the use of a net settlement program, you must also complete the “notice of exercise” form(s) attached to your stock option agreement(s) and return the form(s) to the Company following the instructions on such form. Please note that the “notice of exercise” form is separate from this election to modify your Options. If you do complete and return this election to modify your Options by following the instructions above, you will not need to include cash payment with your notice of exercise. Please note that after you deliver your notice of exercise, it will take several days for the Company to process the exercise of your Options and for the Company’s transfer agent to issue your Option Shares in book entry form. You will then need to deliver a Letter of Transmittal to the depositary for the tender offer as described in the Offer to Purchase.

The tender offer is currently scheduled to expire at 5:00 p.m., New York City time, on November 3, 2014, unless it is extended as described in the Offer to Purchase (such time and date, as they may be extended, the “Expiration Date”). Notwithstanding the October 24, 2014 deadline for electing to use a net settlement exercise procedure, you must make sure to complete all paperwork in sufficient time for your Option Shares to be issued to you, and for you to complete the delivery of those shares to the depositary for the tender offer (as described in the Offer to Purchase), by the Expiration Date. Even if the Expiration Date of the Offer is extended, the October 24, 2014 deadline for electing to modify your Options to use a net settlement procedure will not be extended.

If you have any questions, please contact David Hummel at (410) 753-1545 or dhummel@rand.com.

Sincerely,

Lawrence Rychlak

President and Chief Financial Officer

This communication is for informational purposes only and does not constitute an offer to buy or the solicitation of an offer to sell shares of Rand Worldwide, Inc. common stock. The Company’s offer to buy shares of its common stock is being made only pursuant to the Offer to Purchase and the related materials dated October 3, 2014, as amended and supplemented from time to time. Stockholders and optionholders should read the Offer to Purchase and the related materials carefully because they contain important information. Stockholders may obtain a free copy of the tender offer statement on Schedule TO, the Offer to Purchase and other documents filed with the Securities and Exchange Commission at the Commission’s web site at www.sec.gov. Stockholders and optionholders may also obtain a copy of these documents, without charge, from the information agent, Georgeson, Inc., by calling toll free: 866-357-4029.

Our Board of Directors has approved the tender offer. However, neither we nor our Board of Directors, nor the information agent or the depositary for the tender offer, make any recommendation to you as to whether you should tender your shares. You must decide whether to tender your shares and, if so, how many shares to tender.

ELECTION TO MODIFY OPTIONS

TO ADD A NET SETTLEMENT PROGRAM


		Yes. I wish to modify my Options to allow for payment of the option exercise price through the use of a net settlement program.

		No. I do not wish to modify my Options to allow for payment of the option exercise price through the use of a net settlement program.

If you checked “Yes” above: By signing below, you agree to both: (i) exercise your Options and (ii) deliver a Letter of Transmittal tendering the balance of your Option Shares to the depositary for the tender offer as described in the Offer to Purchase.

Signature

Name of Optionholder

Option Agreement dated: Number of Shares: Exercise Price:

Rand Worldwide (PK) (USOTC:RWWI)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024